THUNDER 200:1 STRENGTH VERY POTENT
Proprietary herbal blend for men.
Beet
Butea superba
Cacao
Carnosine
Passion flower
Citrus sinensis
Damiana
Epimedium sagittatum
Ginseng
Grapefruit
Gynostemma
IcarIin
Kaempferia parviflor
Maca
Moringa oleifera
Pomegranate
Quercetin
Resveratrol
Rubus coreanus
Rutin
Scutellaria baicalensis
Sophora flavescens
Tongcat Ali
Warnings:
As with any supplement, consult your medical practitioner prior to using this product if you are pregnant, may become pregnant, breastfeeding, taking medication, other dietary supplements or have a medical condition. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
*Daily Value has not been established
Probiotic Microbes Sustain Youthful Serum Testosterone Levels and Testicular Size in Aging Mice
… -07 USE OF STROMAL VASCULAR VASCULOGENIC
… -07-008 Exploring the number of low intensity shock wave treatment (LiSWT) sessions needed in patients with VASCULOGENIC ERECTILE DYSFUNCTION
… -08 LONGITUDINAL RISK OF DEVELOPING CARDIO VASCULAR
… -label, Multicenter, Flexible Dose Study to Evaluate the Efficacy and Safety of Viagra (R)(Sildenafil Citrate) in Males with ERECTILE DYSFUNCTION HYPERTENSION
… -S&T-15 THE RELATIONSHIP BETWEEN DIETARY INTAKE AND ENDOTHELIAL FUNCTION AMONG THE VASCULOGENIC
… -term conventional treatment for overlap syndrome (obstructive sleep apnea and chronic obstructive PULMONARY
… ‐rated patient preference and patient‐and partner‐rated preference for tadalafil or sildenafil citrate: results from the Canadian ‘Treatment of Erectile Dysfunction’ …
… , and ERECTILE DYSFUNCTION HEART
… , Multicenter, Flexible Dose Study to Evaluate the Efficacy and Safety of Viagra®(Sildenafil Citrate) in Korean Men with ERECTILE DYSFUNCTION HYPERTENSION
… : EXPLORATION OF THE ASSOCIATION BETWEEN DIETARY INTAKE AND ENDOTHELIAL FUNCTION AMONG VASCULOGENIC
… : metode za očuvanje protoka Kroz unutrašnju ilijačnu arteriju.[Endo VASCULAR
… : POOLED ANALYSIS OF SATISFACTION WITH VARDENAFIL TREATMENT IN MEN WITH ERECTILE DYSFUNCTION
… . FTY720 supplementation partially improves ERECTILE DYSFUNCTION
… . J Sex Med 2007; 4: 226–30. This article was inadvertently listed as a Case Report. It should have been listed as Original Research—Erectile Dysfunction.
… ‘SEXUAL DYSFUNCTIONS: Women’s Sexual Function Improves When Partners Are Administered Vardenafil for Erectile Dysfunction: A Prospective, Randomized …
… /hydrogen sulfide pathway induces cGMP-dependent relaxation of corpus cavernosum and penile arteries from patients with ERECTILE DYSFUNCTION
… ®) on hemodynamic parameters during exercise testing and occurrence of ventricular arrhythmias in patients with ERECTILE DYSFUNCTION CARDIO VASCULAR
… 6.5. Prevalenta disfunctiei erectile la pacientii de sex masculin cu accident VASCULAR
… and 6-month durability of endo VASCULAR VASCULAR ERECTILE DYSFUNCTION
… and Distribution of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in 476 Patients with Erectile Dysfunction: Implications for Endo VASCULAR
… AND INCREASED AORTIC STIFFNESS AND PENILE VASCULAR ERECTILE DYSFUNCTION
… AND INFLAMMATION IN CORPUS CAVERNOSUM ARE INCREASED COMPARED TO ARM BLOOD
… and Partial Bladder Outlet Obstructed Rabbit Corpus Cavernosal Contractility: Modulation of Nitric Oxide-mediated Relaxation and Relevance to Erectile Dysfunction
… and stem cell therapy in the treatment of ERECTILE DYSFUNCTION PULMONARY HYPERTENSION
… AND WAVE REFLECTIONS ARE ASSOCIATED WITH PENILE DOPPLER FINDINGS IN PATIENTS WITH VASCULOGENIC
… ARTERIAL STIFFENING AND WAVE REFLECTIONS IN DIABETES: THE EFFECTS OF AUTONOMIC NEUROPATHY AND ERECTILE DYSFUNCTION
… ARTERY CALCIFICATIONS IN HEMODIALYSIS PATIENTS AND ITS CORRELATION WITH THE PREVALENCE OF ERECTILE DYSFUNCTION
… artery peak systolic velocity among normal adults in Abuja, Nigeria: A Baseline parameter for sonographic diagnosis of VASCULOGENIC
… Assessment of Prevalence and Distribution of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in Patients with Erectile Dysfunction
… assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner’s …
… Association Between Aortic Stiffness, Wave Reflections, and Duration of VASCULOGENIC ERECTILE DYSFUNCTION VASCULAR
… Association of the T-786C, G894T and 4a/4b Polymorphisms of the Endothelial Nitric Oxide Synthase Gene with VASCULOGENIC ERECTILE DYSFUNCTION
… between arterial stiffness, left ventricular geometry and the severity of erectile dysfunction: A ventriculoarterial interaction in ERECTILE DYSFUNCTION
… between the venous shunts of penile corpus spongiosum and cavernous compartments during erection used in the pharmacotherapy of erectile dysfunction.
… C-reactive protein are complementary determinants of global arterial function and early structural changes in HYPERTENSIVE
… cavernosal ARTERY VASCULAR
… CELLS AND REDUCES ENDOTHELIAL INFLAMMATORY MARKERS IN PATIENTS WITH ERECTILE DYSFUNCTION CARDIO VASCULAR
… characterization of population with ERECTILE DYSFUNCTION CARDIO VASCULAR ERECTILE DYSFUNCTION
… COURSE OF TREATMENT EFFECT OF AUTOLOGOUS ADIPOSE STROMAL VASCULAR
… crossover, placebo‐controlled comparative clinical trial of arginine aspartate plus adenosine monophosphate for the intermittent treatment of male erectile dysfunction
… Dimethylamini-Hydrolase Causes Elevation of Asymmetric Dimethyl Arginine in Atherosclerotic Rat Model of VASCULOGENIC
… displayer) for audiovisual sexual stimulation after oral phosphodiesterase type 5 (PDE 5) inhibitor medication for the diagnosis of VASCULOGENIC
… DOPPLER ULTRASOUND AS A DIAGNOSTIC TOOL FOR PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR VASCULOGENIC
… duplex ultrasonography in men with Peyronie’s disease: Is it veno‐occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?
… DYSFUNCTION DETECTED BY PERIPHERAL ARTERIAL TONOMETRY IS MORE PREVALENT IN MEN WITH ERECTILE DYSFUNCTION
… editor re: Giorgio Gandaglia, Alberto Briganti, Graham Jackson, et al. A systematic review of the association between ERECTILE DYSFUNCTION CARDIO VASCULAR
… embolization of an arteriovenous fistula from the arteria bulbi penis to the corpus spongiosum penis in the treatment of erectile dysfunction: normal function regained …
… entitled “Low-intensity shockwave therapy improves hemodynamic parameters in patients with VASCULOGENIC
… Erectile dysfunction shock wave therapy (EDSWT) improves hemodynamic parameters in patients with VASCULOGENIC ERECTILE DYSFUNCTION
… EVALUATION OF ARTERIAL STIFFNESS AND CARDIAC VASCULAR
… EXPRESSING VASCULAR VASCULAR
… expression of VASCULAR
… FOR IDENTIFYING WALL MOTION ABNORMALITIES DURING STRESS TEST IN ERECTILE DYSFUNCTION
… from a database of 48 million men in the United States: Relationship of CARDIO VASCULAR
… FUNCTION OF CAVERNOUS ARTERIES CORRELATES WITH ITS CLINCAL EFFICACY IN PATIENTS WITH ARTERIOGENIC ERECTILE DYSFUNCTION
… growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and VASCULOGENIC ERECTILE DYSFUNCTION
… heart failureRapid realist reviews for interventions to improve access to primary health care for vulnerable populationsAre ERECTILE DYSFUNCTION
… HelpED study: agreement and impact of the erection hardness score on sexual function and psychosocial outcomes in men with ERECTILE DYSFUNCTION
… HISTOMORPHOLOGICAL STRUCTURE AND FUNCTION WITH STEM CELLS IN A RAT MODEL OF NEURO VASCULAR
… HUMAN PLACENTAL STEM CELLS PROMOTE ERECTILE FUNCTION RECOVERY IN A RODENT NEURO VASCULAR
… IMPROVES AORTIC ELASTIC PROPERTIES AND WAVE REFLECTIONS IN PATIENTS WITH ERECTILE DYSFUNCTION VASCULAR
… in Cavernosal ARTERY VASCULAR ERECTILE DYSFUNCTION
… INTIMA MEDIA THICKNESS ARE ASSOCIATED WITH PENILE DOPPLER FINDINGS IN PATIENTS WITH VASCULOGENIC
… is associated with diminished levels of VASCULAR
… LOW INTENSITY SHOCK WAVE THERAPY TO THE PENIS FOR VASCULOGENIC
… MELANOMA WITH PHOSPHODIESTERASE TYPE 5 INHIBITOR USE AMONGST PATIENTS WITH ERECTILE DYSFUNCTION, PULMONARY HYPERTENSION
… MOTION ABNORMALITIES DURING STRESS ECHOCARDIOGRAPHY TESTING IN HYPERTENSIVE VASCULAR
… neuro VASCULAR
… Nogo-B receptor inhibits penile corpus cavernosum VASCULAR ERECTILE DYSFUNCTION
… Nymphaea lotus Linn.(Nymphaeaceae) on N (ω)-nitro-L-arginine methyl ester-induced tissular oxidative damages and ERECTILE DYSFUNCTION HYPERTENSIVE
… of brachial ARTERY ARTERY VASCULOGENIC
… of Chicken Leg Bone Hydrolysates under Different Drying Conditions and Its Effectiveness on Improving ERECTILE DYSFUNCTION HYPERTENSIVE
… OF LOW-INTENSITY EXTRACORPOREAL SHOCKWAVE IN THE TREATMENT OF VASCULOGENIC
… of monocyte count with carotid intima-media thickness, aortic stiffness and penile Doppler findings, in patients with VASCULOGENIC
… of neuro VASCULAR ERECTILE DYSFUNCTION
… of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in 261 Patients with Erectile Dysfunction: Endo VASCULAR
… of penile BLOOD ERECTILE DYSFUNCTION
… of the predictive value of testosterone levels and carotid femoral pulse wave velocity for major adverse CARDIO VASCULAR
… OF THE THERAPEUTIC TARGETING POTENTIAL OF MICRORNA-93 IN THE TREATMENT OF VASCULOGENIC
… of VASCULAR ERECTILE DYSFUNCTION
… ON PENILE MICRO VASCULAR BLOOD HYPERTENSIVE
… on the CARDIO VASCULAR
… on: adipokines, hormonal parameters, and CARDIO VASCULAR ERECTILE DYSFUNCTION
… on: Amino-Terminal Pro-C-Type Natriuretic Peptide is Associated with the Presence, Severity, and Duration of VASCULOGENIC
… PEAK SYSTOLIC VELOCITY IS RELATED TO MAJOR ADVERSE CARDIO VASCULAR HYPERTENSIVE
… Penile Arterial Flow as an Adjunct to Increased Aortic Stiffness for Detecting Myocardial Ischemia During Stress Echocardiography in Erectile Dysfunction …
… penile Doppler ultrasound findings and penile arterial insufficiency under percutaneous transluminal angioplasty for patients with erectile dysfunction
… Plasma Asymmetrical Dimethylarginine (ADMA) as an Independent Predictor for the Presence of CARDIO VASCULAR
… Product Sciences: Articles; Ginsenoside Re Enriched Fraction (GS-F3K1) from Ginseng Berries Ameliorates Ethanol-Induced ERECTILE DYSFUNCTION
… RELAXATION INDUCED BY INSULIN IN HUMAN CORPUS CAVERNOSUM AND PENILE ARTERIES IS IMPAIRED IN ERECTILE DYSFUNCTION.
… relaxation of pudendal ARTERY VASCULAR HYPERTENSIVE
… RETINAL ARTERIOLAR DIAMETER AND INCREASED RETINAL VENULAR DIAMETER IS ASSOCIATED WITH ERECTILE DYSFUNCTION
… RISK FACTORS FOR CARDIO VASCULAR ERECTILE DYSFUNCTION
… Severe and Long-standing “Penile Angina” Are Additively Associated with Poor Exercise Performance in ERECTILE DYSFUNCTION HYPERTENSION
… sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: a comparison with patients with VASCULOGENIC
… SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with ERECTILE DYSFUNCTION
… stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction
… strategy of mesenchymal stem cell injection with VASCULAR
… tea influence expression of VASCULAR VASCULOGENIC
… the Efficacy of Type 5 Phosphodiesterase Inhibitors to Relax Human Corpus Cavernosum and Penile Arteries from Diabetic Patients with Erectile Dysfunction
… the erection hardness score to facilitate patient/partner-healthcare provider communication concerning ERECTILE DYSFUNCTION
… to congratulate you and express my appreciation of the articles’ Understanding prostate cancer’,’Benign prostatic hyperplasia’and’Erectile dysfunction’in the journal of …
… TREATMENT EFFECT OF AUTOLOGOUS ADIPOSE STROMAL VASCULAR
… type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with CARDIO VASCULAR
… value of nitric oxide, lipoprotein (a), and malondialdehyde levels in the peripheral venous and cavernous BLOOD
… VARDENAFIL (LEVITRA®) ON ENDOTHELIAL FUNCTION OF CAVERNOUS AND BRACHIAL ARTERIES IN PATIENTS WITH ERECTILE DYSFUNCTION
… VASCULAR
… VASCULAR
[PP. 23.20] PREVALENCE AND SEVERITY OF ERECTILE DYSFUNCTION HYPERTENSION
[PP. 26.07] IMPACT OF VALSARTAN AND COMBINATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE ON ERECTILE DYSFUNCTION
015 Sepiapterin Supplementation Fails to Ameliorate Diesel Exhaust Particle Exposure-Related Erectile and Coronary ARTERY
021 Topically Applied Sildenafil-nanoparticles Improve Erectile Function in an Aging-rat Model of Erectile Dysfunction
022 Cardiology Referrals, CARDIAC CARDIAC
034 Penile BLOOD ERECTILE DYSFUNCTION
034 Topical application of Sildenafil-nanoparticles (proximal and distal) improve erectile function in an aging-rat model of erectile dysfunction
0389: Preference for ERECTILE DYSFUNCTION HEART
045 Androgen Pattern and Endothelial Dysfunction in Patients With VASCULOGENIC
0510: ERECTILE DYSFUNCTION HEART
076 Sexual dynamics as a critical part in the individualised management of men with ERECTILE DYSFUNCTION
104 Pluripotent Fetal Stem Cells for Treatment of the VASCULAR
1066-196 ERECTILE DYSFUNCTION VASCULAR
1070: Up-Regulation of Nadph Oxidase Contributes to the ERECTILE DYSFUNCTION HYPERTENSIVE
1096-74 CARDIO VASCULAR
1107 Assessment of aortic elastic properties in patients with ERECTILE DYSFUNCTION
1116 Use of stromal VASCULAR VASCULOGENIC
112 Efficacy and Safety of Fixed Dose Combination of Amlodipine and Tadalafil in Both ERECTILE DYSFUNCTION HYPERTENSION
1141-196 Effect of atorvastatin and sildenafil on endothelial function in patients with ERECTILE DYSFUNCTION CARDIO VASCULAR
115 Elevated plasma transforming growth factor-β1 level in patients with VASCULOGENIC
1158 Arterial function and structure parameters are significantly impaired in pre-diabetic men with arterial HYPERTENSION
117 Erectile dysfunction: Looking for a BLOOD
1198 ERECTILE DYSFUNCTION ARTERY
120 CARDIO VASCULAR ERECTILE DYSFUNCTION
1252: Association Between ERECTILE DYSFUNCTION ARTERY
1282: VASCULAR
1324 IS THERE A CONCORDANCE BETWEEN CAROTID AND CAVERNOUS ARTERY
1326: ERECTILE DYSFUNCTION HEART
1333: Association of ERECTILE DYSFUNCTION CARDIO VASCULAR
1338: The Impact of VASCULAR
1340: ERECTILE DYSFUNCTION ARTERY
1351: Erectile dysfunction, HEART
136 Human Cord BLOOD ERECTILE DYSFUNCTION
137 Superparamagnetic Iron Oxide Nanoparticle Targeting of Adipose Tissue-Derived Stem Cells in Diabetes-Associated Erectile Dysfunction
1533 COMPARISON OF RATES AND RISK FACTORS FOR DEVELOPMENT OF ERECTILE DYSFUNCTION
1620: The Comparison of HYPERTENSION
1638: ERECTILE DYSFUNCTION HYPERTENSIVE
17: Female Partners of Men with ERECTILE DYSFUNCTION
176 RELATIONSHIP BETWEEN CORONARY ARTERY VASCULOGENIC ERECTILE DYSFUNCTION
1804 PENILE RE VASCULAR VASCULOGENIC
18F-FLOURIDE UPTAKE IN PENILE ARTERIES: DOES IT REPRESENT ATHEROSCLEROTIC BASIS OF ERECTILE DYSFUNCTION
18F-fluoride positron emission tomographic imaging of penile arteries and erectile dysfunction
18F-fluoride uptake in Penile Arteries and Erectile Dysfunction
207 15 ERECTILE DYSFUNCTION CARDIO VASCULAR
208 Low-Intensity Shock Wave Therapy for Treatment of VASCULOGENIC
208 Relationship between ERECTILE DYSFUNCTION HEART
209 SEVERE ERECTILE DYSFUNCTION ARTERY
213 Nrf2 activation improves both hyperpolarization-and NO-mediated responses in penile vasculature from patients with erectile dysfunction
2132 IMPACT OF RENAL TRANSPLANT ON VASCULOGENIC ERECTILE DYSFUNCTION
221 Comparing ERECTILE DYSFUNCTION VASCULAR ARTERY
225 VARDENAFIL VERSUS SILDENAFIL IN MEN WITH ERECTILE DYSFUNCTION CARDIO VASCULAR
249 Micro VASCULAR
267 Pericyte Number and Micro VASCULAR ERECTILE DYSFUNCTION
285 VASCULAR
287 Erectile Dysfunction, Penile Atherosclerosis and Coronary ARTERY HEART
294 ERECTILE DYSFUNCTION VASCULAR
353 THE PATHOGENETIC BASIS FOR THE TREATMENT OF ERECTILE DYSFUNCTION VASCULAR
355 CARDIORESPIRATORY FITNESS IN MEN WITH ERECTILE DYSFUNCTION
380 Penile Doppler, Vendys® and SphygmoCor® in the Diagnosis of VASCULAR
385 Losartan Preserves Erectile Function by Suppression of Cavernosal Fibrosis and Corporal Veno-Occlusive Dysfunction in Diabetic Rats
417 Spontaneously Diabetic Torii Fatty Rats do not Show ERECTILE DYSFUNCTION
454 Inverse correlation between testosterone and CARDIAC HEART
462 ERECTILE DYSFUNCTION ARTERY
5 ERECTILE DYSFUNCTION
52 Do the HEART ERECTILE DYSFUNCTION
530 Early start of oral sildenafil 100mg for ERECTILE DYSFUNCTION
54 DOES ERECTILE DYSFUNCTION CARDIO VASCULAR
543Vardenafil improves treatment satisfaction and sexual pleasure in men with ERECTILE DYSFUNCTION
580 Family history regarding CARDIO VASCULAR ERECTILE DYSFUNCTION ARTERY
5930Correlation of brachial flow-mediated vasodilatation and ERECTILE DYSFUNCTION ARTERY
670 Percutaneous angioplasty of internal pudendal arteries in the treatment of ERECTILE DYSFUNCTION
676 Penile re VASCULAR
689: Correlation between Penile Doppler Findings and C-Reactive Protein Levels in Patients with ERECTILE DYSFUNCTION VASCULAR
694Is ERECTILE DYSFUNCTION HEART
695Association between ERECTILE DYSFUNCTION ARTERY
697: Nonarteritic Anterior Ischemic Optic Neuropathy in Men Using Sildenafil Citrate for Erectile Dysfunction: A Review of> 44,800 Patients in Clinical and …
699 High BLOOD ERECTILE DYSFUNCTION VASCULAR
706 Influence of socioeconomic factors on the presence and intensity of ERECTILE DYSFUNCTION ARTERY
707 Influence of testosterone deficiency on the BLOOD ERECTILE DYSFUNCTION
733 ERECTILE DYSFUNCTION HYPERTENSIVE
750 CORRECTION OF DIABETIC ERECTILE DYSFUNCTION VASCULAR
864: ERECTILE DYSFUNCTION HEART
909 SOCIODEMOGRAPHIC AND PSYCHOLOGICAL CORRELATES ASSOCIATED WITH ERECTILE DYSFUNCTION HYPERTENSIVE
919 ERECTILE DYSFUNCTION CARDIO VASCULAR
921 INCIDENT HYPERTENSION ERECTILE DYSFUNCTION
952 CORRELATION OF THE ERECTILE DYSFUNCTION VASCULAR
953 PENILE DOPPLER FINDINGS OF ARTERIAL FLOW IN RELATION TO VASCULAR
A case of ERECTILE DYSFUNCTION ARTERY
A combined-constructionist therapeutic approach to couples experiencing erectile dysfunction: Part II
A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction
A Computational Model for the Exploration of VASCULOGENIC
A cross-sectional study of HYPERTENSIVE ERECTILE DYSFUNCTION
A Letter to the Editor Regarding the Original Article by Mulhall et al: Utility of Tacrolimus (FK506) trough level for the Prevention of Erectile Dysfunction
A multidisciplinary approach to assess ERECTILE DYSFUNCTION CARDIO VASCULAR
A Natural Approach to ERECTILE DYSFUNCTION VASCULAR
A new parameter in the diagnosis of VASCULAR ERECTILE DYSFUNCTION ARTERY
A novel experimental model of ERECTILE DYSFUNCTION HEART
A Population Survey to Study the Association Between Microalbuminuria and ERECTILE DYSFUNCTION CARDIO VASCULAR
A population-based study on the association between rheumatoid arthritis and erectile dysfunction
A population-based, longitudinal study of ERECTILE DYSFUNCTION ARTERY
A prospective randomised crossover trial on the effect of vardenafil 10mg on BLOOD ERECTILE DYSFUNCTION
A review of hypogonadism and ERECTILE DYSFUNCTION
A Review on ERECTILE DYSFUNCTION HYPERTENSIVE
A simple noninvasive test to detect VASCULAR
A spontaneous, double-blind, double-dummy cross-over study on the effects of daily vardenafil on arterial stiffness in patients with VASCULOGENIC
A state of art review on vardenafil in men with ERECTILE DYSFUNCTION
A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction
A study of the VASCULOGENIC
A systematic approach to ERECTILE DYSFUNCTION CARDIO VASCULAR
A systematic review of the association between ERECTILE DYSFUNCTION CARDIO VASCULAR
A systematic review of the long-term efficacy of low-intensity shockwave therapy for VASCULOGENIC
A young man with position-dependent erectile dysfunction: diagnostic work-up and interventional therapy of an arteriovenous malformation
AB006. ERECTILE DYSFUNCTION CARDIO VASCULAR
AB008. The link between ERECTILE DYSFUNCTION CARDIO VASCULAR
AB039. Metabolic syndrome/cardio VASCULAR ERECTILE DYSFUNCTION
AB130. The relationship between dietary intake and endothelial function among VASCULOGENIC ERECTILE DYSFUNCTION
AB145. Comparison of the prevalence of CARDIO VASCULAR
AB174. ERECTILE DYSFUNCTION
AB231. The relationship between CARDIO VASCULAR ERECTILE DYSFUNCTION
AB67. Molecular mechanisms of Chinese herbal formula Shuganyiyang (SGYY) capsule of treating arteriogenic ERECTILE DYSFUNCTION
Abnormal insulin signaling: early detection of silent coronary ARTERY
Accounts of the impact of ERECTILE DYSFUNCTION
Activation of the ET‐1/ETA pathway contributes to ERECTILE DYSFUNCTION HYPERTENSION
Acute effect of sildenafil on inflammatory markers/mediators in patients with VASCULOGENIC
Adipokines, hormonal parameters, and CARDIO VASCULAR ERECTILE DYSFUNCTION
Adjustments for smoking, diabetes, HYPERTENSION HEART
Aetiology and management of male ERECTILE DYSFUNCTION CARDIO VASCULAR
Age-matched cavernous peak systolic velocity: a highly sensitive parameter in the diagnosis of arteriogenic erectile dysfunction
Alfuzosin attenuates ERECTILE DYSFUNCTION
All men with VASCULOGENIC ERECTILE DYSFUNCTION CARDIO VASCULAR
Alteration of Redox Homeostasis and Protein Expression of Constitutive Nitric Oxide Synthases Contributes to ERECTILE DYSFUNCTION HEART
Alterations in Endothelial Nitric Oxide Synthase and RhoA/ROCK are Associated with ERECTILE DYSFUNCTION HYPERTENSIVE
Alterations in microRNA expression in a murine model of diet‐induced VASCULOGENIC
Amino-terminal pro-C-type natriuretic peptide is associated with the presence, severity, and duration of VASCULOGENIC
Amiodarone, ERECTILE DYSFUNCTION
An analysis of treatment preferences and sexual quality of life outcomes in female partners of Chinese men with erectile dysfunction
An investigation into the link between vitamin D status, ERECTILE DYSFUNCTION CARDIO VASCULAR
An investigation of sexual dysfunction in female partners of men with erectile dysfunction: how interviews expand on questionnaire responses
Analysis of related factors for ERECTILE DYSFUNCTION HYPERTENSION
Androgen deficiency, ERECTILE DYSFUNCTION VASCULAR
Androgens, ERECTILE DYSFUNCTION CARDIO VASCULAR
VASCULAR -re VASCULAR VASCULAR VASCULAR ARTERY
Angiopoietin-1-induced VASCULAR ERECTILE DYSFUNCTION
Angiotensin II increases corpus cavernosal contractility and oxidative stress in partial bladder outlet obstructed rabbits: relevance to erectile dysfunction
Angiotensin Receptor Blockers for ERECTILE DYSFUNCTION HYPERTENSIVE
Animal models of ERECTILE DYSFUNCTION VASCULAR
Antihypertensive Drug Therapy and Erectile Dysfunction
Antihypertensive drugs and ERECTILE DYSFUNCTION
Antihypertensive therapy causes erectile dysfunction
Antihypertensive treatment and ERECTILE DYSFUNCTION
Antiplatelet (aspirin) therapy as a new option in the treatment of VASCULOGENIC
Aortic stiffness and carotid intima media thickness are associated with penile Doppler findings in patients with VASCULOGENIC
Aortic/penile index is a marker of occult coronary ARTERY HYPERTENSIVE
apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction. Journal of Urology 172: 2347-2349, No. 6, Part 1, Dec 2004 800995972
Application and value of color Doppler ultrasonograghy in the diagnosis of VASCULOGENIC
Application of colour doppler ultrasonography after intracavernous injection in the diagnosis of VASCULOGENIC
Application of colour Doppler ultrasonography in the diagnosis of VASCULOGENIC
Approach to ERECTILE DYSFUNCTION HYPERTENSION ARTERY
Approach to ERECTILE DYSFUNCTION HYPERTENSION ARTERY
Are ERECTILE DYSFUNCTION
Are men with ERECTILE DYSFUNCTION HYPERTENSION
Are VASCULAR ERECTILE DYSFUNCTION
ARTERIAL ELASTIC PROPERTIES IN PATIENTS WITH ERECTILE DYSFUNCTION
Arterial elasticity and ERECTILE DYSFUNCTION HYPERTENSIVE
Arterial ERECTILE DYSFUNCTION
Arterial ERECTILE DYSFUNCTION VASCULAR CARDIO VASCULAR
Arterial erectile dysfunction: different severities of endothelial apoptosis between diabetic patients “responders” and “non responders” to sildenafil
Arterial erectile dysfunction: reliability of new markers of endothelial dysfunction
Arterial erectile dysfunction: reliability of penile Doppler evaluation integrated with serum concentrations of late endothelial progenitor cells and endothelial …
Arterial function and intima-media thickness in HYPERTENSIVE
Arterial HYPERTENSION
Arterial stiffness evaluation for the early detection of endothelial dysfunction in men with ERECTILE DYSFUNCTION
Arterial surgery for erectile dysfunction
Arteriogenic ERECTILE DYSFUNCTION
Arteriosclerosis is associated with ERECTILE DYSFUNCTION
Arteriosclerosis of penile arteries: histological findings and their significance in the treatment of erectile dysfunction
Assays for erectile and bladder dysfunction and VASCULAR
Assessing erectile neurogenic dysfunction from HEART
Assessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunction
Assessment of aortic elastic properties in patients with ERECTILE DYSFUNCTION
Assessment of CARDIO VASCULAR
Assessment of EndoPAT Scores in men with VASCULOGENIC
Assessment of Health States and Erectile Dysfunction-Associated Quality of Life Among Adult Males and Females With Male Partners in Germany, the …
Assessment of Mean Platelet Volume in men with VASCULOGENIC
Assessment of Psychological Factors, Erectile Dysfunction, and Quality of Life before and after Re VASCULAR
Assessment of the relationship between asymmetric dimethylarginine and severity of ERECTILE DYSFUNCTION ARTERY
Association Between Arterial Wave Reflections and Penile Doppler Findings in HYPERTENSIVE VASCULOGENIC
Association between cardiometabolic index and erectile dysfunction: a new index for predicting CARDIO VASCULAR
Association between CARDIO VASCULAR
Association between carotid and femoral atherosclerotic burden and VASCULOGENIC
Association between chronic obstructive PULMONARY
Association between chronic periodontitis and VASCULOGENIC
Association between Coronary ARTERY ERECTILE DYSFUNCTION
Association Between Coronary ARTERY ERECTILE DYSFUNCTION HEART
Association between coronary HEART ERECTILE DYSFUNCTION
Association between endogenous serum testosterone concentrations and arterial stiffness in ERECTILE DYSFUNCTION
Association between ERECTILE DYSFUNCTION CARDIO VASCULAR
Association between ERECTILE DYSFUNCTION CARDIO VASCULAR CARDIO VASCULAR
Association between ERECTILE DYSFUNCTION ARTERY
Association between ERECTILE DYSFUNCTION ARTERY
ASSOCIATION BETWEEN ERECTILE DYSFUNCTION CARDIO VASCULAR
Association between ERECTILE DYSFUNCTION HYPERTENSIVE
Association between ERECTILE DYSFUNCTION ARTERY
Association Between ERECTILE DYSFUNCTION ARTERY
ASSOCIATION BETWEEN ERECTILE DYSFUNCTION CARDIO VASCULAR
Association between ERECTILE DYSFUNCTION CARDIO VASCULAR
Association between erectile dysfunction, testosterone levels and prediction of 10-year CARDIO VASCULAR
Association between periodontal flap surgery for periodontitis and VASCULOGENIC ERECTILE DYSFUNCTION
Association between physical exercise and quality of erection in men with ischaemic HEART ERECTILE DYSFUNCTION
Association between treatment for ERECTILE DYSFUNCTION CARDIO VASCULAR
Association between VASCULAR
VASCULAR -lesions-hardness-penis/129/01222926″>ASSOCIATION BETWEEN VASCULAR
ASSOCIATION OF A TRIAD MORBID: DEPRESSION, ERECTILE DYSFUNCTION HEART
Association of coronary ARTERY
ASSOCIATION OF ERECTILE DYSFUNCTION
Association of ERECTILE DYSFUNCTION CARDIO VASCULAR VASCULAR
Association of peripheral micro VASCULAR
Association of the T‐786C, G894T and 4a/4b polymorphisms of the endothelial nitric oxide synthase gene with VASCULOGENIC ERECTILE DYSFUNCTION
Associations of carotid ARTERY
Asymmetric dimethyl arginine levels correlate with CARDIO VASCULAR
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L‐arginine in patients with arteriogenic and non‐arteriogenic erectile dysfunction
Asymmetrical dimethylarginine (ADMA) is associated with CARDIO VASCULAR
Asymmetrical dimethylarginine and severity of ERECTILE DYSFUNCTION CARDIO VASCULAR
Attitudes and experiences: qualitative perspectives on ERECTILE DYSFUNCTION
Autologous adipose tissue derived stromal VASCULAR VASCULOGENIC
Autologous Stromal VASCULAR
BALNEOTHERAPY AND NEURO VASCULAR ERECTILE DYSFUNCTION
Basic science evidence for the link between ERECTILE DYSFUNCTION
Bibliometric analysis on relations between CARDIO VASCULAR
Bicycle Riding, Arterial Compression and Erectile Dysfunction
Bilateral simultaneous nonarteritic anterior ischemic optic neuropathy after ingestion of sildenafil for erectile dysfunction
Biomarkers, erectile dysfunction, and CARDIO VASCULAR
Bisoprolol Therapy and The Risk of ERECTILE DYSFUNCTION ARTERY
Blood examination for erectile dysfunction
Blood gas changes in the corpora cavernosa: metabolic and histomorphometric implications in the patient with erectile dysfunction
Blood platelet activity in men with VASCULOGENIC
BLOOD PRESSURE AND HEART
Blood pressure-lowering medication and erectile dysfunction: are the drugs to blame?
Blood pressure, antihypertensive medication use, and risk of ERECTILE DYSFUNCTION
Brachial ARTERY
Brachial flow-mediated dilation correlates with vardenafil response in HYPERTENSIVE VASCULOGENIC
Buttock claudication and ERECTILE DYSFUNCTION ARTERY VASCULAR
Calcification of the internal pudendal ARTERY ERECTILE DYSFUNCTION VASCULAR
Can Eosinophil Count, Platelet Count, and Mean Platelet Volume Be a Positive Predictive Factor in Penile Arteriogenic ERECTILE DYSFUNCTION
Can ERECTILE DYSFUNCTION ARTERY
Can ERECTILE DYSFUNCTION CARDIO VASCULAR
Can ERECTILE DYSFUNCTION ARTERY
Can serum asymmetric dimethylarginine become a marker of VASCULOGENIC
Can the International Index of Erectile Function (IIEF-5) be used as a diagnostic tool to the severity of VASCULOGENIC
Can the mean platelet volume be a risk factor for VASCULOGENIC
Captopril treatment reverses ERECTILE DYSFUNCTION HYPERTENSIVE
Cardiac allograft vasculopathy and ERECTILE DYSFUNCTION HEART
Cardiometabolic risk factors in patients with erectile dysfunction
Cardiorenal Determinants of ERECTILE DYSFUNCTION
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR
Cardio VASCULAR VASCULAR
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR VASCULAR ERECTILE DYSFUNCTION
VASCULAR _disease,_metabolic_syndrome_and.9.aspx”>Cardio VASCULAR
Cardio VASCULAR ERECTILE DYSFUNCTION CARDIO VASCULAR
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR HYPERTENSIVE ERECTILE DYSFUNCTION
VASCULAR _effects_of_sildenafil_in_hypertensive_men_with_erectile_dysfunction_and_different_alleles_of_the_type_5_cGMP-specific_phosphodiesterase_PDE5/links/00b4953441ca004133000000.pdf”>Cardio VASCULAR HYPERTENSIVE ERECTILE DYSFUNCTION
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR HEART
VASCULAR _Risk_Factors_in_Patients_with_Erectile_Dysfunction/links/56df355408ae979addef557a.pdf”>Cardio VASCULAR
Cardio VASCULAR CARDIO VASCULAR CARDIO VASCULAR
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR ERECTILE DYSFUNCTION
Cardio VASCULAR
Cardio VASCULAR
Cardiowave analysis in patients with ERECTILE DYSFUNCTION
Carotid ARTERY ERECTILE DYSFUNCTION
Carotid ARTERY ERECTILE DYSFUNCTION
Carvacrol Improves ERECTILE DYSFUNCTION HYPERTENSIVE
CASE REPORT: Association Between ERECTILE DYSFUNCTION ARTERY
Cavernous ARTERY VASCULAR
Central Haemodynamics and prediction of CARDIO VASCULAR
Central hemodynamics and prediction of CARDIO VASCULAR
Central pressures and wave reflections are independently associated with major adverse CARDIO VASCULAR
Changes in ERECTILE DYSFUNCTION CARDIAC
Changes in ERECTILE DYSFUNCTION CARDIO VASCULAR
Characteristics of coronary arteriography among males with coronary ARTERY
Characterization of ERECTILE DYSFUNCTION HEART
Chemistries of love: Impotence, ERECTILE DYSFUNCTION
Chronic administration of an oral Rho kinase inhibitor prevents the development of VASCULOGENIC ERECTILE DYSFUNCTION
Chronic inhibition of nitric‐oxide synthase induces HYPERTENSION ERECTILE DYSFUNCTION
Chronic intermittent hypoxia exposure reduces NOS isoforms in internal pudendal ARTERY
Chronic obstructive PULMONARY ERECTILE DYSFUNCTION
Chronic obstructive PULMONARY
Chronic obstructive PULMONARY
Chronic vardenafil treatment improves erectile function via structural maintenance of penile corpora cavernosa in rats with acute arteriogenic erectile dysfunction
Cigarette smoking and ERECTILE DYSFUNCTION VASCULAR
Cigarette smoking, HYPERTENSION ERECTILE DYSFUNCTION
Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial ERECTILE DYSFUNCTION
Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with ERECTILE DYSFUNCTION ARTERY
Clarifying the relative impacts of VASCULAR ERECTILE DYSFUNCTION
Clinical and imaging outcomes up to 1 year following balloon angioplasty for isolated penile ARTERY
Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart
Clinical cardiology: physician update: ERECTILE DYSFUNCTION CARDIO VASCULAR
Clinical Research of Bushenyixin Tablet for ERECTILE DYSFUNCTION HYPERTENSION
Clinical significance of ERECTILE DYSFUNCTION ARTERY
Clinical, paraclinical and epidemiological profile of ERECTILE DYSFUNCTION
Colour duplex Doppler ultrasonography evaluation of non‐vasculogenic male erectile dysfunction: An Indian perspective
Combination of Gene Therapy with Antioxidant Therapy in a Rat Model of VASCULOGENIC
Combination of stromal VASCULAR
Combination treatment with low intensity extracorporeal shock waves and PDE5 inhibitors for VASCULOGENIC
Combined Therapy of the ERECTILE DYSFUNCTION HYPERTENSION
Commentary to low-energy shock wave therapy ameliorates ERECTILE DYSFUNCTION VASCULAR
Commentary: Angioplasty of Internal Pudendal and Penile Arteries for Arteriogenic Erectile Dysfunction: Reassuring, but the Jury Is Still Out
Commentary: Endo VASCULAR ERECTILE DYSFUNCTION ARTERY
Common grounds for ERECTILE DYSFUNCTION ARTERY
Common pitfalls in some of the experimental studies in erectile function and dysfunction: a consensus article
Communication about ERECTILE DYSFUNCTION
Communication about ERECTILE DYSFUNCTION
Comparative analysis of penile implants in patients with VASCULOGENIC ERECTILE DYSFUNCTION
Comparative efficacy of tadalafil once daily in men with ERECTILE DYSFUNCTION
Comparison of findings on stress myocardial perfusion imaging in men with versus without ERECTILE DYSFUNCTION HEART
Comparison of metabolic syndrome subjects with and without erectile dysfunction–levels of circulating oxidised LDL and arterial elasticity
Comparison of Sexual Dysfunction Before and After Coronary ARTERY ERECTILE DYSFUNCTION
Comparison of the prevalence of CARDIO VASCULAR
Complete BLOOD
Complex Treatment of ERECTILE DYSFUNCTION VASCULAR
VASCULAR -intervention-for-erectile-dysfunction”>Complexities of VASCULAR
Consensus meeting on erectile dysfunction: ERECTILE DYSFUNCTION CARDIO VASCULAR
Conventional and unconventional CARDIO VASCULAR
Coronary ARTERY
Coronary ARTERY ERECTILE DYSFUNCTION
Coronary ARTERY ERECTILE DYSFUNCTION
Coronary ARTERY
Coronary HEART
Coronary phenotypes in patients with ERECTILE DYSFUNCTION HEART
Corpus cavernosum electromyography in patients with VASCULOGENIC
Correction of diabetic ERECTILE DYSFUNCTION VASCULAR
Correlates of ERECTILE DYSFUNCTION PULMONARY
Correlation and risk factors between VASCULAR
Correlation and risk factors between VASCULAR ERECTILE DYSFUNCTION
Correlation Between ERECTILE DYSFUNCTION VASCULAR
Correlation between HYPERTENSION
Correlation between internal pudendal ARTERY ERECTILE DYSFUNCTION ARTERY
Correlation between peak systolic velocity and diameter of cavernosal arteries in flaccid versus dynamic state for the evaluation of erectile dysfunction
Correlation between penile cavernosal ARTERY BLOOD VASCULAR
Correlation between penile duplex findings and stress electrocardiography in men with erectile dysfunction
CORRELATION OF ERECTILE DYSFUNCTION CARDIO VASCULAR
CORRELATION OF PSYCHOLOGICAL FACTORS WITH PERIODONTAL AND ERECTILE DYSFUNCTION HEART
Correlation of the ERECTILE DYSFUNCTION VASCULAR
Correlations between lower urinary tract symptoms, erectile dysfunction, and CARDIO VASCULAR
Could ERECTILE DYSFUNCTION BLOOD
COUPLES’SEXUAL DYSFUNCTIONS: ERECTILE DYSFUNCTION
CRT-93 Prevalence Of Internal Pudendal ARTERY ERECTILE DYSFUNCTION
Current Opinion in VASCULOGENIC
VASCULAR Surgery.pdf”>Current role of VASCULAR
Current state of endo VASCULAR VASCULOGENIC
Cutaneous microcirculatory function predicts the responsiveness to tadalafil in patients with ERECTILE DYSFUNCTION ARTERY
Decrease of the insulin‐like growth factor‐1 bioavailability in spontaneously HYPERTENSIVE
Depression, Erectile Dysfunction, and Coronary HEART
Depression: links with ischemic HEART
Depressive symptoms and ERECTILE DYSFUNCTION ARTERY
Detection of ERECTILE DYSFUNCTION CARDIO VASCULAR
Deterioration of chronotropic responses and HEART
Deterioration of HEART
Determinants of Early Response to Low-Intensity Extracorporeal Shockwaves for the Treatment of VASCULOGENIC
DETERMINANTS OF INCREASED CARDIO VASCULAR
Determination of changes in BLOOD
Determining the Prognostic Implications of ERECTILE DYSFUNCTION CARDIO VASCULAR
Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with ERECTILE DYSFUNCTION
Diabetes, CARDIO VASCULAR
Diabetes, coronary ARTERY ERECTILE DYSFUNCTION
Diagnosing Erectile Dysfunction: flow‐chart
Diagnosis and treatment of ERECTILE DYSFUNCTION CARDIO VASCULAR
Diagnosis and treatment of trauma-associated arteriogenic erectile dysfunction
Diagnosis and treatment of VASCULAR ERECTILE DYSFUNCTION
Diagnosis of arteriogenic ERECTILE DYSFUNCTION
Diagnostic and therapeutic implications of ERECTILE DYSFUNCTION CARDIO VASCULAR
Diagnostic value of four-dimensional CT angiography in arterial ERECTILE DYSFUNCTION
DIAGNOSTICS OF PENILE MICROCIRCULATION DISORDERS IN PATIENTS WITH VASCULOGENIC
Did men with ERECTILE DYSFUNCTION
Dietary antioxidants improve arteriogenic erectile dysfunction
Disfunção erétil como preditor de doença arterial coronariana ERECTILE DYSFUNCTION ARTERY
Do ERECTILE DYSFUNCTION CARDIO VASCULAR
Document Guidelines for the assessment of the vasculogenig erectile dysfunction
Does any association exist between chronic obstructive PULMONARY
Does CARDIO VASCULAR ERECTILE DYSFUNCTION
Does ERECTILE DYSFUNCTION CARDIO VASCULAR
VASCULAR _risk/links/5dc93a4092851c818043d4c6/Does-erectile-dysfunction-improve-the-assessment-of-cardio VASCULAR ERECTILE DYSFUNCTION CARDIO VASCULAR
Does ERECTILE DYSFUNCTION CARDIO VASCULAR
Does radical nephrectomy increase the risk of ERECTILE DYSFUNCTION
Doppler evaluation of erectile dysfunction–Part 1
Doppler evaluation of erectile dysfunction–part 2
Doppler Imaging of Arteriogenic and Venogenic causes of Erectile Dysfunction: A Pictorial Review
Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of ERECTILE DYSFUNCTION PULMONARY HYPERTENSION
Dual implantation of artificial urinary sphincter and inflatable penile prostheses for concurrent male urinary incontinence and erectile dysfunction
Duplex ultrasonography and internal pudendal arteriogram in the diagnosis of trauma-associated arteriogenic ERECTILE DYSFUNCTION
Dynamic observation of penile hemodynamic change in patients with VASCULOGENIC ERECTILE DYSFUNCTION
Dynamic penile peak systolic velocity predicts major adverse CARDIO VASCULAR HYPERTENSIVE
Dysregulation of Dimethylarginine Dimethylaminohydrolase Causes Elevation of Asymmetric Dimethylarginine in a Rat Model of VASCULOGENIC
Early conceptual and linguistic development of a patient and partner treatment satisfaction scale (TSS) for erectile dysfunction
Early endothelial dysfunction as a marker of VASCULOGENIC ERECTILE DYSFUNCTION
Early onset ERECTILE DYSFUNCTION
Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction
Early recoil after balloon angioplasty of erection-related arteries in patients with arteriogenic erectile dysfunction
ED 04. Losartan improves ERECTILE DYSFUNCTION
ED 11. Incompetent cavernous endothelial cell-cell junction is responsible for why ERECTILE DYSFUNCTION VASCULAR
ED 26. Multiple arterial occlusion with clinical manifestations of erectile dysfunction
ED PHARMACOTHERAPY: Comparing Vardenafil and Sildenafil in the Treatment of Men with ERECTILE DYSFUNCTION CARDIO VASCULAR
ED PHARMACOTHERAPY: Sildenafil Citrate 100 mg Starting Dose in Men with ERECTILE DYSFUNCTION
ED PHARMACOTHERAPY: The Efficacy and Safety of Udenafil [Zydena] for the Treatment of ERECTILE DYSFUNCTION HYPERTENSIVE
Editorial Comment on “Low Energy Shock Wave Therapy Ameliorates ERECTILE DYSFUNCTION VASCULAR
Editorial Comment on “ VASCULAR
Editorial on ERECTILE DYSFUNCTION CARDIO VASCULAR
Effect of aerial part and root extracts from Ferula orientalis L. growing in Turkey on ERECTILE DYSFUNCTION
Effect of Aerial Parts and Root Extracts from Four Ferulago Species on ERECTILE DYSFUNCTION
Effect of Aerobic Exercise on C-reactive protein (Crp) and Index of Erectile Function in Subjects with HYPERTENSION
Effect of correcting serum cholesterol levels on erectile function in patients with VASCULOGENIC
Effect of depression on ERECTILE DYSFUNCTION HEART
Effect of endurance CARDIO VASCULAR ERECTILE DYSFUNCTION HEART
Effect of ERECTILE DYSFUNCTION
Effect of Extracts of the Aerial Parts and Roots from Four Ferulago Species on ERECTILE DYSFUNCTION
EFFECT OF HYPOGONADISM ON THE MANAGEMENT PLAN OF SEVERE VASCULOGENIC ERECTILE DYSFUNCTION
Effect of Losartan on C-Reactive Protein and Sexual Function in Patients with HYPERTENSION
Effect of Nitric Oxide Levels in Hypertensi Patient with Erectile Dysfunction
Effect of short‐and long‐term sildenafil treatment on ERECTILE DYSFUNCTION
Effect of Shugan Yiyang capsules on sexual function and sex gland weight in rats with arteriogenic erectile dysfunction
Effect of Shuganyiyang Capsule on the expression of endothelin and connexin43 of rat model with arteriogenic ERECTILE DYSFUNCTION
Effect of sildenafil in cavernous arteries of patients with erectile dysfunction
Effect of sildenafil on arterial stiffness, as assessed by pulse wave velocity, in patients with erectile dysfunction
Effect of sildenafil on CARDIO VASCULAR
Effect of systemic arterial pressure on ERECTILE DYSFUNCTION
Effect of treating ERECTILE DYSFUNCTION HYPERTENSION
Effect of vardenafil on BLOOD ERECTILE DYSFUNCTION
VASCULAR -research/jvree/2008/07/001/effect-weight-reduction- VASCULAR VASCULAR ERECTILE DYSFUNCTION
Effect of Zhenyangjian on the penile hemodynamics of the patients with arterial erectile dysfunction
Effective ERECTILE DYSFUNCTION
Effectiveness and safety of combined treatment of the ERECTILE DYSFUNCTION HYPERTENSION
Effectiveness and safety of the treatment with sildenafil (Viagra) in patients with ERECTILE DYSFUNCTION HYPERTENSION
Effects of autologous adipose-derived stromal VASCULAR ERECTILE DYSFUNCTION HYPERTENSIVE
Effects of chronic vardenafil treatment persist after end of treatment in rats with acute arteriogenic erectile dysfunction
Effects of daily vs. on-demand Vardenafil on arterial stiffness in patients with erectile dysfunction
Effects of hydrogen sulphide donor, sodium hydrosulphide treatment on the ERECTILE DYSFUNCTION HYPERTENSIVE
Effects of icariin on the erectile function and expression of nitrogen oxide synthase isoforms in corpus cavernosum of arterigenic ERECTILE DYSFUNCTION
Effects of Microdesmis keayana alkaloids on VASCULAR
Effects of moxonidine and metoprolol in penile circulation in HYPERTENSIVE
Effects of nonlinear aerobic training on ERECTILE DYSFUNCTION CARDIO VASCULAR
EFFECTS OF PRIMARY HYPERTENSION
Effects of quercetin on intracavernous pressure and expression of nitrogen synthase isoforms in arterial ERECTILE DYSFUNCTION
Effects of tadalafil on platelets and endothelium in patients with ERECTILE DYSFUNCTION CARDIO VASCULAR
Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and CARDIO VASCULAR
Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with VASCULAR
Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and CARDIO VASCULAR
Efficacy and safety of sildenafil citrate in men with ERECTILE DYSFUNCTION HEART
Efficacy and safety of sildenafil citrate in men with ERECTILE DYSFUNCTION HEART
Efficacy and safety of sildenafil citrate in men with ERECTILE DYSFUNCTION ARTERY
Efficacy and Safety of Sildenafil Citrate in Patients with ERECTILE DYSFUNCTION
Efficacy and safety of sildenafil in Asian males with ERECTILE DYSFUNCTION CARDIO VASCULAR
Efficacy and safety of sildenafil in patients with ERECTILE DYSFUNCTION HYPERTENSION
Efficacy and safety of topical Aprostadil Cream (Vitaros®) in HYPERTENSIVE CARDIAC ERECTILE DYSFUNCTION
Efficacy and safety of vardenafil in the treatment of ERECTILE DYSFUNCTION HYPERTENSION
Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in men with ERECTILE DYSFUNCTION
Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study
Efficacy of Low Density Linear Shockwave Treatment in Severe Arteriogenic ERECTILE DYSFUNCTION
Efficacy of tadalafil in the treatment of ERECTILE DYSFUNCTION HYPERTENSIVE
Efficacy of vardenafil for the treatment of ERECTILE DYSFUNCTION HYPERTENSION
Efficacy of VIAGRA®(sildenafil citrate) in men with ERECTILE DYSFUNCTION HYPERTENSION
Elastic properties of the aorta in patients with erectile dysfunction: assessment by conventional and color tissue Doppler echocardiography
Electrocardiographic abnormalities in patients with organic erectile dysfunction: comparison with an age-matched control group
Elevation of asymmetrical dimethylarginine (ADMA) and coronary ARTERY
Elevation of asymmetrical dimethylarginine (ADMA) and coronary ARTERY
Emergency department considerations regarding erectile dysfunction
Emerging molecular targets for treatment of erectile dysfunction: VASCULAR
Endothelial antioxidant compound prolonged the endothelial antiapoptotic effects registered after tadalafil treatment in patients with arterial erectile dysfunction
Endothelial cell activation in men with ERECTILE DYSFUNCTION CARDIO VASCULAR VASCULAR
Endothelial colony forming cells from human umbilical cord BLOOD ERECTILE DYSFUNCTION
Endothelial dysfunction as a common link between ERECTILE DYSFUNCTION CARDIO VASCULAR
Endothelial dysfunction links ERECTILE DYSFUNCTION HEART
Endothelial dysfunction, erectile dysfunction, and coronary HEART
VASCULAR -risk.pdf”>Endothelial Dysfunction: A Concatenation Of Facts In, Erectile Dysfunction, Benign Prostatic Hyperplasia And CARDIO VASCULAR
Endothelial function in patients with VASCULOGENIC
Endothelial function of brachial and cavernous arteries in patients with erectile dysfunction
Endothelial microparticles and erectile dysfunction: an update
Endothelial microparticles correlate with ERECTILE DYSFUNCTION
Endothelial nitric oxide synthase polymorphisms are a risk factor for ERECTILE DYSFUNCTION VASCULAR
VASCULAR /149/01720103″>ENDOTHELIAL-ERECTILE DYSFUNCTION AND CARDIO VASCULAR
Endothelin-1 (ET-1) contributes to ERECTILE DYSFUNCTION HYPERTENSIVE
Endo VASCULAR VASCULAR VASCULOGENIC
Endo VASCULAR
Endo VASCULAR
Endo VASCULAR
Endo VASCULAR
Endo VASCULAR VASCULOGENIC
Endo VASCULAR VASCULOGENIC
Endo VASCULAR
Endo VASCULAR
Endo VASCULAR ERECTILE DYSFUNCTION
Endo VASCULAR ERECTILE DYSFUNCTION
Endo VASCULAR ERECTILE DYSFUNCTION ARTERY
Endo VASCULAR ERECTILE DYSFUNCTION
Endo VASCULAR VASCULOGENIC
Engaging patients in CARDIO VASCULAR
Enhanced External Counterpulsation in Patients with Coronary ARTERY
Enhanced External Counterpulsation in Patients with Coronary ARTERY
Enhanced external counterpulsation in patients with coronary ARTERY
Enhanced external counterpulsation in patients with coronary ARTERY
Enrolling men, their doctors and partners: Individual and collective responses to erectile dysfunction
Epidemiology of ERECTILE DYSFUNCTION HYPERTENSION
EPIDEMIOLOGY: ERECTILE DYSFUNCTION CARDIO VASCULAR
epidemiology: The prevalence of ERECTILE DYSFUNCTION HYPERTENSIVE
Erectile and Sex Hormone Dysfunction and CARDIO VASCULAR
Erectile and Sex Hormone Dysfunction and CARDIO VASCULAR
Erectile dysfunction (ED) as a marker for CARDIO VASCULAR
Erectile dysfunction (ED) is a shared sexual concern of couples II: association of female partner characteristics with male partner ED treatment seeking and …
Erectile Dysfunction (ED), Part I: Its Varieties, Prevalence, Causes, And Relationship Implications
VASCULAR /49/00002413″>Erectile Dysfunction & Peripheral VASCULAR
Erectile dysfunction a predictor of HEART
Erectile dysfunction agents and nonarteritic anterior ischemic optic neuropathy
Erectile dysfunction among HIV-infected men is associated with protease inhibitor containing HAART
Erectile dysfunction among HYPERTENSIVE
Erectile Dysfunction Among HYPERTENSIVE
Erectile dysfunction among male HYPERTENSIVE
Erectile dysfunction among men attending surgical outpatients Department in a Tertiary Hospital in South-Western Nigeria
ERECTILE DYSFUNCTION AMONG THE HYPERTENSIVE
Erectile dysfunction and angiographic extent of coronary ARTERY
Erectile dysfunction and associated risk factors among young Mexican adults: The importance of partner availability
Erectile dysfunction and asymptomatic coronary ARTERY
Erectile Dysfunction and CARDIO VASCULAR
Erectile Dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile Dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
Erectile dysfunction and CARDIO VASCULAR
ERECTILE DYSFUNCTION AND CORONARY ARTERY HYPERTENSIVE
Erectile dysfunction and coronary ARTERY
Erectile dysfunction and coronary ARTERY
Erectile dysfunction and coronary ARTERY
Erectile dysfunction and coronary ARTERY
Erectile dysfunction and coronary ARTERY CARDIAC
Erectile Dysfunction and Coronary ARTERY
Erectile dysfunction and coronary HEART
Erectile dysfunction and depressive mood in men with coronary HEART
Erectile dysfunction and diabetes: a prelude to CARDIO VASCULAR
Erectile dysfunction and essential HYPERTENSION
Erectile dysfunction and HEART
Erectile dysfunction and HEART
Erectile dysfunction and HEART
Erectile dysfunction and HEART
Erectile dysfunction and HYPERTENSION
Erectile dysfunction and HYPERTENSION
Erectile dysfunction and HYPERTENSION CARDIO VASCULAR
Erectile dysfunction and HYPERTENSION
Erectile dysfunction and incidence of CARDIO VASCULAR
Erectile Dysfunction and Incidence of CARDIO VASCULAR
Erectile Dysfunction and Ischaemic HEART
Erectile Dysfunction and its association to CARDIO VASCULAR
Erectile dysfunction and its influence on quality of life in patients with essential HYPERTENSION
Erectile dysfunction and its relationship with CARDIO VASCULAR
Erectile dysfunction and its severity are related to the number of CARDIO VASCULAR
Erectile dysfunction and later CARDIO VASCULAR VASCULAR
Erectile dysfunction and lower urinary tract symptoms should trigger a metabolic screen and CARDIO VASCULAR
Erectile dysfunction and NO: variations of NO penile BLOOD
Erectile dysfunction and prostate brachytherapy doses to the penile bulb and neuro VASCULAR
Erectile dysfunction and relationships: views of men with ERECTILE DYSFUNCTION
Erectile dysfunction and risk of CARDIO VASCULAR
Erectile dysfunction and risk of CARDIO VASCULAR
Erectile dysfunction and risk of clinical CARDIO VASCULAR
Erectile dysfunction and sex hormone changes in chronic obstructive PULMONARY
Erectile dysfunction and silent coronary ARTERY
Erectile dysfunction and sleep apnea syndrome are risk factors of CARDIO VASCULAR
Erectile dysfunction and statin treatment in high CARDIO VASCULAR
Erectile dysfunction and subclinical CARDIO VASCULAR
Erectile dysfunction and subsequent CARDIO VASCULAR
Erectile dysfunction and target organ damage in the early stages of HYPERTENSION
Erectile dysfunction and testosterone deficiency as CARDIO VASCULAR
Erectile dysfunction and testosterone deficiency as gender-specific markers of cardiometabolic risk in minority and non-minority men: Potential role of social …
Erectile dysfunction and the “window of curability”: a harbinger of CARDIO VASCULAR
Erectile dysfunction and the biochemical/molecular/regulation of human penile arteries
Erectile dysfunction and the CARDIO VASCULAR
Erectile dysfunction and the HEART
Erectile dysfunction and undiagnosed diabetes, HYPERTENSION
Erectile Dysfunction and Various CARDIO VASCULAR
Erectile Dysfunction and VASCULAR
Erectile dysfunction and VASCULAR
Erectile dysfunction and VASCULAR
Erectile dysfunction arising from polyarteritis nodosa: a case report
Erectile Dysfunction as a CARDIO VASCULAR
Erectile dysfunction as a CARDIO VASCULAR
Erectile Dysfunction as a CARDIO VASCULAR
Erectile dysfunction as a complication of HEART
Erectile dysfunction as a coronary ARTERY
Erectile dysfunction as a generalized VASCULAR
Erectile dysfunction as a harbinger for increased cardiometabolic risk
Erectile dysfunction as a harbinger of CARDIO VASCULAR VASCULAR
Erectile dysfunction as a marker for CARDIO VASCULAR
Erectile dysfunction as a marker for VASCULAR
Erectile dysfunction as a marker of silent CARDIO VASCULAR VASCULAR
Erectile dysfunction as a predictive factor for coronary ARTERY
ERECTILE DYSFUNCTION AS A PREDICTIVE FACTOR OF CORONARY ARTERY
Erectile dysfunction as a predictor for subsequent atherosclerotic CARDIO VASCULAR
Erectile dysfunction as a predictor of advanced VASCULAR
Erectile dysfunction as a predictor of asymptomatic coronary ARTERY
ERECTILE DYSFUNCTION AS A PREDICTOR OF CARDIO VASCULAR
Erectile dysfunction as a predictor of CARDIO VASCULAR
Erectile dysfunction as a predictor of CARDIO VASCULAR ARTERY
Erectile dysfunction as a predictor of CARDIO VASCULAR
Erectile dysfunction as a predictor of coronary ARTERY
Erectile dysfunction as a predictor of early stage of coronary ARTERY
Erectile dysfunction as a risk factor for coronary HEART
Erectile Dysfunction as a Risk Factor Predicting Coronary ARTERY
Erectile Dysfunction as a Sentinel Marker fo CARDIO VASCULAR
Erectile dysfunction as a sentinel symptom of CARDIO VASCULAR
Erectile dysfunction as a symptom of VASCULAR
Erectile Dysfunction as an ‘Early Diagnostic Window’for Asymptomatic Coronary ARTERY
VASCULAR -diseas-4″>Erectile dysfunction as an early marker for CARDIO VASCULAR
Erectile Dysfunction as an Early Marker of Elevated BLOOD BLOOD
Erectile dysfunction as an early sign of CARDIO VASCULAR
Erectile dysfunction as an independent predictor of future CARDIO VASCULAR
Erectile dysfunction as manifestation of endothelial changes in coronary ARTERY
Erectile dysfunction as the first sign of systemic VASCULAR VASCULAR
Erectile Dysfunction Associated with CARDIO VASCULAR
Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports
Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.
ERECTILE DYSFUNCTION AT PRESENTATION AS AN OPPORTUNITY FOR CARDIO VASCULAR
Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary ARTERY
Erectile dysfunction can predict CARDIO VASCULAR
Erectile dysfunction can predict coronary ARTERY
Erectile dysfunction can signal impending HEART
Erectile Dysfunction Complicating CARDIO VASCULAR
Erectile dysfunction correlates with left ventricular function and precedes CARDIO VASCULAR CARDIO VASCULAR
ERECTILE DYSFUNCTION DRUG (PHOSPHODIESTERASE-5 INHIBITORS) ASSOCIATED WITH NON-ARTERITIC ANTERIOR ISCHAEMIC OPTIC …
Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship?
Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy
Erectile dysfunction heralds onset of CARDIO VASCULAR
Erectile Dysfunction in 101 Consecutive HYPERTENSIVE
Erectile dysfunction in a group of congolese HYPERTENSIVE
Erectile dysfunction in a sample of patients attending a psychiatric outpatient department
Erectile dysfunction in anterior urethral strictures after urethroplasty with reference to VASCULAR
Erectile dysfunction in Arab countries. Part I: Prevalence and correlates
Erectile dysfunction in Arab countries. Part II: Diagnosis and treatment
Erectile dysfunction in CARDIO VASCULAR
Erectile dysfunction in CARDIO VASCULAR
Erectile dysfunction in cerebro VASCULAR
Erectile dysfunction in chronic kidney disease: part one
Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal HYPERTENSION HYPERTENSION
Erectile dysfunction in congenital HEART
Erectile dysfunction in coronary ARTERY HEART
Erectile dysfunction in diabetes mellitus: a risk factor for CARDIO VASCULAR
Erectile dysfunction in essential arterial HYPERTENSION
Erectile dysfunction in HEART
Erectile dysfunction in HEART
Erectile dysfunction in HEART
Erectile dysfunction in HEART ARTERY
Erectile dysfunction in high‐risk HYPERTENSIVE
Erectile dysfunction in HYPERTENSION CARDIO VASCULAR
Erectile dysfunction in HYPERTENSIVE
Erectile dysfunction in HYPERTENSIVE
ERECTILE DYSFUNCTION IN MALE GERIATRIC POPULATION WITH ARTERIAL HYPERTENSION
Erectile dysfunction in male patients with severe chronic obstructive PULMONARY
Erectile dysfunction in men with angiographically documented coronary ARTERY
Erectile dysfunction in men with congenital HEART
Erectile Dysfunction in Men with Essential Arterial HYPERTENSION
Erectile dysfunction in men with high-normal BLOOD
Erectile dysfunction in Nigerian HYPERTENSIVE
Erectile dysfunction in patients under antihypertensive treatment
Erectile dysfunction in patients with arterial HYPERTENSION CARDIO VASCULAR
Erectile dysfunction in patients with CARDIO VASCULAR
Erectile Dysfunction in Patients with CARDIO VASCULAR
Erectile Dysfunction in Patients with Chronic Obstructive PULMONARY
Erectile dysfunction in patients with coronary ARTERY
Erectile dysfunction in patients with HYPERTENSION
Erectile dysfunction in patients with ischemic HEART
Erectile dysfunction in patients with plaque psoriasis: the relation of depression and CARDIO VASCULAR
Erectile dysfunction in primary care: a focus on cardiometabolic risk evaluation and stratification for future CARDIO VASCULAR
Erectile dysfunction in primary care: Sexual health inquiry and CARDIO VASCULAR CARDIO VASCULAR
Erectile dysfunction in PULMONARY
Erectile dysfunction in PULMONARY
Erectile dysfunction in Qatar: Prevalence and risk factors in 1,052 participants—A pilot study
Erectile dysfunction in smokers: a penile dynamic and VASCULAR
Erectile dysfunction in spontaneously HYPERTENSIVE
Erectile dysfunction in the cardiology practice—a patients’ perspective
Erectile dysfunction in the CARDIO VASCULAR
Erectile dysfunction in the case of CARDIO VASCULAR
Erectile dysfunction in the patients with CARDIO VASCULAR
Erectile dysfunction in the trajectory of CARDIO VASCULAR
Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and CARDIO VASCULAR
Erectile dysfunction increases CARDIO VASCULAR
Erectile dysfunction is a signal of risk for CARDIO VASCULAR
Erectile dysfunction is an early predictor of CARDIO VASCULAR
Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary HEART
ERECTILE DYSFUNCTION IS ASSOCIATED WITH ENDOTHELIAL CELL ACTIVATION ALSO IN ABSENCE OF VASCULAR
Erectile Dysfunction is Associated With Retinopathy in Diabetic Men: Two Manifestations of a Systemic Micro- VASCULAR
Erectile dysfunction is associated with subclinical carotid VASCULAR
Erectile dysfunction is associated with subsequent CARDIO VASCULAR
Erectile dysfunction is not independently associated with CARDIO VASCULAR
Erectile dysfunction is positively correlated with mean platelet volume and platelet count, but not with eosinophil count in peripheral BLOOD
Erectile dysfunction is prevalent, and underreported in male HYPERTENSIVE
Erectile dysfunction links to CARDIO VASCULAR
Erectile Dysfunction Management for the Future Arthur L. Burnett, MD
Erectile dysfunction may be an early sign of HEART
Erectile dysfunction may improve by BLOOD HYPERTENSION
Erectile dysfunction may predict coronary ARTERY ARTERY ERECTILE DYSFUNCTION
Erectile dysfunction medication induced-changes in plasma levels of homocysteine and antioxidant enzyme activities as risk factors for CARDIO VASCULAR
Erectile dysfunction medication use in veterans eligible for medicare part D
Erectile dysfunction medications and treatment for cardiometabolic risk factors: a pharmacoepidemiologic study
Erectile dysfunction might be associated with chronic periodontal disease: two ends of the CARDIO VASCULAR
Erectile dysfunction might predict silent unobstructive coronary ARTERY
Erectile dysfunction of sclerodermic patients correlates with digital VASCULAR
Erectile dysfunction of VASCULAR
Erectile dysfunction Part 2: Managing men unresponsive to PDE5 inhibitors
Erectile Dysfunction Precedes and Is Associated with Severity of Coronary ARTERY
Erectile dysfunction precedes coronary ARTERY
Erectile dysfunction precedes other systemic VASCULAR
Erectile Dysfunction Predicts CARDIO VASCULAR
Erectile Dysfunction Predicts CARDIO VASCULAR
Erectile dysfunction predicts CARDIO VASCULAR
Erectile dysfunction predicts CARDIO VASCULAR
Erectile dysfunction predicts coronary HEART
Erectile dysfunction predicts generalised CARDIO VASCULAR
Erectile Dysfunction Predicts High Risk Findings on Myocardial Perfusion SPECT Imaging in Men without Prior HEART
Erectile dysfunction predicts peripheral arterial disease as measured by screening ankle brachial index testing
Erectile dysfunction prevalence and sexual function status in patients with chronic obstructive PULMONARY
Erectile dysfunction prospectively associated with CARDIO VASCULAR
Erectile dysfunction scores are lower in type 2 diabetes mellitus but not correlate with carotis intima media ticknes or coronary arter disease
Erectile dysfunction severity and prediction of CARDIO VASCULAR
Erectile dysfunction severity and SYNTAX score in coronary ARTERY
Erectile dysfunction severity as a risk marker for CARDIO VASCULAR
Erectile dysfunction therapy in special populations and applications: coronary ARTERY
Erectile dysfunction vs. physical capacity and physical activity at invasive treated patients with ischemic HEART
Erectile dysfunction–early sign of CARDIO VASCULAR
Erectile Dysfunction-A Missed Part of Benign Prostate Hyperplasia
Erectile dysfunction—a CARDIO VASCULAR
Erectile dysfunction—overview from a CARDIO VASCULAR
Erectile dysfunction, a new symptom for the cardiologist
Erectile dysfunction, and risk factors of CARDIO VASCULAR
ERECTILE DYSFUNCTION, ARTERIAL HYPERTENSION
Erectile dysfunction, cardiology at the epicenter
Erectile dysfunction, CARDIO VASCULAR
Erectile dysfunction, CARDIO VASCULAR
Erectile dysfunction, depression, and ischemic HEART
Erectile dysfunction, diabetes and CARDIO VASCULAR
Erectile dysfunction, endothelium dysfunction, and micro VASCULAR
ERECTILE DYSFUNCTION, ITS CLINICAL CORRELATES AND PERCEIVED IMPACT ON PARTNERS OF AFFECTED MEN ATTENDING THE GENERAL …
Erectile dysfunction, like diabetes, should be considered a ‘cardio VASCULAR
Erectile dysfunction, loss of libido and low sexual frequency increase the risk of CARDIO VASCULAR
Erectile dysfunction, metabolic syndrome and arterial disease. Clinical–pathological relation by carotid ultrasonography
Erectile dysfunction, metabolic syndrome, and CARDIO VASCULAR
Erectile dysfunction, penile atherosclerosis, and coronary ARTERY HEART
Erectile dysfunction, quality of life, and partnership in prostate cancer
Erectile dysfunction, testosterone deficiency, and risk of coronary HEART
Erectile dysfunction, VASCULAR
Erectile dysfunction: a disease marker for CARDIO VASCULAR
Erectile dysfunction: a marker of early coronary HEART
Erectile Dysfunction: A Marker of Peripheral VASCULAR
Erectile dysfunction: a marker of silent coronary ARTERY
Erectile dysfunction: a marker of subclinic coronary ARTERY
Erectile dysfunction: a potential useful marker for CARDIO VASCULAR
Erectile dysfunction: a sentinel marker for CARDIO VASCULAR
Erectile dysfunction: a significant health need in patients with coronary HEART
Erectile dysfunction: a syndrome heralds HEART
Erectile dysfunction: a VASCULAR
Erectile dysfunction: a warning sign of silent VASCULAR
Erectile dysfunction: a window of opportunity for preventing VASCULAR
Erectile dysfunction: a window to the HEART
Erectile dysfunction: an early marker for HYPERTENSION HYPERTENSIVE
Erectile dysfunction: an early sign of CARDIO VASCULAR
Erectile dysfunction: another window to the HEART
Erectile dysfunction: CARDIO VASCULAR
Erectile dysfunction: CARDIO VASCULAR
Erectile dysfunction: does insulin resistance play a part?
Erectile dysfunction: Endothelial nitric oxide synthase expression is reduced in mononuclear cells from cavernous BLOOD
ERECTILE DYSFUNCTION: ERECTILE DYSFUNCTION HEART HEART
ERECTILE DYSFUNCTION: ERECTILE DYSFUNCTION ARTERY
ERECTILE DYSFUNCTION: ERECTILE DYSFUNCTION CARDIO VASCULAR
Erectile dysfunction: heritability and cognitive and physiological correlates of the subclinical VASCULAR
Erectile dysfunction: indicator of end-organ damage in CARDIO VASCULAR
Erectile dysfunction: main article
Erectile dysfunction: pathophysiologic mechanisms pointing to underlying CARDIO VASCULAR
Erectile dysfunction: prevalence, risk factors and involvement of antihypertensive drugs intervention
Erectile dysfunction: risk factor or manifestation of CARDIO VASCULAR
Erectile dysfunction: the earliest sign of generalized VASCULAR
Erectile dysfunction: The impact on the female partner and on the couple: The role of the urologist [Disturbi dell’erezione: Impatto sulla donna e sulla coppia: Il ruolo …
Erectile dysfunction: the perspectives of patients and partners on counselling
Erectile Dysfunction: The Tip of a VASCULAR CARDIO VASCULAR
Erectile dysfunction: ultrasound evaluation and CARDIO VASCULAR
Erectile dysfunction: Why is it the ignored symptom of CARDIO VASCULAR
Erectile dysfunction. Part 1: investigation and management
Erectile VASCULAR
Erection, erectile dysfunction: what has HEART
Erratum: HEART BLOOD ERECTILE DYSFUNCTION CARDIO VASCULAR
Establishment of arteriogenic ERECTILE DYSFUNCTION
Estimated CARDIO VASCULAR
et al. Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction. Br J Ophthalmol 2006; 90: 154e7. This article has been
Evaluating a continuous medical education program to improve general practitioners awareness and practice on ERECTILE DYSFUNCTION CARDIO VASCULAR
Evaluating the treatment satisfaction of vardenafil in men with ERECTILE DYSFUNCTION
Evaluation and management of ERECTILE DYSFUNCTION HYPERTENSIVE
Evaluation of ambulatory CARDIAC ERECTILE DYSFUNCTION HEART
Evaluation of arterial stiffness and CARDIAC VASCULAR
Evaluation of BLOOD
Evaluation of endothelial function with brachial ARTERY ERECTILE DYSFUNCTION
Evaluation of ERECTILE DYSFUNCTION CARDIO VASCULAR
Evaluation of Helicine Arteries in Patients with ERECTILE DYSFUNCTION
Evaluation Of Linear Shock Wave Therapy In Patients With VASCULOGENIC ERECTILE DYSFUNCTION
Evaluation of penile re VASCULAR
Evaluation of penile VASCULAR
Evaluation of tadalafil in men with ERECTILE DYSFUNCTION
Evaluation of the Nervous and VASCULAR ERECTILE DYSFUNCTION
Evaluation of VASCULAR
Evaluation of VASCULOGENIC
Evaluations of ERECTILE DYSFUNCTION ARTERY
Exercise prevents Western diet-associated ERECTILE DYSFUNCTION ARTERY
Exercise prevents Western-diet associated erectile and coronary ARTERY
Experimental Research of Huoxue Qiwei Granules in the Treatment of ERECTILE DYSFUNCTION
Expression of the Apelin–APJ Pathway and Effects on Erectile Function in a Mouse Model of VASCULOGENIC
External mechanical devices and VASCULAR
Extracorporeal Shock Waves Therapy Delivered by Aries Improves ERECTILE DYSFUNCTION HYPERTENSIVE
Facing ERECTILE DYSFUNCTION
Factors affecting the increased prevalence of ERECTILE DYSFUNCTION HYPERTENSIVE
Factors associated with sex hormones and ERECTILE DYSFUNCTION
Feasibility of dynamic 3-D color Doppler ultrasound for imaging penile VASCULAR ERECTILE DYSFUNCTION
Female partners confronted with erectile dysfunction. A series of 137 patients
FEMALE PARTNERS’ATTITUDES ARE ASSOCIATED WITH TREATMENT SEEKING FOR ERECTILE DYSFUNCTION
Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction
Female sexual partners of men with erectile dysfunction: Biopsychosocial characteristics and quality of life
Fertility Related Quality of Life, Gonadal Function and ERECTILE DYSFUNCTION
Fibrous hamartoma of corpus cavernosum: a rare cause of congenital penile curvature associated with erectile dysfunction
Five-year prospective study on CARDIO VASCULAR ERECTILE DYSFUNCTION
FJVIS 35. Sexual Dysfunction After Aortoiliac Surgery: Does Endo VASCULAR
Flowchart of examination of erectile dysfunction
Folic acid supplementation improves erectile function in patients with idiopathic VASCULOGENIC ERECTILE DYSFUNCTION
Formulation of Double-layer Tadalafil and Amlodipine Complex Tablets to Treat ERECTILE DYSFUNCTION HYPERTENSION
Frequency of sexual activity and CARDIO VASCULAR
Frequency of sexual activity and CARDIO VASCULAR
Frequency of VASCULOGENIC ERECTILE DYSFUNCTION
FTY720 supplementation partially improves ERECTILE DYSFUNCTION
Functional and structural changes in internal pudendal arteries underlie ERECTILE DYSFUNCTION
Functional characterization of platelets in patients with arterial erectile dysfunction
G-protein β3 subunit gene 825C/T polymorphism and its association with the presence, severity, and duration of VASCULOGENIC
GENDER DIFFERENCES IN ATTITUDES OF PARTNERS OF MEN WITH ERECTILE DYSFUNCTION
Graded association between aortic stiffness, wave reflections, and duration of VASCULOGENIC
Graded Association Between Large ARTERY ERECTILE DYSFUNCTION HYPERTENSIVE
GW24-e3520 Association of CARDIO VASCULAR
GW25-e3095 The association between CARDIO VASCULAR ERECTILE DYSFUNCTION
GW26-e0790 ERECTILE DYSFUNCTION ARTERIOSCLEROSIS
GW27-e0510 ERECTILE DYSFUNCTION CARDIO VASCULAR
H 002 HYPERTENSION
Health Promotion for African-American Men: Improving awareness of the link between ERECTILE DYSFUNCTION CARDIO VASCULAR
Heart disease and erectile dysfunction
Heart disease and erectile dysfunction: Management at a nurse-led clinic
Heart disease in erectile dysfunction
Heart disease risk factors predict ERECTILE DYSFUNCTION
Heart disease risk factors predict ERECTILE DYSFUNCTION
Heart rate and BLOOD ERECTILE DYSFUNCTION CARDIO VASCULAR
Heart rate recovery, CARDIAC ERECTILE DYSFUNCTION HEART
Heart rate recovery, CARDIAC ERECTILE DYSFUNCTION HEART
Heart rate reduction with ivabradine improves ERECTILE DYSFUNCTION
Heart Rate Variability in Male Sexual Arousal and Erectile Dysfunction
Heart rate variability in men with erectile dysfunction
Help-seeking Pattern of ERECTILE DYSFUNCTION
Hemodynamic evaluation of the penile arterial system in patients with ERECTILE DYSFUNCTION
HEPATIC STEATOSIS IS INDEPENDENTLY ASSOCIATED WITH ERECTILE DYSFUNCTION: ONE MORE LINK BETWEEN THE LIVER AND CARDIO VASCULAR
Hepatic steatosis is independently associated with erectile dysfunction: One more link between the liver and CARDIO VASCULAR
Hexahydropyrazino [1’2′; 1, 6] pyrido [3, 4-b] indole-1, 4-diones for the treatment of CARDIO VASCULAR
High triglycerides predicts arteriogenic ERECTILE DYSFUNCTION CARDIO VASCULAR
High-tone electric muscles stimulation of thigh augments the impaired penile BLOOD
High-tone electric muscles stimulation of thigh augments the impaired penile BLOOD
How does ivabradine effect ERECTILE DYSFUNCTION HEART
How to save a life during a clinic visit for ERECTILE DYSFUNCTION CARDIO VASCULAR
How to treat ERECTILE DYSFUNCTION CARDIO VASCULAR
How to treat HYPERTENSIVE
HP-03-004 Establishing the safety profile in sexual partners of a new topical glyceryl trinitrate gel for the treatment of erectile dysfunction
HP-07-007 Unveiling the role of vasculogenesis in diabetic ERECTILE DYSFUNCTION
Hypertension and erectile dysfunction
HYPERTENSION AND ERECTILE DYSFUNCTION: NEW INSIGHTS IN HEART
Hypertension is more prevalent in men with erectile dysfunction
Hypertension might be a risk factor for erectile dysfunction: a meta‐analysis
Hypertension, anti‐hypertensive drug therapy and ERECTILE DYSFUNCTION
Hypertension, antihypertensive therapy, and erectile dysfunction
Hypertension, obesity, erectile dysfunction. What kind of drug to choose
Hypertension: the link between ERECTILE DYSFUNCTION ARTERY
Hypertensive medication and erectile dysfunction
I am a male in my late 50s. I have HEART
IIEF-5 cannot be used as a tool for differential diagnosis of VASCULOGENIC
Immediate-and late-hemodynamic coronary effects of tadalafil in men with ERECTILE DYSFUNCTION ARTERY
Impact of ERECTILE DYSFUNCTION
Impact of Lipid and BLOOD ERECTILE DYSFUNCTION CARDIO VASCULAR
Impact of tadalafil once daily in men with erectile dysfunction—including a report of the partners’ evaluation
Impaired arteriogenic rather than veno-occlusive mechanisms are responsible for ERECTILE DYSFUNCTION
Impaired brachial ARTERY ERECTILE DYSFUNCTION CARDIO VASCULAR
Impaired VASCULAR
Impairment of shear-stress-mediated vasodilation of cavernous arteries in erectile dysfunction
Implantation of Autologous Bone Marrow-derived Cells Improves ERECTILE DYSFUNCTION HYPERTENSIVE
Implantation of bioresorbable VASCULAR ARTERY
Implants, mechanical devices, and VASCULAR
Importance of the ERECTILE DYSFUNCTION
Improved penile histology by phalloidin stain: circular and longitudinal cavernous smooth muscles, dual-endothelium arteries, and erectile dysfunction-associated …
Improved spontaneous erectile function in men with mild‐to‐moderate arteriogenic ERECTILE DYSFUNCTION
Improvement in quality of sexual life in female partners of men with ERECTILE DYSFUNCTION
Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: A randomized, double‐blind, placebo …
Improvement of ERECTILE DYSFUNCTION VASCULAR
In the “Heart” of Erectile Dysfunction
Incidence of ERECTILE DYSFUNCTION HYPERTENSIVE
Incidence of extragenital VASCULAR ERECTILE DYSFUNCTION
Incidence of extragenital VASCULAR ERECTILE DYSFUNCTION
Incidental findings during computed tomographic angiography diagnostic work-up in patients with arteriogenic erectile dysfunction
Increased erythrocyte aggregation in men with coronary ARTERY
Increased expression of endothelial-platelet dysfunctional pathway in patients with arterial erectile dysfunction.
Increased expression of insulin-like growth factor-binding protein-3 is implicated in ERECTILE DYSFUNCTION HYPERTENSIVE
Independent determinants of coronary ARTERY ERECTILE DYSFUNCTION
Inflammation, metabolic syndrome, erectile dysfunction, and coronary ARTERY
Influence of age and changes over time on erectile dysfunction: Results from two large cross-sectional surveys 11 years apart
Influence of eNOS gene on CARDIO VASCULAR ERECTILE DYSFUNCTION
Influence of regular use of vardenafil on endothelial and erectile functions in patients with arteriogenic erectile dysfunction
Influence of VASCULAR ERECTILE DYSFUNCTION
Influence of VASCULAR ERECTILE DYSFUNCTION
Influence of VASCULAR ERECTILE DYSFUNCTION
Inhibiting BLOOD
Inhibition of NADPH Oxidase by Apocynin Alleviates ERECTILE DYSFUNCTION HYPERTENSIVE
Initial validation of a novel rat model of VASCULOGENIC ERECTILE DYSFUNCTION
Integrating partners into ERECTILE DYSFUNCTION
Interactions between drugs for ERECTILE DYSFUNCTION CARDIO VASCULAR
Interactions between lower urinary tract symptoms and CARDIO VASCULAR
Internal pudendal ARTERY ARTERY
Interrelation of ERECTILE DYSFUNCTION HYPERTENSION
Interrelationships between ERECTILE DYSFUNCTION HYPERTENSIVE
Intima-media thickening of common carotid arteries is a risk factor for severe ERECTILE DYSFUNCTION VASCULAR
Intima‐media thickness of carotid arteries and ERECTILE DYSFUNCTION
Intima–media thickness and BLOOD ERECTILE DYSFUNCTION
Intracavernous injection of human umbilical cord BLOOD ERECTILE DYSFUNCTION
Intracavernous injections for ERECTILE DYSFUNCTION CARDIO VASCULAR
Introduction: ERECTILE DYSFUNCTION CARDIO VASCULAR
Inverse correlation between testosterone and ventricle ejection fraction, hemodynamics and exercise capacity in HEART
Investigating women’s preference for sildenafil or tadalafil use by their partners with erectile dysfunction: The partners’ preference study
Investigative models in erectile dysfunction: A state‐of‐the‐art review of current animal models
Invited Comments on Billups, K. et al. ERECTILE DYSFUNCTION CARDIO VASCULAR
Irradiation of the Pudendal Arteries Induces ERECTILE DYSFUNCTION
Is chronic obstructive PULMONARY
Is ERECTILE DYSFUNCTION CARDIO VASCULAR
Is ERECTILE DYSFUNCTION CARDIO VASCULAR
Is ERECTILE DYSFUNCTION CARDIO VASCULAR
Is ERECTILE DYSFUNCTION ARTERY
Is ERECTILE DYSFUNCTION HEART
Is ERECTILE DYSFUNCTION HEART
Is ERECTILE DYSFUNCTION VASCULAR
Is ERECTILE DYSFUNCTION VASCULAR
Is ERECTILE DYSFUNCTION CARDIO VASCULAR
Is ERECTILE DYSFUNCTION VASCULAR
Is high cholesterol a risk for erectile dysfunction? Results based on the penile BLOOD
Is metabolic syndrome a useless category in subjects with high CARDIO VASCULAR
Is obesity a further CARDIO VASCULAR
Is penile atherosclerosis the link between ERECTILE DYSFUNCTION CARDIO VASCULAR
Is Self-Report of ERECTILE DYSFUNCTION CARDIO VASCULAR
Is serum uric acid level correlated with ERECTILE DYSFUNCTION ARTERY
Is the relationship between cigarette smoking and male ERECTILE DYSFUNCTION CARDIO VASCULAR
Is there a concordance between carotid and penile cavernosal ARTERY
Is there a link between ERECTILE DYSFUNCTION ARTERY
Is there a relationship between penile VASCULOGENIC
Is there a relationship between severity of coronary ARTERY
Isolated polyarteritis nodosa of the genitourinary tract presenting with severe erectile dysfunction: a case report with long-term follow-up
Johnson & Åsberg: Enrolling Men, their Doctors, and Partners: Individual and Collective Responses to Erectile Dysfunction
l-Arginine and tetrahydrobiopterin, but not sodium nitrite partially restored ERECTILE DYSFUNCTION
Lack of predictive correlation between peripheral arterial tone and colour flow Doppler parameters in men with erectile dysfunction.
LC–MS/MS software for screening unknown ERECTILE DYSFUNCTION
Lesion pattern in patients with ERECTILE DYSFUNCTION
Letter by Li et al Regarding Article,“Erectile Dysfunction as an Independent Predictor of Future CARDIO VASCULAR
Letter by Nunes Regarding Article,“Clinical Cardiology: Physician Update: ERECTILE DYSFUNCTION CARDIO VASCULAR
Letter by Su and Li Regarding Article,“Erectile Dysfunction as an Independent Predictor of Future CARDIO VASCULAR
Letter Regarding Article by Gazzaruso et al,“Relationship Between ERECTILE DYSFUNCTION
Letter regarding the article “the impact of hypomagnesemia on ERECTILE DYSFUNCTION
Levitra-test in diagnosis of VASCULOGENIC
Lifestyle Changes, Erectile Dysfunction, and Female Sexual Dysfunction: HEART
Lifestyle management of erectile dysfunction: the role of CARDIO VASCULAR
Lifestyle modification in ERECTILE DYSFUNCTION HYPERTENSION
Lifestyle modifications and pharmacotherapy for CARDIO VASCULAR
Linking CARDIO VASCULAR ERECTILE DYSFUNCTION
Linking ERECTILE DYSFUNCTION ARTERY
Lipoprotein‐associated phospholipase A 2 levels are associated with ERECTILE DYSFUNCTION ARTERY
Liver & gallbladder: based ERECTILE DYSFUNCTION
Liver & gallbladder: based erectile dysfunction:(part one)
Loadable Polymeric Particles for Therapeutic Use in ERECTILE DYSFUNCTION
Local delivery of COMP-angiopoietin-1 protein as a novel therapeutic strategy for VASCULAR
VASCULAR -erectile-dysfunction-patients-20-months-follow-up/”>Long Term Efficacy of Low Intensity Linear Focused Shockwave Therapy for VASCULAR ERECTILE DYSFUNCTION
Losartan improves ERECTILE DYSFUNCTION
Losartan preserves erectile function by suppression of apoptosis and fibrosis of corpus cavernosum and corporal veno-occlusive dysfunction in diabetic rats
VASCULAR -erectile-dysfunction-patients/”>Low Intensity Linear Focused Shockwave Therapy: a New Treatment to Improve the Quality of Life of VASCULAR ERECTILE DYSFUNCTION
Low-dose tadalafil improves arterial erectile dysfunction
Low-energy shock wave therapy ameliorates ERECTILE DYSFUNCTION VASCULAR
Low-energy Shock Wave Therapy—A Novel Treatment Option for ERECTILE DYSFUNCTION CARDIO VASCULAR
Low-intensity extracorporeal shock wave therapy of VASCULOGENIC
Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients With VASCULOGENIC
Low-intensity shockwave therapy improves hemodynamic parameters in patients with VASCULOGENIC
Low‐Intensity Extracorporeal Shock Wave Therapy in VASCULAR
Lower urinary tract symptoms in patients with erectile dysfunction: is there a VASCULAR
Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to VASCULAR
Male ERECTILE DYSFUNCTION CARDIO VASCULAR
Male ERECTILE DYSFUNCTION HYPERTENSION
Male sexuality and CARDIO VASCULAR
Management of ERECTILE DYSFUNCTION HYPERTENSION
Management of ERECTILE DYSFUNCTION VASCULAR
Management of ERECTILE DYSFUNCTION CARDIO VASCULAR
Management of ERECTILE DYSFUNCTION CARDIO VASCULAR
Management of Erectile Dysfunction: An Under-recognition of HYPERTENSION
Management of erectile dysfunction: do not forget HYPERTENSION
Management of Erectile Dysfunction: Do Not Forget HYPERTENSION
Managing ERECTILE DYSFUNCTION HEART
Managing ERECTILE DYSFUNCTION HYPERTENSION
Managing ERECTILE DYSFUNCTION HYPERTENSIVE
Managing ERECTILE DYSFUNCTION CARDIO VASCULAR
Mean platelet volume and platelet distribution as a diagnostic marker for penile VASCULAR
Mean platelet volume might be an effective indicator of arterial erectile dysfunction
Measurement of endothelial dysfunction via peripheral arterial tonometry predicts VASCULOGENIC
Mechanism of androgen in improving ERECTILE DYSFUNCTION VASCULAR
Mechanisms of VASCULOGENIC ERECTILE DYSFUNCTION
Mediterranean diet linked to improved CARDIO VASCULAR ERECTILE DYSFUNCTION
Men with type 2 diabetes and ERECTILE DYSFUNCTION
Metabolic syndrome in men with low testosterone levels: relationship with CARDIO VASCULAR
Metabolic syndrome/cardio VASCULAR ERECTILE DYSFUNCTION
Microcirculatory changes in penis with VASCULOGENIC
Micro VASCULAR
Micro VASCULAR ERECTILE DYSFUNCTION
VASCULAR _function_and_incident_erectile.1.aspx”>Micro VASCULAR
MODERATE OR SEVERE ERECTILE DYSFUNCTION ARTERY
Modifiable risk factors for erectile dysfunction: an assessment of the awareness of such factors in patients suffering from ischaemic HEART
Molecular basis of veno-occlusion and the molecular pathology of VASCULOGENIC
Morphologic findings and BLOOD
Morphological and functional evidence for the contribution of the pudendal ARTERY
Moulik PK, Hardy KJ: HYPERTENSION ERECTILE DYSFUNCTION
MP-03.09: The COUPLE-project: pooled analysis of satisfaction with vardenafil treatment in men with ERECTILE DYSFUNCTION
MP-03.18: Vardenafil improves treatment satisfaction and sexual pleasure in men with ERECTILE DYSFUNCTION
MP-03.20: Female partners’ attitudes are associated with treatment seeking for ERECTILE DYSFUNCTION
MP-11.08: ERECTILE DYSFUNCTION ARTERY
MP25-16 PENILE RE VASCULAR
MP40-16 ONE OUT OF THREE MEN SEEKING MEDICAL HELP FOR ERECTILE DYSFUNCTION BLOOD
MP76-04 ANDROGENIC THERAPY IN TREATING PATIENTS WITH VASCULOGENIC
Multidisciplinary management of VASCULAR
N-acetylcysteine ameliorates the ERECTILE DYSFUNCTION
N16 VASCULAR ERECTILE DYSFUNCTION
NADPH oxidase activation: A mechanism of HYPERTENSION
Nanoparticle improved stem cell therapy for ERECTILE DYSFUNCTION
Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction
Natural history of ERECTILE DYSFUNCTION HYPERTENSIVE
NDP103: MANAGEMENT OF ERECTILE DYSFUNCTION VASCULAR
Near-infrared spectroscopy to assess penile BLOOD VASCULOGENIC
Nebivolol dilates human penile arteries and reverses ERECTILE DYSFUNCTION
Nebivolol versus other beta blockers in patients with HYPERTENSION
Negative stress echocardiographic study predicts excellent long-term prognosis in patients with erectile dysfunction
Neural and VASCULAR
Neurogenic erectile dysfunction: State of the art!
New immunophenotype of BLOOD ERECTILE DYSFUNCTION
New immunophenotype of circulating endothelial progenitor cells and endothelial microparticles in patients with ERECTILE DYSFUNCTION
New insights into HYPERTENSION
Nitroxyl anion as a novel relaxant molecule in the rat pudendal ARTERY
NO problem: arterial and venous endothelial function and erectile dysfunction.
Nocturnal penile erections: the role of RigiScan in the diagnosis of VASCULAR
Nocturnal systolic BLOOD HYPERTENSIVE
Non-arteritic anterior ischemic optic neuropathy and the treatment of erectile dysfunction
Non-arteritic anterior ischemic optic neuropathy associated with ERECTILE DYSFUNCTION
Non-arteritic anterior ischemic optic neuropathy, ERECTILE DYSFUNCTION
VASCULAR _imaging_for_erecti20160605-32372-1g95bhe.pdf”>Non-invasive VASCULAR
Non‐arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction
Nonarteritic Anterior Ischemic Optic Neuropathy and ERECTILE DYSFUNCTION
Nonarteritic Anterior Ischemic Optic Neuropathy and the Treatment of Erectile Dysfunction
Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction
NONINVASIVE IDENTIFICATION OF VASCULOGENIC ERECTILE DYSFUNCTION
Nonresponse to PDE5 inhibitors in erectile dysfunction. Part 2: alternative therapeutic strategies
Nonresponse to phosphodiesterase 5 inhibitors in erectile dysfunction. Part 1: related factors
Not Only Diabetes Mellitus, but also Impaired Glucose Tolerance is Associated with ERECTILE DYSFUNCTION HYPERTENSIVE
Novel therapy for arteriogenic erectile dysfunction.
Obstructive Sleep Apnea Associated With ERECTILE DYSFUNCTION CARDIO VASCULAR
Obstructive Sleep Apnea Associated With ERECTILE DYSFUNCTION CARDIO VASCULAR
On call. My wife and I both enjoy the” Harvard Men’s Health Watch” newsletter. We’ve read that ERECTILE DYSFUNCTION HEART
OP-041 HEART
OP-114 [AJC» Preventive cardiology] ERECTILE DYSFUNCTION ARTERY
OR 37: Relationship of arterial elasticity and ERECTILE DYSFUNCTION HYPERTENSIVE
OR 38: Sildenafil citrate has mild nitrate-like hemodynamic effects in patients with coronary ARTERY
Oral l‐citrulline supplementation improves erectile function in rats with acute arteriogenic erectile dysfunction
Original immunophenotype of BLOOD ERECTILE DYSFUNCTION
ORIGINAL RESEARCH–ERECTILE DYSFUNCTION: Is the Relationship Between Cigarette Smoking and Male ERECTILE DYSFUNCTION CARDIO VASCULAR
ORIGINAL RESEARCH–ERECTILE DYSFUNCTION: Posttraumatic Nonischemic Priapism Treated with Autologous BLOOD
Outcome of penile re VASCULAR ERECTILE DYSFUNCTION
OUTCOMES ASSESSMENT: Further Psychometric Validation of the Sexual Life Quality Questionnaire for Men with ERECTILE DYSFUNCTION
Oxidative stress and molecular reactions in arteriogenic erectile dysfunction
Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants
VASCULAR _disease_on_obesity_and_penile_erectile_dysfunction/links/56a277cd08ae232fb201af0c.pdf”>Oxidative stress, endothelial dysfunction and VASCULAR
P-01-010 Evaluation of BLOOD
P-01-011 VASCULAR
P-01-013 The first patient-focussed smartphone application about ERECTILE DYSFUNCTION
P-01-017 Therapeutic correction testosterone deficiency in HYPERTENSIVE ERECTILE DYSFUNCTION
P-01-036 Female partners confronted with erectile dysfunction. A series of 137 patients.
P-01-046 Low intensity extracorporeal shock wave therapy in patients with VASCULOGENIC
P-01-051 Evaluation of the effectiveness of low-energy shock wave therapy in diabetic patients with VASCULAR
P-03-041 ERECTILE DYSFUNCTION HEART
P-10: Different effect of valsartan and lisinopril on sildenafil use in HYPERTENSIVE
P-275: ERECTILE DYSFUNCTION BLOOD BLOOD
P-313: Efficacy and safety of tadalafil in men with ERECTILE DYSFUNCTION HYPERTENSION
P-379: Determinants of ERECTILE DYSFUNCTION HYPERTENSION
P-39: Long-term sildenafil administration improves aortic stiffness in patients with ERECTILE DYSFUNCTION VASCULAR
P-405: Prevalence of asymptomatic coronary ARTERY VASCULOGENIC
P-42: Efficacy and safety of Vardenafil, a selective phosphodiesterase 5 inhibitor, in men with ERECTILE DYSFUNCTION
P-581: Relationship between ERECTILE DYSFUNCTION
P-62: Efficacy of VIAGRA®(sildenafil citrate) in men with ERECTILE DYSFUNCTION HYPERTENSION
P-64: Safety of VIAGRA®(sildenafil citrate) in men with ERECTILE DYSFUNCTION HYPERTENSION
P. 034 ERECTILE DYSFUNCTION VASCULAR
P1404Carotid atherosclerosis, aortic stiffness and penile VASCULAR
P2 purinoceptor subtype changes in patients with VASCULOGENIC
P2642 Optimal BLOOD HYPERTENSIVE
P2644 Coronary atherosclerotic burden and risk of major adverse CARDIAC HYPERTENSIVE
P3004Differences in macro VASCULAR VASCULAR HYPERTENSIVE
P4408Coronary ARTERY
P4456Association between glucose metabolic status and global arterial function and early structural changes in men with erectile dysfunction
P4738 ERECTILE DYSFUNCTION HEART
VASCULAR -disease-patients-erectile/298/00130762″>P499Subclinical VASCULAR
P5345 Association and prevalence of post-stroke ERECTILE DYSFUNCTION CARDIO VASCULAR
P6413 Prevalence of ERECTILE DYSFUNCTION ARTERY
P806 High normal BLOOD VASCULAR
Partner responses to sildenafil citrate (Viagra) treatment of erectile dysfunction
Partner responses to sildenafil treatment of erectile dysfunction
Partner satisfaction and successful treatment outcomes for men with ERECTILE DYSFUNCTION
Pathophysiologic Investigation of VASCULOGENIC ERECTILE DYSFUNCTION
Pathophysiological mechanisms of ERECTILE DYSFUNCTION HYPERTENSIVE
Pathophysiology, evaluation and treatment of erectile dysfunction: review article/Fisiopatologia, avaliacao e tratamento da disfuncao eretil: artigo de revisao
Patterns of Cavernosal Arterial Flow in Patients with Erectile Dysfunction, as Evaluated by Color Doppler Flowmetry
PD27-03 TIGHTER BLOOD ERECTILE DYSFUNCTION HYPERTENSIVE
PD28-07 HEART ERECTILE DYSFUNCTION
PD28-09 PERCUTANEOUS ANGIOPLASTY OF INTERNAL PUDENDAL ARTERIES FOR THE TREATMENT OF ERECTILE DYSFUNCTION
PD45-09 EARLY DETECTION OF CARDIO VASCULAR ERECTILE DYSFUNCTION
PDE-5 Inhibitors and the Increase Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Males with Erectile Dysfunction
PDE5 inhibitors for the treatment of ERECTILE DYSFUNCTION HYPERTENSION
PDE5 inhibitors in treatment of ERECTILE DYSFUNCTION CARDIO VASCULAR
Peak systolic velocity in patients with arterial ERECTILE DYSFUNCTION
Peak systolic velocity of cavernosal ARTERY
Penile Arterial Insufficiency and Long-standing ERECTILE DYSFUNCTION
Penile arterial waveform analyzing system for early identification of young adults with high risk of erectile dysfunction
Penile ARTERY
Penile ARTERY ERECTILE DYSFUNCTION VASCULAR
Penile BLOOD ERECTILE DYSFUNCTION
PENILE DOPPLER ULTRASOUND EVALUATION OF PATIENTS WITH ERECTILE DYSFUNCTION, HYPERTENSION
Penile Doppler ultrasound predicting CARDIO VASCULAR
Penile doppler ultrasound predicts CARDIO VASCULAR
Penile duplex pharmaco‐ultrasonography of cavernous arteries in men with ERECTILE DYSFUNCTION
PENILE EXTENSIBILITY, OFFICE FAST TEST FOR ASSESSMENT OF PENILE FIBROSIS IN VASCULOGENIC ERECTILE DYSFUNCTION
Penile hemodynamics in health and VASCULOGENIC
Penile re VASCULAR
Penile re VASCULAR ERECTILE DYSFUNCTION
Penile re VASCULAR VASCULOGENIC ERECTILE DYSFUNCTION
Penile re VASCULAR
Penile re VASCULAR
Penile VASCULAR ERECTILE DYSFUNCTION
Penile VASCULAR
VASCULAR -interventions.html”>Penile venous stripping surgery is a viable option for ERECTILE DYSFUNCTION VASCULAR
Percutaneous angioplasty of internal pudendal arteries for the treatment of ERECTILE DYSFUNCTION
Percutaneous intervention therapy for VASCULAR
PERICARDIAL FAT AND ERECTILE DYSFUNCTION HYPERTENSION
Periodontal disease and VASCULOGENIC
Peripheral arterial disease and ERECTILE DYSFUNCTION
Peripheral atherosclerosis in patients with arterial erectile dysfunction
Peripheral VASCULAR ERECTILE DYSFUNCTION HEART
Pharmaceutical care for one patient with diabetes mellitus complicating HYPERTENSION
Pharmacogenetics of erectile dysfunction: navigating into uncharted waters
Pharmacologic therapy for ERECTILE DYSFUNCTION CARDIO VASCULAR
Pharmacotherapy of erectile dysfunction: focus on CARDIO VASCULAR
PHARMACOTHERAPY: Hemodynamic Effects of Sildenafil Citrate and Isosorbide Mononitrate in Men with Coronary ARTERY
Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction
Phosphodiesterase inhibition: ERECTILE DYSFUNCTION
Phosphodiesterase type 5 in men with VASCULOGENIC
Photoacoustic imaging: A potential new tool for diagnosing VASCULOGENIC
Photoplethysmography analysis of ARTERY
Physical Exercise in the Management of ERECTILE DYSFUNCTION HEART
Physiology of penile vasculature: endothelium and erectile dysfunction
PIH15 BARRIERS TO COMMUNICATION ABOUT ERECTILE DYSFUNCTION
PL 41. The impact of glycosylated serum protein on endothelial dysfunction and VASCULAR
Plasma chitotriosidase activity and arteriogenic erectile dysfunction: association with the presence, severity, and duration
Plasma levels of endothelin‐1, angiotensin II, nitric oxide and prostaglandin E2 in the venous and cavernosal BLOOD
Plasma myeloperoxidase in patients with ERECTILE DYSFUNCTION
Platelet indices in VASCULOGENIC
Plexiform neurofibroma of the penis associated with ERECTILE DYSFUNCTION
PM076 ERECTILE DYSFUNCTION
PO-01-015 One out of three men seeking medical help for ERECTILE DYSFUNCTION BLOOD
PO-01-057 Prognostic value of penile duplex ultrasound in patients started on sildenafil for erectile dysfunction
POD-05.04: A congenital factor in the development of erectile dysfunction: pelvic ARTERY
Pomegranate juice causes a partial improvement through lowering oxidative stress for ERECTILE DYSFUNCTION
Poor response to alprostadil ICI test is associated with arteriogenic ERECTILE DYSFUNCTION CARDIO VASCULAR
Postcompression test in diagnosis of VASCULOGENIC
Poster 32: Effect of EECP on ERECTILE DYSFUNCTION ARTERY
Potentials for the correction of endothelial and ERECTILE DYSFUNCTION ARTERY
PP-020 The Relation between ERECTILE DYSFUNCTION ARTERY ARTERY
PP-105 Deterioration of HEART
VASCULAR _ORIGIN.396.aspx”>PP. 02.06: ERECTILE DYSFUNCTION VASCULAR CARDIO VASCULAR
PP. 41.13: ERECTILE DYSFUNCTION HYPERTENSIVE VASCULAR
Predicting ERECTILE DYSFUNCTION VASCULAR
PREDICTION OF CARDIO VASCULAR
Prediction of CARDIO VASCULAR
Prediction of CARDIO VASCULAR
Prediction of clinical efficacy of levitra (vardenafil) in patients with arteriogenic erectile dysfunction
Prediction of coronary HEART ERECTILE DYSFUNCTION
Predictive value of peak systolic velocity of cavernous ARTERY
Premature Ejaculation and ERECTILE DYSFUNCTION
Presence of LDL modified by myeloperoxidase in the penis in patients with VASCULAR
Presence of LDL Modified by Myeloperoxidase in the Penis in Patients with VASCULAR
Prevalence and Association between ERECTILE DYSFUNCTION ARTERY
Prevalence and CARDIO VASCULAR ERECTILE DYSFUNCTION
Prevalence and risk factors for ERECTILE DYSFUNCTION HYPERTENSION
Prevalence ERECTILE DYSFUNCTION HYPERTENSION
Prevalence of asymptomatic coronary ARTERY VASCULOGENIC
Prevalence of CARDIO VASCULAR
Prevalence of ERECTILE DYSFUNCTION HYPERTENSION
Prevalence of ERECTILE DYSFUNCTION HYPERTENSIVE
Prevalence of ERECTILE DYSFUNCTION HYPERTENSIVE
Prevalence of ERECTILE DYSFUNCTION ARTERY
Prevalence of ERECTILE DYSFUNCTION HYPERTENSIVE
Prevalence of ERECTILE DYSFUNCTION HYPERTENSIVE
Prevalence of ERECTILE DYSFUNCTION HEART
Prevalence of ERECTILE DYSFUNCTION HEART
Prevalence of ERECTILE DYSFUNCTION HEART
Prevalence of ERECTILE DYSFUNCTION CARDIO VASCULAR CARDIO VASCULAR
Prevalence of ERECTILE DYSFUNCTION HEART
Prevalence of ERECTILE DYSFUNCTION VASCULAR
Prevalence of internal pudendal ARTERY ERECTILE DYSFUNCTION ARTERY
Prevalence of risk factors of CARDIO VASCULAR
Prevention and management of CARDIO VASCULAR
Prevention and treatment of ERECTILE DYSFUNCTION
Prevention and treatment of ERECTILE DYSFUNCTION
Prevention of CARDIO VASCULAR
Prevention of VASCULOGENIC ERECTILE DYSFUNCTION
Primary ARTERY
Progesterone reduces ERECTILE DYSFUNCTION HYPERTENSIVE
Prognostic factors for the VASCULAR ERECTILE DYSFUNCTION
Prognostic utility of ERECTILE DYSFUNCTION CARDIO VASCULAR
Progress of Study on HYPERTENSION ERECTILE DYSFUNCTION
Progression of ERECTILE DYSFUNCTION CARDIO VASCULAR
Prolactin levels independently predict major CARDIO VASCULAR
Protection of penile VASCULAR
PS-04-006 The beneficial effect of hydrogen sulfide donor, sodium hydrosulfide on ERECTILE DYSFUNCTION HYPERTENSIVE
PS-04-016 Injecting BLOOD
PS-07-002 Penile VASCULAR
PS-07-003 High triglycerides predicts arteriogenic ERECTILE DYSFUNCTION CARDIO VASCULAR
PS-07-007 Autologous adipose tissue derived stromal VASCULAR VASCULOGENIC
PS-07-009 Low intensity extracorporeal shock wave therapy in French patients with VASCULOGENIC
PS-08-002 Analysis of the knowledge of relation between modifiable risk factors and ERECTILE DYSFUNCTION HEART
PS-08-003 VASCULAR
PS-08-011 Longitudinal risk of developing CARDIO VASCULAR
PS-08-014 Assessment of the treatment efficacy of the low-energy shock wave therapy in patients with VASCULAR
PS-08-016 Can intracavernosal botulinum toxin injection salvage VASCULAR ERECTILE DYSFUNCTION
Psychologic Aspects of ERECTILE DYSFUNCTION HEART
Psychological and interpersonal correlates in men with ERECTILE DYSFUNCTION
Pudendal Arteriography for Erectile Dysfunction
Pudendal ARTERY ERECTILE DYSFUNCTION
Pudendal ARTERY ERECTILE DYSFUNCTION
Pudendal ARTERY
Pudendal nerve and internal pudendal ARTERY
Pulmonary fibrosis induces ERECTILE DYSFUNCTION
Pulse pressure independently predicts major CARDIO VASCULAR
PWH6 PATIENT AND PARTNER TREATMENT SATISFACTION SCALE (TSS) IN ERECTILE DYSFUNCTION
Quality of life in ERECTILE DYSFUNCTION
R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical VASCULAR
Racial disparities in ERECTILE DYSFUNCTION
Radiation diagnostics of arteriovenous erectile dysfunction: history and development
Radiation dose to the neuro VASCULAR ERECTILE DYSFUNCTION
Radiologic anatomy of arteriogenic erectile dysfunction: a systematized approach
Randomized trial of CPAP and vardenafil on erectile and arterial function in men with obstructive sleep apnea and erectile dysfunction
Re: Association between Treatment for ERECTILE DYSFUNCTION CARDIO VASCULAR
Re: Associations of Carotid ARTERY
Re: Does any Association Exist between Chronic Obstructive PULMONARY
Re: Endo VASCULAR
Re: ERECTILE DYSFUNCTION CARDIO VASCULAR
Re: ERECTILE DYSFUNCTION ARTERY
Re: ERECTILE DYSFUNCTION CARDIO VASCULAR
Re: ERECTILE DYSFUNCTION ARTERY
Re: ERECTILE DYSFUNCTION BLOOD
Re: Erectile Dysfunction, VASCULAR
VASCULAR _Disease__Eur_Urol_2014%3B65:968_78_”>Re: Giorgio Gandaglia, Alberto Briganti, Graham Jackson, et al. A Systematic Review of the Association Between ERECTILE DYSFUNCTION CARDIO VASCULAR
Re: Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients with VASCULOGENIC
Re: Outcome of penile re VASCULAR ERECTILE DYSFUNCTION
Re: oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants
Re: Penile duplex pharmaco‐ultrasonography of cavernous arteries in men with ERECTILE DYSFUNCTION
Re: Prognostic Utility of ERECTILE DYSFUNCTION CARDIO VASCULAR
Re: Relationship of Asymmetric Dimethylarginine With Penile Doppler Ultrasound Parameters in Men With VASCULOGENIC
Re: Sexual Activity and ERECTILE DYSFUNCTION ARTERY
Re: Subclinical VASCULAR
Re: Tadalafil treatment had a modest effect on endothelial cell damage and repair ability markers in men with ERECTILE DYSFUNCTION VASCULAR
Re: The Influence of Internal Iliac ARTERY VASCULAR
Re: the prevalence of HYPERTENSION
Re: the Princeton III Consensus recommendations for the management of ERECTILE DYSFUNCTION CARDIO VASCULAR
Re: The VASCULAR ERECTILE DYSFUNCTION
Re: Tighter BLOOD ERECTILE DYSFUNCTION HYPERTENSIVE
Re: VASCULAR
Re: Vasculogenesis and Diabetic Erectile Dysfunction: How Relevant is Glycemic Control?
Re: Weaker Masturbatory Erection May Be a Sign of Early CARDIO VASCULAR ERECTILE DYSFUNCTION
RE:“CIGARETTE SMOKING AND ERECTILE DYSFUNCTION VASCULAR
Relation between HYPERTENSION
Relation of C-reactive protein and other CARDIO VASCULAR VASCULAR
Relation of ERECTILE DYSFUNCTION ARTERY
Relation of Postexercise Reduction of Arterial BLOOD ERECTILE DYSFUNCTION HEART
Relationship Between ERECTILE DYSFUNCTION HEART
Relationship between ERECTILE DYSFUNCTION CARDIO VASCULAR
Relationship between ERECTILE DYSFUNCTION ARTERY
Relationship between ERECTILE DYSFUNCTION VASCULAR
Relationship between Erectile Dysfunction, CARDIO VASCULAR
Relationship Between Erectile Dysfunction, Diabetes and Dyslipidemia in HYPERTENSIVE
Relationship between hyperuricemia and ERECTILE DYSFUNCTION HYPERTENSION
RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNOEA AND ERECTILE DYSFUNCTION HYPERTENSION
Relationship between sleep disorders and erectile dysfunction, depression and quality of life in male patients with systolic HEART
Relationship between treatment of ERECTILE DYSFUNCTION CARDIO VASCULAR
Relationship between VASCULAR
Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with VASCULOGENIC
Relationship of BLOOD ERECTILE DYSFUNCTION HYPERTENSION
Relieving symptoms of ERECTILE DYSFUNCTION VASCULAR
RENIN AND ALDOSTERONE IN NEVER-TREATED HYPERTENSIVE
Research Article Tadalafil Transdermal Delivery with Alpha-lipoic Acid Self Nanoemulsion for Treatment of ERECTILE DYSFUNCTION
Response and Rebuttal to Editorial Comment on “ VASCULAR
Response by Uddin et al to Letters Regarding Article,“Erectile Dysfunction as an Independent Predictor of Future CARDIO VASCULAR
Response to Letter Regarding Article,“Clinical Cardiology: Physician Update: ERECTILE DYSFUNCTION CARDIO VASCULAR
RETRACTED: Association between ERECTILE DYSFUNCTION ARTERY
Retracted: Impact of polymorphisms in the oestrogen receptors alpha and beta (ESR 1, ESR 2) genes on risk of VASCULOGENIC
Retracted: Impact of polymorphisms in the oestrogen receptors alpha and beta (ESR1, ESR2) genes on risk of VASCULOGENIC
Re VASCULAR ERECTILE DYSFUNCTION
Review of ERECTILE DYSFUNCTION CARDIO VASCULAR
Rhythmic Oscillations of Human Penile Bioimpedance in Healthy Individuals and in Patients with VASCULAR
Risk factors for ERECTILE DYSFUNCTION CARDIO VASCULAR
Risk factors of ERECTILE DYSFUNCTION VASCULAR
Risk factors of ERECTILE DYSFUNCTION CARDIO VASCULAR
Risk of Melanoma With Phosphodiesterase Type 5 Inhibitor Use Among Patients With Erectile Dysfunction, PULMONARY HYPERTENSION
Role of 2D Strain in the Early Identification of CARDIAC ERECTILE DYSFUNCTION
Role of Colour Doppler Ultrasound Examination of Cavernosal ARTERY VASCULOGENIC
Role of exercise treadmill testing in the management of erectile dysfunction: a joint CARDIO VASCULAR
Role of female partners in the diagnosis and treatment of erectile dysfunction
Role of high sensitive troponin in diagnosing subclinical coronary ARTERY
Role of methylenetetrahydrofolate reductase gene polymorphisms (C677T, A1298C, and G1793A) in the development of early onset VASCULOGENIC
Role of pelvic floor muscle exercises in management of ERECTILE DYSFUNCTION PULMONARY
Role of penile VASCULAR ERECTILE DYSFUNCTION
Role of the cardiologist: clinical aspects of managing erectile dysfunction
Role of Traditional CARDIO VASCULAR ERECTILE DYSFUNCTION ARTERY
Rupture of an Artificial Urinary Sphincter Secondary to Use of a Vacuum Pump for Erectile Dysfunction
S047: Could ERECTILE DYSFUNCTION ARTERY
S141 The effect of losartan on fibrosis occurred in an castrated male rats model of veno-occlusive erectile dysfunction
S64 Interrelationships between ERECTILE DYSFUNCTION HYPERTENSION
Safety and efficacy of sildenafil citrate in men with ERECTILE DYSFUNCTION HYPERTENSION
Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with ERECTILE DYSFUNCTION HYPERTENSION
Safety and six-month durability of angioplasty for isolated penile ARTERY
Safety, Efficacy, and Patient and Partner Acceptability of Vardenafil Orally Disintegrating Tablets for the Treatment of Erectile Dysfunction.
Salvage of end-stage ERECTILE DYSFUNCTION VASCULAR
Screening for ERECTILE DYSFUNCTION CARDIO VASCULAR
Screening for ERECTILE DYSFUNCTION
Screening for ischemic HEART
Scrutiny of CARDIO VASCULAR ERECTILE DYSFUNCTION
Second consensus conference on CARDIO VASCULAR
Self‐rated health and classical risk factors for coronary HEART ERECTILE DYSFUNCTION
Serum adropin as a predictive biomarker of ERECTILE DYSFUNCTION ARTERY
Serum Arginase II level can be a novel indicator for ERECTILE DYSFUNCTION VASCULOGENIC
Serum Arginase-2 Level in Patients with VASCULOGENIC
Serum endocan as a predictive biomarker of CARDIO VASCULAR ERECTILE DYSFUNCTION
Serum from patients with ERECTILE DYSFUNCTION VASCULAR
Serum from patients with ERECTILE DYSFUNCTION CARDIO VASCULAR
Serum Levels of Asymmetric Dimethylarginine and Testosterone Among Egyptian Type 2 Diabetic Men with ERECTILE DYSFUNCTION ARTERY
Serum levels of human growth hormone during different penile conditions in the cavernous and systemic BLOOD
Severe depressive symptoms and CARDIO VASCULAR
Severity of coronary ARTERY ERECTILE DYSFUNCTION
Severity of female sexual dysfunction in partners of men after radical prostatectomy correlates with erectile function of the male partner
Sex, erectile dysfunction, and the HEART
Sex, The HEART
Sex, the HEART
Sexual activity and CARDIO VASCULAR ERECTILE DYSFUNCTION HEART
Sexual activity and ERECTILE DYSFUNCTION ARTERY
Sexual activity, erectile dysfunction, and incident CARDIO VASCULAR
Sexual dysfunction and chronic obstructive PULMONARY ERECTILE DYSFUNCTION PULMONARY
Sexual Dysfunction And Chronic Obstructive PULMONARY ERECTILE DYSFUNCTION
Sexual dysfunction in women partners of men with erectile dysfunction
Sexual experience of female partners of men with erectile dysfunction: the female experience of men’s attitudes to life events and sexuality (FEMALES) study
Sexual function, satisfaction, and association of ERECTILE DYSFUNCTION CARDIO VASCULAR CARDIO VASCULAR
Sexual life quality of spinal cord-injured men receiving pharmacological treatment for ERECTILE DYSFUNCTION
Shock Wave Therapy in VASCULOGENIC
Should ERECTILE DYSFUNCTION ARTERY
Should men with mild ERECTILE DYSFUNCTION CARDIO VASCULAR
Should patients with ERECTILE DYSFUNCTION CARDIO VASCULAR
Shugan Yiyang capsule increases the expressions of VEGF, IGF and Akt1 in the rat model of arteriogenic erectile dysfunction
Significance of phentolamine redosing during prostaglandin E1 penile color Doppler ultrasonography in diagnosis of VASCULAR
Sildenafil (Viagra): new data, new confidence in treating ERECTILE DYSFUNCTION CARDIO VASCULAR
Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction
Sildenafil citrate for ERECTILE DYSFUNCTION
Sildenafil citrate for ERECTILE DYSFUNCTION CARDIO VASCULAR
Sildenafil citrate in the treatment of ERECTILE DYSFUNCTION HYPERTENSION
Sildenafil citrate vs intracavernous alprostadil for patients with arteriogenic erectile dysfunction: a randomised placebo controlled study
Sildenafil for ERECTILE DYSFUNCTION HYPERTENSION
Sildenafil improves quality of life in men with HEART
Sildenafil is well tolerated by ERECTILE DYSFUNCTION
Sildenafil: from angina to ERECTILE DYSFUNCTION PULMONARY HYPERTENSION
Small-vessel lower extremity arterial disease and erectile dysfunction: The Rancho Bernardo study
Smart material based penile stimulation ERECTILE DYSFUNCTION
Smoking causes ERECTILE DYSFUNCTION VASCULAR
Socio-demographic and psychosocial correlates of ERECTILE DYSFUNCTION HYPERTENSIVE
Standard operating procedures for VASCULAR VASCULAR
Standardization of VASCULAR
Standardization of VASCULAR
Strategies in the oral pharmacotherapy of male ERECTILE DYSFUNCTION
Strategies in the oral pharmacotherapy of male ERECTILE DYSFUNCTION
Stratification of penile VASCULAR ERECTILE DYSFUNCTION
STRESS IMAGING IN A MAN WITH HYPERTROPHIC CARDIOMYOPATHY AND ERECTILE DYSFUNCTION
Stress imaging in men with hypertrophic cardiomyopathy and erectile dysfunction
Structure elucidation of phototransformation products of unapproved analogs of the ERECTILE DYSFUNCTION
Study of Carotid Intimal Medial Thickness by Ultrasonography as A Marker of Subclinical Atherosclerosis in Males with VASCULOGENIC
Subclinical coronary ARTERY ERECTILE DYSFUNCTION
Subclinical coronary ARTERY
Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of ERECTILE DYSFUNCTION HEART
Subclinical endothelial dysfunction and low‐grade inflammation play roles in the development of ERECTILE DYSFUNCTION HEART
Subclinical VASCULAR
Subclinical VASCULAR
Superparamagnetic iron oxide nanoparticle targeting of adipose tissue-derived stem cells in diabetes-associated erectile dysfunction
Surgical Treatments for VASCULOGENIC
Surveillance of CARDIO VASCULAR ERECTILE DYSFUNCTION
Switching from Nitrate Therapy to Ranolazine in Patients with Coronary ARTERY
Sympathetic Skin Response in Patients with VASCULAR
Systems and methods for preventing, managing and/or treating peripheral neuropathy, peripheral VASCULAR
T02-O-07 Do female partners’ attitudes affect treatment-seeking behaviour and treatment utilisation in men with erectile dysfunction? The Females study
T05-O-04 Association between ERECTILE DYSFUNCTION ARTERY
T09-O-19 CARDIO VASCULAR
T09-O-44 Consistent benefits with vardenafil in men with ERECTILE DYSFUNCTION
T09-P-01 After the treatment of women with vaginismus: dealing with ERECTILE DYSFUNCTION
Tadalafil for ERECTILE DYSFUNCTION CARDIO VASCULAR
Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives
Tadalafil Once-Daily: Patient and Partner Perspective in the Management of Erectile Dysfunction
Tadalafil treatment had a modest effect on endothelial cell damage and repair ability markers in men with ERECTILE DYSFUNCTION VASCULAR
TCT-515 PUDENDAL ARTERY ERECTILE DYSFUNCTION
Testing endothelial function of brachial and cavernous arteries in patients with erectile dysfunction
Testosterone and CARDIO VASCULAR
Testosterone deficiency in patients with erectile dysfunction: When should a higher CARDIO VASCULAR
Testosterone level and endothelial dysfunction in patients with VASCULOGENIC
Testosterone Replacement Enhances Internal Pudendal ARTERY ERECTILE DYSFUNCTION
The application of spiral multislice computer tomography at the complex diagnosis of VASCULOGENIC
The ARTERY VASCULAR ERECTILE DYSFUNCTION ARTERY
The article:” Is there a link between soft drinks and erectile dysfunction?”
The assessment of sexual function in women with male partners who have erectile dysfunction
The assessment of VASCULAR
The association between chronic periodontitis and VASCULOGENIC
The association between ERECTILE DYSFUNCTION CARDIO VASCULAR
The association between ERECTILE DYSFUNCTION
The association of arterial stiffness with ERECTILE DYSFUNCTION
The association of ERECTILE DYSFUNCTION CARDIO VASCULAR
THE ASSOCIATION OF ERECTILE DYSFUNCTION HEART
The association of glomerular filtration rate and ERECTILE DYSFUNCTION ARTERY
The association of Intron 4 VNTR and Glu298Asp polymorphisms of the nitric oxide synthetase 3 gene and VASCULOGENIC ERECTILE DYSFUNCTION
The Association of Subclinical VASCULAR ERECTILE DYSFUNCTION
The burden of ERECTILE DYSFUNCTION HYPERTENSIVE
The choice of antihypertensive drugs in patients with erectile dysfunction
The Comparison of the Effects of Nebivolol and Metoprolol on ERECTILE DYSFUNCTION ARTERY
The correlation between CARDIO VASCULAR
The correlation between ERECTILE DYSFUNCTION ARTERY ARTERY
The correlation between high sensitivity C-reactive protein and ERECTILE DYSFUNCTION HYPERTENSION
The correlation between HYPERTENSION
THE CORRELATION OF ERECTILE DYSFUNCTION
The cure security and effectiveness of ERECTILE DYSFUNCTION CARDIO VASCULAR
The Dark Side of Testosterone Deficiency: Diabetes, Metabolic Syndrome, CARDIO VASCULAR
The difference of HEART
The direction and severity of penile curvature does not have an impact on concomitant VASCULOGENIC ERECTILE DYSFUNCTION
The Effect of Atorvastatin on the Male HYPERTENSIVE
The Effect of CARDIO VASCULAR ERECTILE DYSFUNCTION
The effect of lifestyle modification and CARDIO VASCULAR
The Effect of Modified CARDIAC ERECTILE DYSFUNCTION ARTERY
The Effect of Nebivolol on ERECTILE DYSFUNCTION HYPERTENSIVE
The effect of non-dipper pattern of HYPERTENSION
The Effect of Partial Bladder Outlet Obstruction on ERECTILE DYSFUNCTION
THE EFFECT OF THE METHOD OF ED DIAGNOSIS ON PREDICTION OF CARDIO VASCULAR
The effect of treatment in men with ERECTILE DYSFUNCTION
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the CARDIO VASCULAR
The effect of VASCULAR
The effect of VASCULAR VASCULAR
The Effects of Metabolic Syndrome on Severity of ERECTILE DYSFUNCTION PULMONARY
The effects of risk factors for VASCULAR
The Efficacy of the Intima-media Thickness (IMT) to Predict CARDIO VASCULAR VASCULOGENIC ERECTILE DYSFUNCTION
The engineering analysis of bioheat equation and penile hemodynamic relationships in the diagnosis of erectile dysfunction: part I—theoretical study and …
The engineering analysis of bioheat equation and penile hemodynamic relationships in the diagnosis of erectile dysfunction: part II—model optimization using …
The ERECTILE DYSFUNCTION HYPERTENSIVE
The ERECTILE DYSFUNCTION CARDIO VASCULAR
The ERECTILE DYSFUNCTION CARDIO VASCULAR
The erectile–endothelial dysfunction nexus: new opportunities for CARDIO VASCULAR
The evolution of VASCULAR
The expanding sphere of primary prevention for coronary ARTERY
The female partner’s satisfaction with sildenafil citrate treatment of erectile dysfunction
The HelpED study: Impact of change in erection hardness on the sexual function and quality of life of female partners of men with erectile dysfunction
The impact of depression, microvasculopathy, and fibrosis on development of ERECTILE DYSFUNCTION
The impact of ERECTILE DYSFUNCTION
The Importance of valsartan in the treatment of hypertonic patients with erectile dysfunction
The Incidence of Nonarteritic Anterior Ischemic Optic Neuropathy in Men Using Sildenafil Citrate for ERECTILE DYSFUNCTION
The influence of different metabolic syndrome definitions in predicting VASCULOGENIC
The influence of Internal iliac ARTERY VASCULAR
The Influence of Socioeconomic Status on the Presence and Degree of ERECTILE DYSFUNCTION ARTERY
The interlinked depression, erectile dysfunction, and coronary HEART
The Intimate Link Between ERECTILE DYSFUNCTION HEART
The link between ERECTILE DYSFUNCTION CARDIO VASCULAR
THE LINK BETWEEN ERECTILE DYSFUNCTION CARDIO VASCULAR
The link between periodontitis and ERECTILE DYSFUNCTION
The link between VASCULOGENIC ARTERY ARTERY VASCULAR
VASCULAR -disease/24/01222926″>The links between ERECTILE DYSFUNCTION CARDIO VASCULAR
The Metabolic Investigation of Erectile Dysfunction: Cardiometabolic Risk Stratification
The metabolic syndrome and erectile dysfunction: multiple VASCULAR
The pathophysiology of ERECTILE DYSFUNCTION VASCULAR
The penile BLOOD
The predictive value of arteriogenic ERECTILE DYSFUNCTION ARTERY
The predictivity of ischemic HEART
The prevalence of ERECTILE DYSFUNCTION ARTERY
The prevalence of ERECTILE DYSFUNCTION HEART
The prevalence of ERECTILE DYSFUNCTION VASCULAR
The prevalence of HYPERTENSION
The Princeton III Consensus recommendations for the management of ERECTILE DYSFUNCTION CARDIO VASCULAR
The Prognostic Role of ERECTILE DYSFUNCTION CARDIO VASCULAR
The Real-Life Safety and Efficacy of vardenafil (REALISE) study: results in men from Europe and overseas with ERECTILE DYSFUNCTION CARDIO VASCULAR
The relation between ERECTILE DYSFUNCTION ARTERY ARTERY
The relation between metabolic syndrome (hypercholesterolemia, dyslipidemia, HYPERTENSION
The Relationship among Thiazide Like Diuretic, Uric Acid and ERECTILE DYSFUNCTION HYPERTENSIVE
The relationship between dietary intake and endothelial function among VASCULOGENIC ERECTILE DYSFUNCTION
The relationship between endothlial ABD erectile dysfunction, levels of testosterone and CARDIO VASCULAR
The relationship between neo VASCULAR
The Relationship between Systemic HYPERTENSION
The relationship between uric acid and ERECTILE DYSFUNCTION HYPERTENSIVE
The relationship of ERECTILE DYSFUNCTION CARDIO VASCULAR
The research of selenium on phenotype reversion of corpus cavernosum smooth muscle cells in HYPERTENSIVE
The risk of coronary HEART
The risk of ERECTILE DYSFUNCTION PULMONARY
The risk of ERECTILE DYSFUNCTION PULMONARY
The Role ERECTILE DYSFUNCTION CARDIO VASCULAR
The Role of Scoparone from Artemisia capillaris on Erectile Dysfunction
The role of serum testosterone testing: routine hormone analysis is an essential part of the initial screening of men with erectile dysfunction
The role of the partner in ERECTILE DYSFUNCTION
The role of the sexual partner in managing erectile dysfunction
The safety of 5-phosphodiesterase inhibitors in the treatment of ERECTILE DYSFUNCTION CARDIO VASCULAR
The SIAMS-ED trial: a national, independent, multicentre study on cardiometabolic and hormonal impairment of men with ERECTILE DYSFUNCTION
The start of pharmacological activity after sublingual administration of sildenafil citrate in 30 patients affected by erectile dysfunction.
The Swedish medical discourse: Impotence, ERECTILE DYSFUNCTION
The temporal relationship between ERECTILE DYSFUNCTION CARDIO VASCULAR
The treatment and psychology of ERECTILE DYSFUNCTION HEART
The treatment of ERECTILE DYSFUNCTION
The treatment satisfaction scale: A multidimensional instrument for the assessment of treatment satisfaction for ERECTILE DYSFUNCTION
The triad of endothelial dysfunction, CARDIO VASCULAR
The triad: erectile dysfunction-endothelial dysfunction-cardio VASCULAR
The use of intracavernous injection and audiovisual sexual stimulation during real-time pharmacopenile Doppler ultrasonography in VASCULOGENIC
THE USE OF RIGISCAN® EXAMINATION IN DIAGNOSING PATIENTS WITH ERECTILE DYSFUNCTION
The value of dynamic color duplex scanning in the diagnosis of VASCULAR
The value of international index of erectile function-5 in assessment of the severity of VASCULOGENIC
The VASCULAR ERECTILE DYSFUNCTION
The VASCULAR ERECTILE DYSFUNCTION
Therapeutic effect of an interval exercise training program in the management of ERECTILE DYSFUNCTION HYPERTENSIVE
Therapy of ERECTILE DYSFUNCTION
Therapy of ERECTILE DYSFUNCTION HEART
There is a link between ERECTILE DYSFUNCTION HEART
There is no correlation between ERECTILE DYSFUNCTION VASCULAR
THIS ARTICLE HAS BEEN RETRACTED Physical therapy for premature ejaculation, ERECTILE DYSFUNCTION
Tighter BLOOD ERECTILE DYSFUNCTION HYPERTENSIVE
Time course of development of ERECTILE DYSFUNCTION ARTERY
TIME COURSE OF ERECTILE DYSFUNCTION BLOOD
Topically applied curcumin-loaded nanoparticles treat ERECTILE DYSFUNCTION
Transperineal ultrasound imaging of the internal pudendal ARTERY
Traumatic VASCULOGENIC
Treatment by stem cell therapy of ERECTILE DYSFUNCTION
Treatment of ERECTILE DYSFUNCTION
Treatment of ERECTILE DYSFUNCTION HEART
Treatment of ERECTILE DYSFUNCTION HEART
Treatment of ERECTILE DYSFUNCTION CARDIO VASCULAR
Treatment of ERECTILE DYSFUNCTION HYPERTENSION HEART
Treatment of ERECTILE DYSFUNCTION HEART
Treatment of ERECTILE DYSFUNCTION CARDIO VASCULAR
Treatment of VASCULOGENIC ERECTILE DYSFUNCTION
Treatment program for ERECTILE DYSFUNCTION CARDIO VASCULAR
Triad of Health Status, Depression and ERECTILE DYSFUNCTION HEART
Two birds with one stone: regular use of PDE5 inhibitors for treating male patients with ERECTILE DYSFUNCTION CARDIO VASCULAR
Type 5 phosphodiesterase inhibitors in the treatment of ERECTILE DYSFUNCTION CARDIO VASCULAR
Umbelliferone isolated from Zosima absinthifolia roots partially restored ERECTILE DYSFUNCTION
Unfavourable endothelial and inflammatory state in ERECTILE DYSFUNCTION ARTERY
Uninsured Patients With Nonischemic HEART
Update on drug interactions with phosphodiesterase-5 inhibitors prescribed as first-line therapy for patients with ERECTILE DYSFUNCTION PULMONARY HYPERTENSION
Uric acid level and ERECTILE DYSFUNCTION ARTERY
Uric acid may cause of ERECTILE DYSFUNCTION HYPERTENSIVE
Use of impaza in the treatment of ERECTILE DYSFUNCTION HYPERTENSION
Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion
Use of nanoparticles to monitor human mesenchymal stem cells transplanted into penile cavernosum of rats with erectile dysfunction
Use of VASCULAR
Usefulness of an abnormal aortic/penile index to predict the presence of coronary ARTERY ERECTILE DYSFUNCTION
Usefulness of electromyography of the cavernous corpora (CC EMG) in the diagnosis of arterial erectile dysfunction
Uses of VASCULAR
USING VASCULAR ERECTILE DYSFUNCTION
Using zidena in the treatment of ERECTILE DYSFUNCTION HYPERTENSION
Vacuum erection device in treatment of organic ERECTILE DYSFUNCTION VASCULAR
Valsartan treatment reverses ERECTILE DYSFUNCTION
Value of Color Doppler Ultrasonography in the Diagnosis of VASCULAR
Vardenafil for ERECTILE DYSFUNCTION HYPERTENSION … . Taurine supplementation improves ERECTILE DIABETES DYSFUNCTION
… 5 phosphodiesterase inhibitor suppressed the apoptosis of corporal smooth muscle through the facilitation of akt signaling in DIABETIC ERECTILE DYSFUNCTION
… A POTENCY TO PROTECT ERECTILE DIABETIC ERECTILE DYSFUNCTION
… Abstracts: 30 The influence of DIABETES ERECTILE ERECTILE DYSFUNCTION
… Ameliorates ERECTILE DIABETIC ERECTILE DYSFUNCTION
… ANALYSIS OF THE EFFICACY AND SAFETY OF ONCE-DAILY TADALAFIL IN MEN WITH ERECTILE DYSFUNCTION DIABETES
… and safety of low-intensity shockwave therapy plus tadalafil 5 mg once daily in men with type 2 DIABETES ERECTILE DYSFUNCTION
… ARE ELEVATED IN TYPE 2 DIABETIC ERECTILE DYSFUNCTION
… ASSESSMENT OF CORPORA CAVERNOSA TISSUE IN DIABETIC DIABETIC ERECTILE DYSFUNCTION
… ASSESSMENT OF SILDAFENIL FOR THE MANAGEMENT OF PATIENTS WITH ERECTILE DYSFUNCTION DIABETES
… associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with DIABETIC ERECTILE DYSFUNCTION
… concentrated materials from mulberry fruit have a potency to protect ERECTILE DIABETIC ERECTILE DYSFUNCTION
… Effect of DIABETES ERECTILE DIABETES ERECTILE DYSFUNCTION
… effect of two intracavernous autologous bone marrow derived mesenchymal stem cells injections in DIABETIC ERECTILE DYSFUNCTION
… EFFECTS OF ADIPOSE-DERIVED STEM CELLS-BASED MICRO-TISSUES ON ERECTILE DYSFUNCTION DIABETIC
… endothelial progenitor cells: one of the possible mechanisms involved in the chronic administration of melatonin preventing ERECTILE DYSFUNCTION DIABETIC
… ERECTILE ERECTILE DYSFUNCTION DIABETES
… function through attenuation of oxidative stress, restoration of Akt activity and protection of endothelial and smooth muscle cells in DIABETIC ERECTILE DYSFUNCTION
… Improves ERECTILE DYSFUNCTION DIABETES DYSFUNCTION
… Improves ERECTILE DIABETES DYSFUNCTION
… improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 DIABETES ERECTILE DYSFUNCTION
… Improves Parameters of Endothelial Inflammation and of Hypogonadism in Male Patients with Type 2 DIABETES ERECTILE DYSFUNCTION
… IN THE CORPUS CAVERNOSUM OF DIABETIC ERECTILE DYSFUNCTION
… Inhibitor Suppressed the Apoptosis of Corporal Smooth Muscle Through the Facilitation Of AKT Signaling in DIABETIC ERECTILE DYSFUNCTION
… Inhibitor Suppresses Apoptosis of Corporal Smooth Muscle by Potentiating Akt Signalling in a Rat Model of DIABETIC ERECTILE DYSFUNCTION
… into functional interaction between GNB3 C825T and eNOS T‐786C, G894T gene polymorphisms and association with susceptibility to DIABETIC ERECTILE DYSFUNCTION
… Life Events and Sexuality study: The influence of DIABETES ERECTILE ERECTILE DYSFUNCTION
… May Ameliorate ERECTILE DIABETES DYSFUNCTION
… NOVEL IN VITRO THREE DIMENTIONAL SCAFFOLDLESS MODEL OF CAVERNOUS TISSUE FOR STUDY OF DIABETIC ERECTILE DYSFUNCTION
… OF COMP-ANGIOPOIETIN-1 PROTEIN AS A NOVEL THERAPEUTIC STRATEGY FOR TYPE II DIABETES ERECTILE DYSFUNCTION
… OF LONGNONCODING RIBONUCLEIC ACID EXPRESSION PATTERNS IN CORPUS CAVERNOSUM OF DIABETIC ERECTILE DYSFUNCTION
… of mahogany (Swietenia macrophylla) and axlewood (Anogeissus leiocarpus) stem bark on some enzymes implicated in ERECTILE DYSFUNCTION DIABETES
… OF PHOSPHODIESTERASE-5 IMPROVES THERAPEUTIC EFFICACY OF ADIPOSE-DERIVED STEM CELLS FOR ERECTILE DYSFUNCTION DIABETIC
… Peyronie’s disease is a relatively common condition, with an incidence of 3-9%. It is often associated with DIABETES ERECTILE DYSFUNCTION
… POSSIBLE MECHANISM OF EXTRACORPOREAL SHOCK WAVE THERAPY ON STREPTOZOTOCIN INDUCED DIABETIC ERECTILE DYSFUNCTION
… RECEPTOR ANTAGONIST ON VEGF SIGNALING IN DIABETIC DIABETES ERECTILE DYSFUNCTION
… SERUM C-REACTIVE PROTEIN LEVELS AND RESPONSE RATE TO TADALAFIL 5 MG ONCE DAILY IN ERECTILE DYSFUNCTION DIABETES
… services for men with DIABETES ERECTILE DYSFUNCTION DIABETES ERECTILE DYSFUNCTION
… STRESS-INDUCED SYSTEMIC AND CAVERNOSAL MOLECULAR ALTERATIONS–THEIR ROLE IN THE PROGRESSION OF DIABETIC ERECTILE DYSFUNCTION
… Supplementation Improves ERECTILE DIABETES DYSFUNCTION
… treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with DIABETIC ERECTILE DYSFUNCTION
… with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of DIABETIC ERECTILE DYSFUNCTION
04 Relationship between ERECTILE DYSFUNCTION DIABETIC
06 LISWT Might Improve the Genitoperineal Sensation and ERECTILE DYSFUNCTION DIABETIC
079 Separate or Combined Treatments with Human Bone Marrow-Derived Stem Cells and Substance P of ERECTILE DYSFUNCTION DIABETES
081 Intracavernous Injection of Adipose-derived Stem Cells (ASCs) Improves ERECTILE DYSFUNCTION DIABETIC
101 Determining Factors Associated with Early Onset of ERECTILE DYSFUNCTION DIABETES
1014 Adipose derived stem cells ameliorate DIABETIC ERECTILE DYSFUNCTION
1027 POTENTIAL ROLE OF MIR-93 IN TYPE II DIABETES ERECTILE DYSFUNCTION
1043: Phosphorylated Endothelial Nitric Oxide Synthase Regulatory Mechanisms in the Pathogenesis of DIABETES ERECTILE DYSFUNCTION
1044: Gene Expression Changes Associated with ERECTILE DYSFUNCTION DIABETES
1046: Intrinsic and Extrinsic Apoptotic Pathways are Employed in Neuropatidc and DIABETIC ERECTILE DYSFUNCTION
1053: Effects of Antioxidants (A-Lipoic Acid and Selenium) in Prevention of ERECTILE DYSFUNCTION DIABETIC
1076: Smooth Muscle Specific Expression of HSLO Restores ERECTILE DYSFUNCTION DIABETIC
108: Increased Superoxide Formation with Simulated Low-Grade Systemic Inflammation: Implications for ERECTILE DYSFUNCTION DIABETES
DYSFUNCTION &ots=UOSxeaTk07&sig=XN8BocnsoAhyxe4Kx6wFmFhIYjs”>11 ERECTILE DYSFUNCTION DIABETES
1144 SEVERE ERECTILE DYSFUNCTION DIABETES
117 Adherence of Primary Care Physicians to the Canadian DIABETES ERECTILE DYSFUNCTION
1203: Apoptotic Pathways are Employed in Neuropathic and DIABETIC ERECTILE DYSFUNCTION
124 Serum C-reactive protein levels and response rate to tadalafil 5 mg once daily in ERECTILE DYSFUNCTION DIABETES
1329 DIABETIC ERECTILE DYSFUNCTION
1411: Rhoa/Rho-Kinase Suppresses Endothelial Nitric Oxide Synthase in the Penis: Novel Mechanism for DIABETIC ERECTILE DYSFUNCTION
1413: Altered Rock-I and Rock-II Expression in a DIABETIC ERECTILE DYSFUNCTION
1420: Detrimental Effect of Cigarette Smoking on ERECTILE DYSFUNCTION DIABETES
1424: Oxidative Stress and Antioxidant Therapy: Their Potential for Salvage Therapy in DIABETES ERECTILE DYSFUNCTION
16: How should ERECTILE DYSFUNCTION DIABETES
1672 EFFICACY AND SAFETY OF ORAL MIRODENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION DIABETIC
170 Triad of Depression, DIABETES ERECTILE DYSFUNCTION
194 DIABETES ERECTILE DYSFUNCTION
218 Inhibition of microRNA-92a improved ERECTILE DYSFUNCTION DIABETIC DYSFUNCTION
249 Preliminary Study on the Relationship Between Gut Microbiota and Type 2 DIABETIC ERECTILE DYSFUNCTION
273 Melatonin receptor-mediated ameliorative effect against ERECTILE DYSFUNCTION DIABETES
276 Adipose-derived stem cell-derived exosomes ameliorate ERECTILE DYSFUNCTION DIABETES
312 EFFECT OF VARDENAFIL TREATMENT IN THE PLASMA PROTEOME OF PATIENTS WITH ERECTILE DYSFUNCTION DIABETES
370 EFFICACY AND SAFETY OF ORAL MIRODENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION DIABETES
389 Penile Tissue Nicotinamide Phosphoribosyltransferase (Nampt) as a Potential Player in the ERECTILE DYSFUNCTION DIABETIC
395 Calpain Inhibition Improves DIABETIC ERECTILE DYSFUNCTION
492 Linking endothelial progenitor cells and DIABETIC ERECTILE DYSFUNCTION
493 Inhibition of phosphodiesterase-5 improves therapeutic efficacy of adipose-derived stem cells for ERECTILE DYSFUNCTION DIABETIC
595 Is the Oral Glucose Tolerance Test a valid tool for DIABETES ERECTILE DYSFUNCTION
602 A comparison of baseline ERECTILE ERECTILE DYSFUNCTION DIABETES
620 Detection of neurogenic ERECTILE DYSFUNCTION DIABETIC
651 LISWT might improve the genitoperineal sensation and ERECTILE DYSFUNCTION DIABETIC
703 GENOME WIDE ASSOCIATION STUDY IDENTIFIES NOVEL GENES FOR ERECTILE DYSFUNCTION DIABETES
790: Progenitor Cell-Derived Endothelial Cell Therapy Restores DIABETES ERECTILE DYSFUNCTION
802 INFLIXIMAB PROTECTS AGAINST DIABETIC ERECTILE DYSFUNCTION
890 Treatment of DIABETES ERECTILE DYSFUNCTION
924 CHANGES IN THE PLASMA PROTEOME OF PATIENTS WITH ERECTILE DYSFUNCTION DIABETES
955: Serum Biomarkers of Endothelial Function and Oxidative Stress after Daily Dosing of Sildenafil in Type 2 DIABETIC ERECTILE DYSFUNCTION
96 TEN-YEAR PERSPECTIVE ON THERAPY FOR ERECTILE DYSFUNCTION DIABETES
DYSFUNCTION _In_Male_ DIABETIC DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION DIABETIC
A comprehensive review of ERECTILE DYSFUNCTION DIABETES
A meta-analysis on efficacy and tolerability of sildenafil for ERECTILE DYSFUNCTION DIABETES
A possible new risk factor in DIABETIC ERECTILE DYSFUNCTION
A rat animal model of type-II DIABETES ERECTILE DYSFUNCTION
A study of relation of serum testosterone levels and ERECTILE DYSFUNCTION DIABETES
A study on effect of inhibitors of AGE S in the treatment of ERECTILE DYSFUNCTION DIABETES
A Therapeutic confirmatory study to assess the safety and efficacy of Zydena®(Udenafil) for the treatment of ERECTILE DYSFUNCTION DIABETES
AB095. Increased expression of TMEM16A/Ano1 chloride channel associated with DIABETIC ERECTILE DYSFUNCTION
AB157. Treatment of DIABETIC ERECTILE DYSFUNCTION
AB196. The long-term administration of tadalafil on STZ-induced DIABETIC ERECTILE DYSFUNCTION
AB230. Calpain inhibition improves DIABETIC ERECTILE DYSFUNCTION
AB240. Therapeutic effects of adipose-derived stem cells-based micro-tissues on ERECTILE DYSFUNCTION DIABETIC
Aberrant expression of Wnt family contributes to the pathogenesis of DIABETES ERECTILE DYSFUNCTION
Activation of the NGF/TrkA signaling pathway attenuates DIABETIC ERECTILE DYSFUNCTION
Acupuncture for ERECTILE DYSFUNCTION DIABETIC
Acupuncture in the Treatment of ERECTILE DYSFUNCTION DIABETIC
Addition of metformin to sildenafil treatment for ERECTILE DYSFUNCTION DIABETIC
Adherence to Mediterranean diet and ERECTILE DYSFUNCTION DIABETES
Adipose-derived adult stem cells and new technique for intracavernosal injection for ERECTILE DYSFUNCTION DIABETES
Adipose-derived stem cell-derived exosomes ameliorate ERECTILE DYSFUNCTION DIABETES
Adipose-Derived Stem Cells for the Treatment of DIABETIC ERECTILE DYSFUNCTION DIABETIC
Advanced glycation end-products: a common pathway in DIABETES ERECTILE DYSFUNCTION
Advances in DIABETIC ERECTILE DYSFUNCTION
Advances in etiology of DIABETES ERECTILE DYSFUNCTION
Advances in Etiology of DIABETES ERECTILE DYSFUNCTION
Advances in pathogenesis and treatment of DIABETIC ERECTILE DYSFUNCTION
Age-related androgen deficiency and ERECTILE DYSFUNCTION DIABETES
Albuminuria is an independent risk factor of ERECTILE DYSFUNCTION DIABETES
Alcohol consumption and prevalence of ERECTILE DYSFUNCTION DIABETES
DIABETIC -penis/2626/00076734″>ALTERED CAVEOLIN EXPRESSION IN DIABETIC ERECTILE DYSFUNCTION
Altered Penile Caveolin Expression in DIABETES ERECTILE DYSFUNCTION
An assessment of ERECTILE DYSFUNCTION DIABETIC
An audit of prevalence and management of ERECTILE DYSFUNCTION DIABETES
DIABETES onthenet.com/uploads/resources/dotn/_master/1128/files/pdf/dpc12-6-363-6.pdf”>An audit of self-awareness of ERECTILE DYSFUNCTION DIABETES
DIABETES .com/article/S1499-2671(14)00368-2/abstract”>An Intervention to Empower DIABETES ERECTILE DYSFUNCTION
An investigation of ERECTILE DYSFUNCTION DIABETES
Analysis of correlative risk factors for DIABETIC ERECTILE DYSFUNCTION
Androgen deficiency and ERECTILE DYSFUNCTION DIABETES
Androgen pattern in patients with type 2 DIABETES ERECTILE DYSFUNCTION
Androgen, estrogen, and progesterone receptor gene regulation during DIABETIC ERECTILE DYSFUNCTION
Angiotensin II silencing alleviates ERECTILE DYSFUNCTION DIABETES
Antioxidant treatment with quercetin ameliorates ERECTILE DYSFUNCTION DIABETIC
APPRAISAL OF MALE ERECTILE DYSFUNCTION DIABETES
Approach to the clarification of ERECTILE DYSFUNCTION DIABETIC
Are phosphodiesterase inhibitors effective and safe for men with DIABETES ERECTILE DYSFUNCTION
Assessing Adherence to Annual Dilated Eye Exam Recommendations in Patients with DIABETES ERECTILE DYSFUNCTION
Assessing the Association between Impaired Fasting Glucose, DIABETES ERECTILE DYSFUNCTION
Assessment and treatments for ERECTILE DYSFUNCTION DIABETES
Assessment of ERECTILE DYSFUNCTION DIABETES
Assessment of ERECTILE DYSFUNCTION DIABETIC
Assessment of quality of life and ERECTILE DYSFUNCTION DIABETIC
Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of ERECTILE DYSFUNCTION DIABETES
Association between comorbidity and ERECTILE DYSFUNCTION DIABETES
DIABETES medicine.com/articles/may_2008/DI%20May%2008%2015-16.pdf”>Association between glycemic control and ERECTILE DYSFUNCTION DIABETIC
association between polymorphism of endothe-lial nitric oxide synthase gene and type 2 DIABETIC ERECTILE DYSFUNCTION
Association between sarcopenia and ERECTILE DYSFUNCTION DIABETES
Association of Age and Duration of DIABETES ERECTILE DYSFUNCTION DIABETES
Association of ERECTILE DYSFUNCTION DIABETES
Association of glycemic control with risk of ERECTILE DYSFUNCTION DIABETES
Association of hypogonadism and type II DIABETES ERECTILE DYSFUNCTION
Association of pupil responses with severity of ERECTILE DYSFUNCTION DIABETES
DIABETES journals.org/content/25/8/1458.short”>Association of type and duration of DIABETES ERECTILE DYSFUNCTION
ATTITUDES AND TREATMENT SEEKING IN MEN WITH ERECTILE DYSFUNCTION DIABETES
AVANAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION DIABETIC
Avanafil for the treatment of ERECTILE DYSFUNCTION DIABETES
B cell lymphoma-2-modified bone marrow-derived mesenchymal stem cells transplantation for the treatment of DIABETES ERECTILE DYSFUNCTION
BASIC SCIENCE: Enhancement of Both EDHF and NO/cGMP Pathways Is Necessary to Reverse ERECTILE DYSFUNCTION DIABETIC
Beneficial effect of low dose medical ozone in the type 2 DIABETIC ERECTILE DYSFUNCTION
Beneficial effect of PEDF-transfected ADSCs on ERECTILE DYSFUNCTION DIABETIC
Benefits from Fruit/Vegetable Consumption on ERECTILE DYSFUNCTION DIABETIC
Bergamot polyphenolic fraction counteracts ERECTILE DYSFUNCTION DIABETES
Biochemical parameters among type 2 DIABETIC ERECTILE DYSFUNCTION
Biochemical Parameters among Type 2 DIABETIC ERECTILE DYSFUNCTION
Blockade of toll-like receptor 4 attenuates ERECTILE DYSFUNCTION DIABETIC
Calcitonin gene-related peptide induces phenotypic transformation of corpus cavernosum smooth muscle cells in DIABETIC ERECTILE DYSFUNCTION
Calcium dobesilate for the treatment of ERECTILE DYSFUNCTION DIABETES
Cavernosal tissue nitrite, nitrate, malondialdehyde and glutathione levels in DIABETIC DIABETIC ERECTILE DYSFUNCTION
DYSFUNCTION – DIABETIC ERECTILE DYSFUNCTION DIABETIC
Centrally mediated ERECTILE DYSFUNCTION DIABETES
Changes of nNOS and AchE expression in penis and spinal cord of rats with DIABETES ERECTILE DYSFUNCTION
Characterization of corpus cavernosum smooth muscle cell phenotype in DIABETIC ERECTILE DYSFUNCTION
Chinese Medicine Leading to ERECTILE DYSFUNCTION DIABETES
Chronic administration of sildenafil modified the impaired VEGF system and improved the ERECTILE DIABETIC ERECTILE DYSFUNCTION
Chronic sildenafil in men with DIABETES ERECTILE DYSFUNCTION
Circulating endothelial progenitor cells in type 1 DIABETIC ERECTILE DYSFUNCTION
Circulating monocyte oxidative activity is increased in patients with type 2 DIABETES ERECTILE DYSFUNCTION
Clinical and psychological predictors of incidence of self-reported ERECTILE DYSFUNCTION DIABETES
Clinical aspects of ERECTILE DYSFUNCTION DIABETES
Clinical efficacy of Apomorphine SL in ERECTILE DYSFUNCTION DIABETIC
Clinical evaluation of ERECTILE DYSFUNCTION DIABETIC
Clinical observation of combined therapeutic effect of lipo-PGE1 and mecobalamin on DIABETES ERECTILE DYSFUNCTION
Clinical Observation of Modified Tao Hong Siwu Decoction Combined with Lipo-prostaglandin E1 for DIABETES ERECTILE DYSFUNCTION
Clinical Observation on the Treatment of ⅡType DIABETIC ERECTILE DYSFUNCTION
Clinical profile of type 2 DIABETIC ERECTILE DYSFUNCTION
Clinical significance and expression of microRNA in DIABETIC ERECTILE DYSFUNCTION
Clinical significance of serum testosterone levels in young and middle-aged men with type 2 DIABETES ERECTILE DYSFUNCTION
Clinical Study for Treatment of Penis ERECTILE DYSFUNCTION DIABETES
Clinical study on ERECTILE DYSFUNCTION DIABETIC DIABETIC
Clinical treatment of ERECTILE DYSFUNCTION DIABETIC
DIABETES journals.org/content/28/7/1739.abstract”>Clinical, socioeconomic, and lifestyle parameters associated with ERECTILE DYSFUNCTION DIABETIC
Combination of mesenchymal stem cell injection with icariin for the treatment of DIABETES ERECTILE DYSFUNCTION
Combined sildenafil with vacuum erection device therapy in the management of DIABETIC ERECTILE DYSFUNCTION
Commentary on–“Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETIC ERECTILE DYSFUNCTION
Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for ERECTILE DYSFUNCTION DIABETIC
Comparison between vardenafil plus testosterone undecanoate and vardenafil alone in the treatment of DIABETIC ERECTILE DYSFUNCTION
Comparison of efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETES ERECTILE DYSFUNCTION
Comparison of Improving Effects for DIABETIC ERECTILE DYSFUNCTION
Comparison of the effects of epalrestat plus sildenafil with sildenafil alone on ERECTILE DYSFUNCTION DIABETIC
Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETIC ERECTILE DYSFUNCTION
Comparison of the first intake of vardenafil and tadalafil in patients with DIABETIC DIABETIC ERECTILE DYSFUNCTION
Comparison of the therapeutic effects of adipose‑derived and bone marrow mesenchymal stem cells on ERECTILE DYSFUNCTION DIABETIC
Compounded Treatments for ERECTILE DYSFUNCTION DIABETES
Constitutive NOS uncoupling and NADPH oxidase upregulation in the penis of type 2 DIABETIC ERECTILE DYSFUNCTION
Contractile mechanisms in DIABETES ERECTILE DYSFUNCTION
Coping with ERECTILE DYSFUNCTION DIABETES
Coronary flow velocity reserve reduction is comparable in patients with ERECTILE DYSFUNCTION DIABETES
CORPUS CAVERNOSUM ELECTROMYOGRAPHY IN PATIENTS WITH DIABETES ERECTILE DYSFUNCTION
Correction of DIABETES ERECTILE DYSFUNCTION
Correlation between brain-derived neurotrophic factor expression in the nerve system and ERECTILE DYSFUNCTION DIABETIC
Correlation between nNOS expression and ERECTILE DYSFUNCTION DIABETES
Correlation of Adiponectin With Testosterone in Patients With and Without Type 2 DIABETES ERECTILE DYSFUNCTION
DIABETIC _Men_with_Erectile_ DYSFUNCTION DIABETIC DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION
Correlation of nerve growth factor expression with ERECTILE DYSFUNCTION DIABETIC
Current opinions on the relationships between atherosclerosis, type 2 DIABETES ERECTILE DYSFUNCTION
Current Views on the Treatment Algorithm in Patients with DIABETES ERECTILE DYSFUNCTION
Daily Oral l-Arginine Plus Tadalafil in DIABETIC ERECTILE DYSFUNCTION
Daily tadalafil prevents ERECTILE DYSFUNCTION DIABETIC
Decreased endogenous hydrogen sulfide generation in penile tissues of DIABETIC ERECTILE DYSFUNCTION
Decreased expression of pigment epithelium-derived factor related to the pathogenesis of DIABETES ERECTILE DYSFUNCTION
Density and distribution of connexin 43 in corpus cavernosum tissue from DIABETIC ERECTILE DYSFUNCTION
Depressive symptoms and prevalence of ERECTILE DYSFUNCTION DIABETES
Determinants of ERECTILE DYSFUNCTION DIABETES
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION DIABETIC
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETES ,_Dizzy_Spells,_and_Erectile_ DYSFUNCTION DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETES ERECTILE DYSFUNCTION
DIABETIC ERECTILE DYSFUNCTION
DIABETIC ERECTILE DYSFUNCTION
DIABETIC ERECTILE DYSFUNCTION
DIABETIC ERECTILE DYSFUNCTION DIABETIC
DIABETIC -medicine-supplement/diames/2002/04/002/ DIABETIC DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION
DIABETIC ERECTILE DYSFUNCTION DIABETES
DIABETIC DIABETES ERECTILE DYSFUNCTION
DIABETIC DIABETES ERECTILE DYSFUNCTION DIABETES
DIABETIC ERECTILE DYSFUNCTION DIABETIC
DIABETIC -men-with-erectile- DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION
Diagnosis of ERECTILE DYSFUNCTION DIABETES
Differential expression of nerve injury-induced protein 1 (Ninjurin 1) in in vivo and in vitro models for DIABETIC ERECTILE DYSFUNCTION
Differentially expressed microRNAs in the corpus cavernosum from a murine model with type 2 DIABETES ERECTILE DYSFUNCTION
Discussion of correlative factors and risk in patients with DIABETIC ERECTILE DYSFUNCTION
Doppler Evaluation Of ERECTILE DYSFUNCTION DIABETIC
Double blind placebo controlled crossover clinical trial of sildenafil citrate in patients with DIABETES ERECTILE DYSFUNCTION
Downregulated lncRNA-MIAT confers protection against ERECTILE DYSFUNCTION DIABETIC
Dyslipidaemia as a risk factor for ERECTILE DYSFUNCTION DIABETES
Dyslipidemia as an Early Harbinger of ERECTILE DYSFUNCTION DIABETIC
Early administration of phosphodiesterase 5 inhibitors after induction of DIABETES ERECTILE DYSFUNCTION
ED 06. The long-term administration of tadalafil on STZ-induced DIABETIC ERECTILE DYSFUNCTION
ED 20. Neurotrophic effect of bone marrow mesenchymal stem cells for ERECTILE DYSFUNCTION DIABETIC
ED 30. Effects of the testosterone replacement therapy and tadalafil on Chinese patients of DIABETIC ERECTILE DYSFUNCTION
ED PHARMACOTHERAPY: Efficacy and Safety of Flexible‐Dose Vardenafil in Men with Type 1 DIABETES ERECTILE DYSFUNCTION
Effect of bone marrow mesenchymal stem cells on improving ERECTILE DYSFUNCTION DIABETIC
Effect of icarisid II on DIABETIC ERECTILE DYSFUNCTION
Effect of Ik kinases in DIABETIC ERECTILE DYSFUNCTION
Effect of oxidative stress and iNOS on DIABETIC ERECTILE DYSFUNCTION
Effect of oxidative stress on DIABETIC ERECTILE DYSFUNCTION
Effect of propionyl-l-carnitine, l-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of ERECTILE DYSFUNCTION DIABETES
Effect of Psoralea corylifolia Linn in sexual ERECTILE DYSFUNCTION DIABETIC
Effect of rutin on DIABETIC ERECTILE DYSFUNCTION
Effect of tadalafil on ERECTILE DYSFUNCTION DIABETES
Effect of Tetrandrine on ERECTILE DIABETIC ERECTILE DYSFUNCTION
Effect of Transdermal Testosterone or Alpha-Lipoic Acid on ERECTILE DYSFUNCTION DIABETES
Effect of Yishen Decoction on Penial Ultrastructure and nNOS Expression Level in DIABETIC ERECTILE DYSFUNCTION
Effect of YiShenHuoXueTang on albuginea penis fibroelastic tissue in DIABETIC ERECTILE DYSFUNCTION
Effects of a Topical Saffron (Crocus sativus L) Gel on ERECTILE DYSFUNCTION DIABETIC
EFFECTS OF A TOPICAL SAFFRON (CROCUS SATIVUS L) GEL ON ERECTILE DYSFUNCTION DIABETIC
Effects of a water‐soluble curcumin protein conjugate vs. pure curcumin in a DIABETIC ERECTILE DYSFUNCTION
Effects of angiotensin II on male rats with DIABETIC ERECTILE DYSFUNCTION
Effects of Moxibustion on Apoptosis of Penile ERECTILE ERECTILE DYSFUNCTION DIABETES
Effects of moxibustion on ERECTILE DIABETIC ERECTILE DYSFUNCTION
Effects of moxibustion on ERECTILE DIABETIC ERECTILE DYSFUNCTION
Effects of moxibustion on serum AGEs in DIABETIC ERECTILE DYSFUNCTION
Effects of next-generation low-energy extracorporeal shockwave therapy on ERECTILE DYSFUNCTION DIABETES
Effects of phosphodiesterase 5 inhibitor on ERECTILE DYSFUNCTION DIABETES
Effects of sildenafil on ERECTILE DYSFUNCTION DIABETES
DIABETES journals.org/content/25/12/2159.short”>Effects of tadalafil on ERECTILE DYSFUNCTION DIABETES
Effects of tadalafil on ERECTILE DYSFUNCTION DIABETES
Efficacy and safety of fixed-dose Udenafil (Zydena®) in men with DIABETES ERECTILE DYSFUNCTION
Efficacy and safety of oral mirodenafil in the treatment of ERECTILE DYSFUNCTION DIABETIC
EFFICACY AND SAFETY OF ORAL MIRODENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION DIABETES
Efficacy and safety of PDE5 inhibitors in the treatment of DIABETES ERECTILE DYSFUNCTION
Efficacy and safety of phosphodiesterase inhibitors for ERECTILE DYSFUNCTION DIABETIC
Efficacy and safety of sildenafil in men with type 2 DIABETES ERECTILE DYSFUNCTION
Efficacy and safety of tadalafil 2.5 mg and 5 mg administered once a day in men with DIABETES ERECTILE DYSFUNCTION
EFFICACY AND SAFETY OF TADALAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION DIABETIC
Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with DIABETES ERECTILE DYSFUNCTION
Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in type 1 DIABETIC ERECTILE DYSFUNCTION
Efficacy of sildenafil citrate in treatment of ERECTILE DYSFUNCTION DIABETES
Efficacy of tadalafil for the treatment of ERECTILE DYSFUNCTION DIABETES
Efficacy of tadalafil once daily in men with DIABETES ERECTILE DYSFUNCTION
Efficacy of Tadalafil-SZ in the treatment of ERECTILE DYSFUNCTION DIABETES DIABETES
Endothelial and ERECTILE DYSFUNCTION DIABETES
Endothelial DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION
DYSFUNCTION -patients/157/01222926″>ENDOTHELIAL FUNCTION OF ERECTILE DYSFUNCTION DIABETES
Endothelial impairment and bone marrow‐derived CD34+/133+ cells in DIABETIC ERECTILE DYSFUNCTION
Endothelin antagonism and DIABETIC ERECTILE DYSFUNCTION DIABETIC
Engineered Mesenchymal Stem Cells Expressing Stromal Cell-derived Factor-1 Improve ERECTILE DYSFUNCTION DIABETIC
Enhanced relaxation of DIABETIC ERECTILE DYSFUNCTION
Epigenetic silencing of microRNA‐874‐3p implicates in ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
DYSFUNCTION %20among%20 DIABETIC ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
DIABETES journals.org/content/25/2/284″> ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
DYSFUNCTION _in_ DIABETIC DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETIC
ERECTILE DYSFUNCTION DIABETIC
DYSFUNCTION _the_factors_of_erectile_ DYSFUNCTION DIABETIC DYSFUNCTION DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION DIABETIC
DYSFUNCTION -how-it-works-what-can-be-donewhen-i- DIABETES ERECTILE DYSFUNCTION DIABETES
ERECTILE DYSFUNCTION DIABETIC
Erythrocyte aldose reductase correlates with ERECTILE DYSFUNCTION DIABETIC
Essential role of brain‐derived neurotrophic factor (bdnf) in DIABETIC ERECTILE DYSFUNCTION
Establishment of a cell culture model of corpus cavernosum smooth muscle cells derived from DIABETIC ERECTILE DYSFUNCTION
Establishment of a rat model of DIABETIC ERECTILE DYSFUNCTION
Establishment of DIABETIC ERECTILE DYSFUNCTION
Establishment of DIABETIC ERECTILE DYSFUNCTION
Establishment of DIABETIC ERECTILE DYSFUNCTION
Ethnic differences of ERECTILE DYSFUNCTION DIABETES
ETIOLOGIC ASPECTS OF ERECTILE DYSFUNCTION DIABETES
Etiologic factors of ERECTILE DYSFUNCTION DIABETES
Etiology and management of ERECTILE DYSFUNCTION DIABETES
Eucommia ulmoides Oliv. Leaf Extract Improves ERECTILE DYSFUNCTION DIABETIC
Evaluation and treatment of ERECTILE DYSFUNCTION DIABETES
Evaluation of a progressive treatment program for ERECTILE DYSFUNCTION DIABETES
Evaluation of ERECTILE DYSFUNCTION DIABETIC
Evaluation of ERECTILE DYSFUNCTION DIABETES
DIABETIC %20Patients%20with%20Erectile%20 DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION
EVALUATION THE KNOWLEDGE & PERCEPTION OF DIABETIC DIABETIC ERECTILE DYSFUNCTION
Exercise training improves central NMDA-induced ERECTILE DYSFUNCTION DIABETES
Exercising current treatments for ERECTILE DYSFUNCTION DIABETES
Expression change and significance of heme oxygenase in the corpus cavernosum of DIABETIC ERECTILE DYSFUNCTION
Expression of nerve growth factor in cavernous tissue and its effects on the treatment of rats with DIABETIC ERECTILE DYSFUNCTION
Expression of neuronal nitric oxide synthase in corpus cavernosum with DIABETIC ERECTILE DYSFUNCTION
Expressions of eNOS and connexin 43 in the penile tissue of rats with DIABETIC ERECTILE DYSFUNCTION
Extracellular vesicles from human urine-derived stem cells ameliorate ERECTILE DYSFUNCTION DIABETIC
Farnesoid X receptor activation improves ERECTILE DYSFUNCTION DIABETES
Free radical-scavenging activity of Korean red ginseng for ERECTILE DYSFUNCTION DIABETES
Frequency and determinants of ERECTILE DYSFUNCTION DIABETIC
FREQUENCY AND PREDICTORS OF ERECTILE DYSFUNCTION DIABETIC
Frequency and Predictors of ERECTILE DYSFUNCTION DIABETES
FREQUENCY AND RISK FACTORS OF ERECTILE DYSFUNCTION DIABETES
Frequency and Severity of ERECTILE DYSFUNCTION DIABETIC
Frequency of autonomic neuropathy in patients with ERECTILE DYSFUNCTION DIABETES
DIABETES /diab/2002/06/002/frequency-erectile- DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION DIABETIC
Frequency of hypogonadism and ERECTILE DYSFUNCTION DIABETIC
Frequency of hypogonadism in males with type 2 DIABETES ERECTILE DYSFUNCTION
From the Cochrane Library: Phosphodiesterase inhibitors are effective in treating ERECTILE DYSFUNCTION DIABETIC
Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 DIABETES ERECTILE DYSFUNCTION
Gastrointestinal autonomic neuropathy, erectile-, bladder-and sudomotor DYSFUNCTION DIABETES
Gene expression profile comparison in the penile tissue of DIABETES ERECTILE DYSFUNCTION
Glutathione levels in patients with ERECTILE DYSFUNCTION DIABETES
Glyco-metabolic profile among type 2 DIABETIC ERECTILE DYSFUNCTION
Glycosylated Hemoglobin as a Predictor for Effectiveness of Sildenafil Citrate for DIABETIC ERECTILE DYSFUNCTION
Gonadal and ERECTILE DYSFUNCTION DIABETIC
Gross saponin of Tribulus terrestris improves ERECTILE DYSFUNCTION DIABETIC
Group B streptococcal septicemia following intracavernous injection therapy for ERECTILE DYSFUNCTION DIABETES
GWAS identifies novel risk locus for ERECTILE DYSFUNCTION DIABETES
GWAS identifies risk locus for ERECTILE DYSFUNCTION DIABETES
Herbs in the treatment of DIABETES ERECTILE DYSFUNCTION
High prevalence of ERECTILE DYSFUNCTION DIABETES
High prevalence of ERECTILE DYSFUNCTION DIABETIC
High prevalence of ERECTILE DYSFUNCTION DIABETES
Hormonal determinants of ERECTILE DYSFUNCTION DIABETES
How I treat and manage ERECTILE DYSFUNCTION DIABETIC
How often do we ask about ERECTILE DYSFUNCTION DIABETES
How to treat ERECTILE DYSFUNCTION DIABETES
Human urine-derived stem cells alone or genetically-modified with FGF2 improve type 2 DIABETIC ERECTILE DYSFUNCTION
Hydrogen therapy may be a promising, safe and effective treatment for DIABETIC ERECTILE DYSFUNCTION
Hyperhomocysteinemia is a risk factor for ERECTILE DYSFUNCTION DIABETES
Hypogonadism, ERECTILE DYSFUNCTION DIABETES
Hypogonadotropic hypogonadism in ERECTILE DYSFUNCTION DIABETES
Hypovitaminosis D is associated with ERECTILE DYSFUNCTION DIABETES
Hypoxia precondition promotes adipose-derived mesenchymal stem cells based repair of DIABETIC ERECTILE DYSFUNCTION
IDENTIFICATION OF MICRORNA EXPRESSION PROFILE IN DIABETIC ERECTILE DYSFUNCTION
Identifying patients with type 2 DIABETES ERECTILE DYSFUNCTION
Imbalanced low-grade inflammation and endothelial activation in patients with type 2 DIABETES ERECTILE DYSFUNCTION
Impact of DIABETES ERECTILE DYSFUNCTION
Impact of ERECTILE DYSFUNCTION DIABETES
Impact of ERECTILE DYSFUNCTION DIABETES
Impact of undiagnosed pre DIABETES ERECTILE DYSFUNCTION
Impaired veno-occlusion and associated decreases in cavernosal elastin and collagen in a type II DIABETIC ERECTILE DYSFUNCTION
Implanted muscle-derived stem cells ameliorate ERECTILE DYSFUNCTION DIABETES
Improvement in ERECTILE DYSFUNCTION DIABETIC
Improvement in ERECTILE DYSFUNCTION DIABETIC
Improvement of sexual behavior, sperm quantity and quality by Quercetin in streptozotocin-induced DIABETIC ERECTILE DYSFUNCTION
Improving the primary care management of ERECTILE DYSFUNCTION DIABETES
DIABETES _and_erectile.22.aspx”>In adult men with DIABETES ERECTILE DYSFUNCTION
In vivo tracking on longer retention of transplanted myocardin gene-modified adipose-derived stem cells to improve ERECTILE DYSFUNCTION DIABETIC
Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in DIABETES ERECTILE DYSFUNCTION
Inactivation of the Ras/MAPK/PPARγ signaling axis alleviates DIABETIC ERECTILE DYSFUNCTION
Increased expression of arginase II in human DIABETIC DIABETIC ERECTILE DYSFUNCTION
Increased expression of TRPC 4 channels associated with ERECTILE DYSFUNCTION DIABETES
Increasing age, prostate weight, and DIABETES ERECTILE DYSFUNCTION
Independent predictors of ERECTILE DYSFUNCTION DIABETES
Induced testosterone deficiency: from clinical presentation of fatigue, ERECTILE DYSFUNCTION DIABETES
Infection induced inflammation is associated with ERECTILE DYSFUNCTION DIABETES
DIABETES -associated/8/00076734″>Insights and interventions in DIABETES ERECTILE DYSFUNCTION
Intracavernosal injection therapy and surgical therapy in DIABETIC ERECTILE DYSFUNCTION
Intracavernosal injection therapy and surgical therapy in DIABETIC ERECTILE DYSFUNCTION
DYSFUNCTION _in_ DIABETIC DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION DIABETIC
Intracavernous delivery of synthetic angiopoietin-1 protein as a novel therapeutic strategy for ERECTILE DYSFUNCTION DIABETIC
Investigation of DIABETIC ERECTILE DYSFUNCTION
Is DIABETIC ERECTILE DYSFUNCTION
Is type 2 DIABETES ERECTILE DYSFUNCTION
JTE‐013 Supplementation Improves ERECTILE DYSFUNCTION DIABETES
La dysfonction érectile chez les personnes atteintes de diabète en Côte-d’Ivoire: ERECTILE DYSFUNCTION DIABETES
Lack of central nitric oxide triggers ERECTILE DYSFUNCTION DIABETES
Lipoxin A4 improves ERECTILE DYSFUNCTION DIABETES
Localization of increased insulin-like growth factor binding protein-3 in DIABETIC ERECTILE DYSFUNCTION
Long-term efficacy and safety of DIABETIC ERECTILE DYSFUNCTION
Long‐term treatment with intracavernosal injections in DIABETIC ERECTILE DYSFUNCTION
DIABETES journals.org/content/28/11/2637.short”>Longitudinal assessment of quality of life in patients with type 2 DIABETES ERECTILE DYSFUNCTION
Longitudinal patterns of occurrence and remission of ERECTILE DYSFUNCTION DIABETES
Low dose daily versus on-demand high dose tadalafil in DIABETIC ERECTILE DYSFUNCTION
Low testosterone and severity of ERECTILE DYSFUNCTION DIABETES
Low-Intensity Extracorporeal Shockwave Therapy for ERECTILE DYSFUNCTION DIABETIC
Lower urinary tract symptoms and ERECTILE DYSFUNCTION DIABETES
Lycopene ameliorates ERECTILE DYSFUNCTION DIABETIC
Management and treatment of DIABETES ERECTILE DYSFUNCTION
Management of ERECTILE DYSFUNCTION DIABETES
Management of ERECTILE DYSFUNCTION DIABETES
Management of ERECTILE DYSFUNCTION DIABETES
Management of ERECTILE DYSFUNCTION DIABETIC
Management of ERECTILE DYSFUNCTION DIABETES
Management strategies for gastrointestinal, erectile, bladder, and sudomotor DYSFUNCTION DIABETES
Managing ERECTILE DYSFUNCTION DIABETES
Mechanistic link between ERECTILE DYSFUNCTION DYSFUNCTION DIABETIC
Men with DIABETES ERECTILE DYSFUNCTION
Mesenchymal Stem Cells Treatment for ERECTILE DYSFUNCTION DIABETIC
Meta-analysis on the risk factors for ERECTILE DYSFUNCTION DIABETES
Metabolic risk factors, endothelial DYSFUNCTION ERECTILE DYSFUNCTION DIABETES
Metabolic syndrome and ERECTILE DYSFUNCTION DIABETIC
Methods for treating ERECTILE DYSFUNCTION DIABETES
MICE WITH NULL LEPTIN RECEPTOR AS A TRANSLATIONAL MODEL OF TYPE II DIABETES ERECTILE DYSFUNCTION
Microarray analysis reveals novel gene expression changes associated with ERECTILE DYSFUNCTION DIABETIC
Microarray data analysis of genes related with ERECTILE DYSFUNCTION DIABETIC
MicroRNA‐205 is associated with DIABETES ERECTILE DYSFUNCTION
Mirabegron, A Selective β3-Adrenoceptor Agonist Causes an Improvement in ERECTILE DYSFUNCTION DIABETIC
Molecular mechanisms associated with DIABETIC ERECTILE DYSFUNCTION
Molecular mechanisms involved in ERECTILE DYSFUNCTION DIABETES
Molecular targets for DIABETES ERECTILE DYSFUNCTION
Morphological assessment of corpora cavernosa tissue in DIABETIC DIABETIC ERECTILE DYSFUNCTION
Mouse model of ERECTILE DYSFUNCTION DIABETES
MP-07.06 Effect of Vardenafil Treatment in the Plasma Proteome of Patients With ERECTILE DYSFUNCTION DIABETES
MP43-09 Effects of platelet rich plasma on improving ERECTILE DYSFUNCTION DIABETIC
MP43-20 JTE-013 SUPPLEMENTATION IMPROVES ERECTILE DYSFUNCTION DIABETES
MP74-17 TRAJECTORIES OF ERECTILE DYSFUNCTION DIABETES
MP84-10 ORGASMIC AND ERECTILE DYSFUNCTION DIABETES
MP86-14 TREATMENT OF DIABETES ERECTILE DYSFUNCTION
MP89-01 VASOHIBIN-1 IS A NOVEL THERAPEUTIC TARGET FOR DIABETIC ERECTILE DYSFUNCTION
MP89-04 CF602 IMPROVES ERECTILE DYSFUNCTION DIABETIC
Multidisciplinary Workshop Improves ERECTILE DIABETIC ERECTILE DYSFUNCTION
Myoinositol/folic acid combination for the treatment of ERECTILE DYSFUNCTION DIABETES
Nerve Growth Factor Improves the Outcome of Type 2 DIABETES ERECTILE DYSFUNCTION
Neuroprotective effects of melatonin on ERECTILE DYSFUNCTION DIABETIC
Neurotrophic effect of bone marrow mesenchymal stem cells for ERECTILE DYSFUNCTION DIABETIC
Neurotrophin and ERECTILE DYSFUNCTION DIABETES
New possibilities for treatment of ERECTILE DYSFUNCTION DIABETES
New treatment options for ERECTILE DYSFUNCTION DIABETES
Nitric Oxide‐Releasing Polymeric Microspheres Improve DIABETES ERECTILE DYSFUNCTION
Nocturia and prevalence of ERECTILE DYSFUNCTION DIABETES
Nocturnal electrobioimpedance volumetric assessment in DIABETIC ERECTILE DYSFUNCTION
NON DIABETIC ERECTILE DYSFUNCTION
Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of ERECTILE DYSFUNCTION DIABETES
DIABETES researchclinicalpractice.com/article/S0168-8227(14)70244-X/abstract”>OP38 THERAPEUTIC IMPACT OF DIABETIC ERECTILE DYSFUNCTION DIABETIC
Optimizing treatment for DIABETES ERECTILE DYSFUNCTION
Oral sildenafil in the treatment of ERECTILE DYSFUNCTION DIABETIC
Oral testosterone undecanoate reverses ERECTILE DYSFUNCTION DIABETES
Organic, relational and psychological factors in ERECTILE DYSFUNCTION DIABETES
Oxidative stress and antioxidant therapy: Their impact in DIABETES ERECTILE DYSFUNCTION
Oxidative stress and DIABETIC ERECTILE DYSFUNCTION
Ozone Therapy in Type 2 DIABETIC ERECTILE DYSFUNCTION
Ozone Therapy in Type 2 DIABETIC ERECTILE DYSFUNCTION
P-01-016 Successful results of complex and gradual treatment of ERECTILE DYSFUNCTION DIABETES
P-03-017 Severity and associations of ERECTILE DYSFUNCTION DIABETIC
P-03-044 Androgen deficiency-induced ERECTILE DYSFUNCTION DIABETES
P2-73 Changes of nNOS in The Rats of DIABETES ERECTILE DYSFUNCTION
Panax notoginseng saponins improve the ERECTILE DYSFUNCTION DIABETIC
Pancreatic kininogenase improves ERECTILE DIABETIC ERECTILE DYSFUNCTION
Pathobiology of ischiocavernosus and bulbospongiosus muscles in long-term DIABETIC ERECTILE DYSFUNCTION
Pathogenic mechanisms of ERECTILE DYSFUNCTION DIABETES
Pathophysiology and treatment of DIABETIC ERECTILE DYSFUNCTION
Pathophysiology of DIABETIC ERECTILE DYSFUNCTION
DIABETES _Mellitus_and_Erectile_ DYSFUNCTION DIABETES DYSFUNCTION DIABETES ERECTILE DYSFUNCTION
Patterns and their correlates of seeking treatment for ERECTILE DYSFUNCTION DIABETIC
PD-10.06: Localization of increased insulin-like growth factor binding protein-3 in the DIABETIC ERECTILE DYSFUNCTION
PD49-04 ADIPOSE-DERIVED STEM CELL-DERIVED EXOSOMES AMELIORATE ERECTILE DYSFUNCTION DIABETES
PD50-11 A comparison of baseline ERECTILE ERECTILE DYSFUNCTION DIABETES
DYSFUNCTION _IN_MEN.3.aspx”>PDE-5 INHIBITORS FOR ERECTILE DYSFUNCTION DIABETES
PDE5 inhibitors offer new prospects for ERECTILE DYSFUNCTION DIABETES
PDE5 inhibitors: targeting ERECTILE DYSFUNCTION DIABETIC
Penile axial rigidity and Doppler ultrasonography parameters in patients with ERECTILE DYSFUNCTION DIABETES
Penile Dimensions of DIABETIC DIABETIC ERECTILE DYSFUNCTION
Peyronie’s disease in DIABETIC ERECTILE DYSFUNCTION
Pharmaceutical composition for preventing or treating DIABETIC ERECTILE DYSFUNCTION
Pharmacotherapy for ERECTILE DYSFUNCTION DIABETIC
Phenotype modulation of smooth muscle in corpus cavernosum in penis tunica albuginea in DIABETES ERECTILE DYSFUNCTION
Phosphodiesterase inhibitors for ERECTILE DYSFUNCTION DIABETES
Phosphodiesterase type 5 inhibitors for the treatment of ERECTILE DYSFUNCTION DIABETES
Phosphodiesterase-5 inhibitors for ERECTILE DYSFUNCTION DIABETES
Physical activity and prevalence of ERECTILE DYSFUNCTION DIABETES
DYSFUNCTION %20among%20 DIABETES ERECTILE DYSFUNCTION DIABETES
Physicians’ and patients’ perception of sexuality in DIABETIC ERECTILE DYSFUNCTION
Pilot genome-wide association search identifies potential loci for risk of ERECTILE DYSFUNCTION DIABETES
Platelet Indices as a marker for early prediction of ERECTILE DYSFUNCTION DIABETIC
PO-01-010 Synergistic effects of extracorporeal shockwave therapy and Korean herbal formulation on ERECTILE DYSFUNCTION DIABETIC
PO-01-014 Impact of undiagnosed pre DIABETES ERECTILE DYSFUNCTION
PO-01-068 Hormonal factors in patients with ERECTILE DYSFUNCTION DIABETES
DIABETES researchclinicalpractice.com/article/S0168-8227(14)70642-4/abstract”>PO348 ASSOCIATION OF ERECTILE DYSFUNCTION DIABETES
POS-01.78: Study on correlation between metabolic syndrome and DIABETES ERECTILE DYSFUNCTION
Potential of phloroglucinol to improve ERECTILE DYSFUNCTION DIABETES
Preconditioning of adipose‐derived stem cells by phosphodiesterase‐5 inhibition enhances therapeutic efficacy against DIABETES ERECTILE DYSFUNCTION
DIABETES -hypogonadism-amp-erectile- DYSFUNCTION DIABETES ERECTILE DYSFUNCTION
Predictors for ERECTILE DYSFUNCTION DIABETIC
Predictors of ERECTILE DYSFUNCTION DIABETES
Predictors of ERECTILE DYSFUNCTION DIABETES
Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with ERECTILE DYSFUNCTION DIABETES
Prevalence and associations of ERECTILE DYSFUNCTION DIABETES
Prevalence and correlates of ERECTILE DYSFUNCTION DIABETES
Prevalence and correlates of ERECTILE DYSFUNCTION DIABETIC
Prevalence and determinants of ERECTILE DYSFUNCTION DIABETIC
Prevalence and determinants of ERECTILE DYSFUNCTION DIABETES
Prevalence and Factors Associated with Quality of Life among DIABETIC ERECTILE DYSFUNCTION
PREVALENCE AND PREDICTORS OF ERECTILE DYSFUNCTION DIABETES
Prevalence and risk factors associated with ERECTILE DYSFUNCTION DIABETES
DYSFUNCTION _in_ DIABETIC DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION DIABETIC
Prevalence and risk factors for ERECTILE DYSFUNCTION DIABETIC
Prevalence and risk factors of ERECTILE DYSFUNCTION DIABETIC
Prevalence and risk factors of ERECTILE DYSFUNCTION DIABETES
Prevalence and severity of ERECTILE DYSFUNCTION DIABETIC
Prevalence of Adult-Onset Hypogonadism and ERECTILE DYSFUNCTION DIABETES
Prevalence of and risk factors for ERECTILE DYSFUNCTION DIABETIC
Prevalence of DIABETES ERECTILE DYSFUNCTION
Prevalence of ERECTILE DYSFUNCTION DIABETES
DYSFUNCTION _among_Saudi_type_2_ DIABETIC DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION DIABETIC
Prevalence of ERECTILE DYSFUNCTION DIABETIC DIABETIC
Prevalence of ERECTILE DYSFUNCTION DIABETIC DIABETIC
Prevalence of ERECTILE DYSFUNCTION DIABETIC
Prevalence of ERECTILE DYSFUNCTION DIABETES
Prevalence of ERECTILE DYSFUNCTION DIABETIC
Prevalence of ERECTILE DYSFUNCTION DIABETES
Prevalence of ERECTILE DYSFUNCTION DIABETES
Prevalence of ERECTILE DYSFUNCTION DIABETIC
Prevalence of ERECTILE DYSFUNCTION DIABETES
Prevalence of ERECTILE DYSFUNCTION DIABETIC
Prevalence of ERECTILE DYSFUNCTION DIABETIC
Prevalence of ERECTILE DYSFUNCTION DIABETES
Prevalence of hypogonadism in type 2 DIABETIC ERECTILE DYSFUNCTION DIABETES
Prevalence of risk factors of ERECTILE DYSFUNCTION DIABETES
Prevalence of, and risk factors for ERECTILE DYSFUNCTION DIABETIC
Prevalence, correlates, attitude and treatment seeking of ERECTILE DYSFUNCTION DIABETIC
PREVALENCE, INCIDENCE AND RISK FACTORS OF ERECTILE DYSFUNCTION DIABETES
DIABETES /1233/00076734″>PROFILE OF MICRORNA EXPRESSION IN A MODEL OF DIABETES ERECTILE DYSFUNCTION
Prolactinoma in a DIABETIC ERECTILE DYSFUNCTION
DIABETES _Obes_J_Prospective_Observational_Longitudinal_Study_Evaluating_Erectile_ DYSFUNCTION DIABETIC DIABETES DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION DIABETIC
Protective effects of hydrogen-rich saline against ERECTILE DYSFUNCTION DIABETIC
DIABETIC -cavernosal/25/01222926″>PROTEIN STRUCTURAL ALTERATIONS IN DIABETIC ERECTILE DYSFUNCTION
PS 21. Mechanisms of DIABETES ERECTILE DYSFUNCTION
PS-04-007 The beneficial effect of a selective ifunny channels blocker, ivabradine on ERECTILE DYSFUNCTION DIABETIC
PS-04-009 Vasohibin-1 is a novel therapeutic target for DIABETIC ERECTILE DYSFUNCTION
DYSFUNCTION _among_ DIABETIC DIABETIC ERECTILE DYSFUNCTION DIABETIC DIABETIC
Purinergic Neurotransmission in ERECTILE DYSFUNCTION DIABETIC
Radiological methods in the diagnosis of cavernous hemodynamic disorders in men with DIABETES ERECTILE DYSFUNCTION
Rare case of manifestation of ERECTILE DYSFUNCTION DIABETES DIABETIC
Re: addition of metformin to sildenafil treatment for ERECTILE DYSFUNCTION DIABETIC
Re: Combination of Mesenchymal Stem Cell Injection with Icariin for the Treatment of DIABETES ERECTILE DYSFUNCTION
Re: Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETIC ERECTILE DYSFUNCTION
Re: ERECTILE DYSFUNCTION DIABETES
Re: men with DIABETES ERECTILE DYSFUNCTION
Re: Optimizing treatment for DIABETES ERECTILE DYSFUNCTION
Re: Prevalence of ERECTILE DYSFUNCTION DIABETIC DIABETIC
Re: Self-Reported Sitting Time and Prevalence of ERECTILE DYSFUNCTION DIABETES
Re: Skin Autofluorescence (a Marker for Advanced Glycation End Products) and ERECTILE DYSFUNCTION DIABETES
Re: Treatment of DIABETES ERECTILE DYSFUNCTION
Recent advances in the treatment of ERECTILE DYSFUNCTION DIABETES
Redefining the role of long-acting phosphodiesterase inhibitor tadalafil in the treatment of DIABETIC ERECTILE DYSFUNCTION
Relation Between ERECTILE DYSFUNCTION DIABETIC
Relationship between DIABETIC DIABETIC ERECTILE DYSFUNCTION DIABETIC
DYSFUNCTION _and_HbA1C_Percentage_in_ DIABETIC DYSFUNCTION DIABETIC ERECTILE DYSFUNCTION DIABETIC
Relationship between ERECTILE DYSFUNCTION DIABETIC
Relationship between gut microbiota and type 2 DIABETIC ERECTILE DYSFUNCTION
Relationship Between Sexual Desire, Premature Ejaculation and ERECTILE DYSFUNCTION DIABETES
Relationship of DIABETIC ERECTILE DYSFUNCTION
Reminder of important clinical lesson: ERECTILE DYSFUNCTION DIABETES
Repositioning of molsidomine for its efficacy in DIABETES ERECTILE DYSFUNCTION
Research Progress of Traditional Chinese Medicine in Treatment of DIABETIC ERECTILE DYSFUNCTION
Resveratrol and quercetin protect isolated mouse corpora cavernosa from in vitro-induced DIABETIC ERECTILE DYSFUNCTION
Resveratrol and sildenafil synergistically improve DIABETES ERECTILE DYSFUNCTION DIABETIC
Review of ERECTILE DYSFUNCTION DIABETIC
DYSFUNCTION .50.aspx?Ppt=Article%7Cajnonline:2008:02000:00050%7C%7C”>Revisions to the labeling of ERECTILE DYSFUNCTION DIABETES
RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for DIABETES ERECTILE DYSFUNCTION
Rigiscan evaluation of men with DIABETES ERECTILE DYSFUNCTION DIABETES
Risk factors associated with ERECTILE DYSFUNCTION DIABETIC
DYSFUNCTION _in20160212-932-1rqca58.pdf”>Risk factors for ERECTILE DYSFUNCTION DIABETES
Role of disturbed fatty acids metabolism in the pathophysiology of DIABETIC ERECTILE DYSFUNCTION
Role of endogenous nitric oxide synthase inhibitor in ERECTILE DYSFUNCTION DIABETIC
Role of JAK2 in the Pathogenesis of DIABETIC ERECTILE DYSFUNCTION
Role of miR-145 in ERECTILE DYSFUNCTION DIABETIC
Role of Nitric Oxide and its Signal Transduction Pathway in DIABETIC ERECTILE DYSFUNCTION
Role of oxidative stress‐induced systemic and cavernosal molecular alterations in the progression of DIABETIC ERECTILE DYSFUNCTION
Role of Oxidative Stress, Adiponectin and Endoglin in the Pathophysiology of ERECTILE DYSFUNCTION DIABETIC DIABETIC
S116 PREVALENCE OF ERECTILE DYSFUNCTION DIABETES
Sat-300: Risk factors of ERECTILE DYSFUNCTION DIABETES
Screening and managing ERECTILE DYSFUNCTION DIABETIC
Self-reported sitting time and prevalence of ERECTILE DYSFUNCTION DIABETES
Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 DIABETIC ERECTILE DYSFUNCTION
Tim –
This blend is a potent supercharger of sexual energy! Every aspect of my life benefits when I take it, and my lady partner couldn’t be more satisfied 😉
I’ve had 10+ of the most reputable male libido supplements on the market, but this one is a league above the rest.
Shortly after ingestion, I can feel its pure, potent nutrition being gladly greedily and magnetically pulled in and put to good work.
Not only have my sexual escapades benefited from this blend, but my spiritual practices have been bumped into a higher gear too, as I have more energy to channel up the spine into the higher centers of consciousness.
Supercharge your life!
Rob Helfrick –
Gavin to me is an intuitive self trained master herbalist I’ve experienced his original interstellar blend which is an amazing overall health tonic I’ve also used trinity over time which is a wonderful universal helper for all that ails the mind body spirit harmonizing the mental emotional body in a way that is unsurpassed by anything I’ve ever tried and I’ve tried it all. It seems he has a relationship to the plant world with herbs that goes far beyond a mere education. Though I have nothing major that has debilitated me recently I’ve read testimonials from people that have and have had unusual if not miraculous results from taking his herbs regularly. I highly recommend his genius to my friends and I believe his products are very universal and can and do help the world at large. We all have a gift to bring to this world and herbalism Is obvious to me is one of his. Thanks Gavin for your contribution to my own journey
Rob Helfrick –
I have taken different aphrodisiacs in the past thunder is by far the best its very balanced and i feel like beyond sexual benefits which it seems to promote overall desire and endurance I feel my vitality go up and feel over all that that is also a remarkable benefit of thunder. Just to say another kickass blend from Gavin, Rock on Brother.
Gordon Fenty –
Thunder is a one of a kind blend. After taking it, I’ve felt recharged and ready for action in all aspects of my life. Thank you for your hard work and dedication with all your herbs blends, it has changed my life.
Chad –
I’d been looking for a daily use sexual supplement for some time. I tried Stamina rx and Extenze but they gave me adverse side effects along with viagra.
Then I found a sample pack of Thunder Penis at my doorstep courtesy of Gavin. The first day I started taking it I felt a difference and I haven’t missed a day since.
Here’s why: It provides a boost in my energy level that helps with every day activities. My job calls for stamina and alertness. As for what it is especially designed for, I have tons of raves. With Thunder Penis I’m sustaining firmer and longer lasting erections then I have had in years (truth), prolonging the pleasure for me and my partner. It’s also increased sensitivity in my penis. Instead of struggling to achieve an orgasm, I actually have to hold it back. Sperm production has definitely increased. My ejaculations are more copious and forceful, and more pleasurable.
Last but not least, my recovery time has been shortened. With only a few minutes in between rounds, I can regain arousal and engage in another period of sex and enjoy subsequent orgasms.
On a recent get together with my special lady, I achieved climax three times in just over two hours.
I’m nearly 40, but I feel like 25 again. Thanks to Interstellar!!!
Paul –
I want to talk a moment about “Thunder.” I’m in my early thirties and have had heart problems for the past 17 years. Some days are fine, other days not so fine—and I’ve noticed over the years that when my heart is having problems, my prostate is having problems. In fact, sometimes it gets so bad that I don’t orgasm or ejaculate; it’s just done. Which, let’s be honest, sucks. And here’s the kicker—I’m in great shape, have a sixpack, and am strong.
I decided to give Thunder a try and—wow! This stuff is potent and works! It took about a week of consistent use for me to really notice the benefits, but when they did, I am not joking, not giving any hyperbole, I had the best sex of my entire life and consistently had mind-blowing sex while using the herbs. I honestly didn’t know that it could feel so good (sorry if that’s too much info, but it’s true!).
For me, I didn’t feel like a teenager again where the wind changes direction and now I have to adjust to avoid embarrassment. What I did feel was more alive and ready for the day. Because of the aforementioned prostate problems, peeing can sometimes be difficult. While using Thunder, I could pee like a champion racehorse. Which, if you’ve ever not been able to pee and it wakes you up in the night, you’ll know it’s one of the worst things ever. Thunder changed that for me. I love this stuff.
Thanks, Gavin! This stuff is great!
Cheri Webb (verified owner) –
I’m writing this review because it is a blessing. I’m almost 50 in good shape but I noticed I wasn’t able to “salute” for more than 15 minutes. This was troubling for me as well as my wife. She started juicing and I joined her. Then she started with fasting and I joined. When she found about the groups and herbs it really was a game changer. I’m always ready when she’s ready. Love the herbs.
Scotty Schmadebeck –
Thunder is by FAR my favorite blend ive tried so far! It makes me feel so powerful and full of energy. I have felt so much more confident since i began to take it.
I noticed the benefits right away after trying this blend for the first time. I had an amazing workout that day and went on a 3 mile run. Prior to taking Thunder i was hardly able to run one mile without feeling gassed…
Okay nows the best part. I’ve have so much more confidence that i now can talk to any girl that i want to! I used to be so shy so this has been lifechanging. I really cant say enough about thunder. Its the TRUTH!
reid rowlett –
This stuff is like rocket fuel, one of my favorite blends!
Not only for the bedroom but also the gym!
it makes me feel like a greek god, like I can accomplish anything and take anything on!
lift heavier, move faster, train longer, last longer……… 😉
this mixed in with the rest of the blends I take is a winning formula, I like to take a good dose of thunder on its own before I go out on the town, it makes me feel
more confident and just more alpha really, like no one can fuck with me.
also recently I’ve been very disciplined with taking the blends and following the 22/2 fasting Gavin recommends.
not to lose weight but to actually put weight on, in the form of muscle, 3 weeks ago I was very low fat and 70kg, 3 weeks later with a strict training regime I’ve put 3.5kg of solid muscle on, I put this down to the blends and Gavin’s advice, cannot recommend enough!!!!!!!
Abraham Hermosillo (verified owner) –
Thunder, in short, will make your dick hard af. There is no denying the potency of this product. My girlfriend has thanked me time and time again in her bursts of laughter and joy after making love. This will definitely make you juiced up.
The blood flow is amazing. This aids in other aspects outside of your new and improved rod. I’ve noticed my circulation is through the roof. Even just laying in bed and feeling my blood flow through all parts of my body is such a relaxing, enjoyable, and even meditative practice.
I feel amazing taking this in conjunction with pine pollen and other products such as shilajit. I feel as though my masculinity thrives while taking these supplements and my health has improved drastically since taking the blends consistently
Anoop (verified owner) –
Wow what can I say, I feel like Zeus himself! This blend has honestly changed my life in all aspects, (mentally physically and emotionally)whenever I take it I feel energised and ready to take on the world !
I went from only being able to achieve climax once and being done for the whole day to being ready to go straight away once again, its honestly amazing how this has boosted my confidence and makes me perform perfectly with the ladies 😉
Thank you Gavin for recommending this miracle blend, I take this religiously 2 times a day and it works wonders !
Cameron Thomas –
As a young man Thunder is just an awesome supplement to have, the benefits are obvious if you’ve read the name of the blend but I honestly didn’t expect it to work as well as it did…
I only ordered the sample size when I bought other blends just to see what happened and I was actually amazed with my performance after taking it — it’s not an area of life I’ve ever struggled with anyway but the comparative difference is incredible…
I’m not sure who was more impressed between me or the girls who experienced me taking it :’)
This is a MUST HAVE for men of any age!!! Big shoutout to Gavin for making this absolute beauty of a blend!!!
Anh Duc Nguyen –
I started with Interstellar back in 2020 and I can never look back, as the benefits it has provided me are an excellent value for money. At first I was skeptical because of the price, but please trust me there are no regrets!
Below are the products that I have been taking and it’s health benefits to me.
– Trinity- will give you a sense of calmness, stillness, and relaxed state of mind. If you’re short tempered like me then you start to become more cool, things stop bothering you.
– Seven Sages – from all the food you eat, your environment, the people you surround yourself with, the media. It creates a negative thinking on you at times without you noticing, you wake up at times with a negative outlook on life. But Seven Sages clears all of this. You take it and you just feel absolutely blessed, no negativeness.
– Nebula the confidence giver. This has particular helped me overcome myself, I do boxing and with Nebula lets just say I punch a lot more back! In the gym, the last rep that I struggle with: Nebula helps me get it.
– Alderstone this specifically helps me within the gym, my muscle mass and testosterone level increase dramatically with this.
– Thunder helps me with my sex life, I was suffering from premature ejaculation and low libido. This boosts me way back up. Its also the greatest aphrodisiac, you don’t have to wait so long for your next round!
– Pine Pollen at first its a bit to drink this as its clumpy but if you’re about your health then mind over matter 🙂. This help improve my skin so much, smoother!
All in all, each condition you are facing Intestellar will have a solution. Especially Gavin, I message him on facebook for any queries and he points me in the correct direction. Can’t thank him enough.
Everyone tends to fast with these blends but to be honest, I don’t. But I still reap the benefits (of course if I fast it will be more) so don’t worry if you can’t fast. As long as you take them.
Best
Christian Lyons (verified owner) –
I first purchased Thunder as a sample and I liked it so much I bought the standard size of it. This blend combined with following the fasting protocol (VERY IMPORTANT!) will cure any symptoms of erectile dysfunction. You’ll feel “full”, you’ll have an abundance of stamina, but more importantly, you’ll leave a lasting impression. Even if you’re someone who does not suffer symptoms from ED, but rather just looking to enhance their game; it’s a must have blend to have in your arsenal !!
Matthew W –
“I spent 9 years in pain searching for how to get back to going after what I really wanted. Finally after taking blends for a few months, I’m completely back to it. You don’t want to know the number of issues I was having from hiding from my dreams but all of them are solved. Depression, anxiety, muddled and cloudy thinking, emotional pain. I was really praying hard for something to help me. Finally found it.
Luteolin helped me think normally again.
Trinity allowed and eased my nervous system to work out the trauma.
Spaceborn put my mind and body in a higher place.
Seven Sages allowed me to see subtleties in what was going on with me.
Autonomous let my mind be unencumbered when understanding.
Rewire eased the process of changing habits.
Supernova gave me that kick to keep working through it.
Matcha let me focus in a relaxed state.
Stomach reset really seemed to remove a lot of issues automatically, like a fresh slate with how emotions, brain, and gut are connected.
Thunder is making me less controllable and under others’ influence. Big D energy.
The others are just as powerful.
Not to mention fasting making me push through it without physical distraction and coffee to keep me energized. Never would drink coffee before now it’s the best part of my day. I did combine it also with a healing technique called NET but I doubt it’s necessary unless you’re as fucked up as I was lol.
Blends are it man. Buy them.”
Ivonne Bohorquez –
Wow, I’m 35 years old and noticed my erections were not as prominent as they once were. I have always been hesitant to buy herbal formulas that claim to work for male libido and sexual drive. However, after an initial reviewing the ingredients in Thunder, I was confident to try out this formula. I haven’t tried other sexual potency formulas since I feared they would increase my existing heart palpitations and anxious tendencies. I have also never tried viagra since I think that’s bad for your heart over the longterm and like I’ve mentioned in previous reviews, I always prioritize my heart health.
My girlfriend (who also now takes these blends on a regular basis) was very pleased with the results. Harder and bigger erections which gave me extra confidence in the bedroom and a light feeling of euphoria. Thunder is a must have for any men looking to improve sexual performance and impress their partner. To reiterate, I did not have to worry about this blend giving me any increased heart palpitations or anxiety.
Thunder is now one of my favorite blends for all the reasons listed and I also think it has increased my testosterone in a very natural way and added enduring energy to my gym workouts (a huge benefit for any man over the age of 30.)
This blend will boost your performance as a man not only in the bedroom but in life overall. Rest assured if you have any doubts or anxiety about trying a blend like this, you will not be disappointed. 100% exceeded my expectations!!!